id	sid	tid	token	lemma	pos
dpc-4095	1	1	dermatology	dermatology	NOUN
dpc-4095	1	2	:	:	PUNCT
dpc-4095	1	3	practical	practical	ADJ
dpc-4095	1	4	and	and	CCONJ
dpc-4095	1	5	conceptual	conceptual	ADJ
dpc-4095	1	6	original	original	ADJ
dpc-4095	1	7	article	article	NOUN
dpc-4095	1	8	|	|	ADV
dpc-4095	1	9	dermatol	dermatol	ADJ
dpc-4095	1	10	pract	pract	NOUN
dpc-4095	1	11	concept	concept	NOUN
dpc-4095	1	12	.	.	PUNCT
dpc-4095	2	1	2024;14(3):e2024170	2024;14(3):e2024170	NUM
dpc-4095	2	2	1	1	NUM
dpc-4095	2	3	the	the	DET
dpc-4095	2	4	difference	difference	NOUN
dpc-4095	2	5	between	between	ADP
dpc-4095	2	6	sars	sar	NOUN
dpc-4095	2	7	-	-	PUNCT
dpc-4095	2	8	cov-2	cov-2	NOUN
dpc-4095	2	9	associated	associate	VERB
dpc-4095	2	10	telogen	telogen	NOUN
dpc-4095	2	11	effluvium	effluvium	NOUN
dpc-4095	2	12	and	and	CCONJ
dpc-4095	2	13	telogen	telogen	NOUN
dpc-4095	2	14	effluvium	effluvium	NOUN
dpc-4095	2	15	due	due	ADP
dpc-4095	2	16	to	to	ADP
dpc-4095	2	17	other	other	ADJ
dpc-4095	2	18	causes	cause	NOUN
dpc-4095	2	19	didem	didem	PROPN
dpc-4095	2	20	kazan1,2	kazan1,2	PROPN
dpc-4095	2	21	,	,	PUNCT
dpc-4095	2	22	defne	defne	NOUN
dpc-4095	2	23	özkoca3	özkoca3	PROPN
dpc-4095	2	24	,	,	PUNCT
dpc-4095	2	25	nazlı	nazlı	VERB
dpc-4095	2	26	dizen	dizen	ADJ
dpc-4095	2	27	namdar1	namdar1	PROPN
dpc-4095	2	28	1	1	NUM
dpc-4095	2	29	kutahya	kutahya	NOUN
dpc-4095	2	30	health	health	NOUN
dpc-4095	2	31	science	science	PROPN
dpc-4095	2	32	university	university	PROPN
dpc-4095	2	33	,	,	PUNCT
dpc-4095	2	34	evliya	evliya	NOUN
dpc-4095	2	35	celebi	celebi	NOUN
dpc-4095	2	36	training	training	NOUN
dpc-4095	2	37	and	and	CCONJ
dpc-4095	2	38	research	research	NOUN
dpc-4095	2	39	hospital	hospital	NOUN
dpc-4095	2	40	,	,	PUNCT
dpc-4095	2	41	dermatology	dermatology	NOUN
dpc-4095	2	42	and	and	CCONJ
dpc-4095	2	43	venerology	venerology	NOUN
dpc-4095	2	44	clinic	clinic	NOUN
dpc-4095	2	45	,	,	PUNCT
dpc-4095	2	46	kutahya	kutahya	PROPN
dpc-4095	2	47	,	,	PUNCT
dpc-4095	2	48	turkey	turkey	PROPN
dpc-4095	2	49	2	2	NUM
dpc-4095	2	50	istanbul	istanbul	PROPN
dpc-4095	2	51	arel	arel	PROPN
dpc-4095	2	52	university	university	PROPN
dpc-4095	2	53	,	,	PUNCT
dpc-4095	2	54	department	department	NOUN
dpc-4095	2	55	of	of	ADP
dpc-4095	2	56	dermatology	dermatology	NOUN
dpc-4095	2	57	and	and	CCONJ
dpc-4095	2	58	venerology	venerology	NOUN
dpc-4095	2	59	,	,	PUNCT
dpc-4095	2	60	istanbul	istanbul	PROPN
dpc-4095	2	61	,	,	PUNCT
dpc-4095	2	62	turkey	turkey	PROPN
dpc-4095	2	63	3	3	NUM
dpc-4095	2	64	zonguldak	zonguldak	PROPN
dpc-4095	2	65	atatürk	atatürk	NOUN
dpc-4095	2	66	state	state	PROPN
dpc-4095	2	67	hospital	hospital	NOUN
dpc-4095	2	68	,	,	PUNCT
dpc-4095	2	69	dermatology	dermatology	NOUN
dpc-4095	2	70	and	and	CCONJ
dpc-4095	2	71	venerology	venerology	NOUN
dpc-4095	2	72	clinic	clinic	PROPN
dpc-4095	2	73	,	,	PUNCT
dpc-4095	2	74	zonguldak	zonguldak	PROPN
dpc-4095	2	75	,	,	PUNCT
dpc-4095	2	76	turkey	turkey	NOUN
dpc-4095	2	77	key	key	ADJ
dpc-4095	2	78	words	word	NOUN
dpc-4095	2	79	:	:	PUNCT
dpc-4095	2	80	telogen	telogen	NOUN
dpc-4095	2	81	efflivium	efflivium	NOUN
dpc-4095	2	82	,	,	PUNCT
dpc-4095	2	83	dermoscopy	dermoscopy	NOUN
dpc-4095	2	84	,	,	PUNCT
dpc-4095	2	85	trichoscopy	trichoscopy	NOUN
dpc-4095	2	86	,	,	PUNCT
dpc-4095	2	87	sars	sar	NOUN
dpc-4095	2	88	-	-	PUNCT
dpc-4095	2	89	cov-2	cov-2	PART
dpc-4095	2	90	citation	citation	NOUN
dpc-4095	2	91	:	:	PUNCT
dpc-4095	3	1	kazan	kazan	PROPN
dpc-4095	3	2	d	d	PROPN
dpc-4095	3	3	,	,	PUNCT
dpc-4095	3	4	özkoca	özkoca	NOUN
dpc-4095	3	5	d	d	NOUN
dpc-4095	3	6	,	,	PUNCT
dpc-4095	3	7	dizen	dizen	PRON
dpc-4095	3	8	namdar	namdar	NOUN
dpc-4095	3	9	n.	n.	NOUN
dpc-4095	3	10	the	the	DET
dpc-4095	3	11	difference	difference	NOUN
dpc-4095	3	12	between	between	ADP
dpc-4095	3	13	sars	sar	NOUN
dpc-4095	3	14	-	-	PUNCT
dpc-4095	3	15	cov-2	cov-2	NOUN
dpc-4095	3	16	associated	associate	VERB
dpc-4095	3	17	telogen	telogen	NOUN
dpc-4095	3	18	effluvium	effluvium	NOUN
dpc-4095	3	19	and	and	CCONJ
dpc-4095	3	20	telogen	telogen	NOUN
dpc-4095	3	21	effluvium	effluvium	NOUN
dpc-4095	3	22	due	due	ADP
dpc-4095	3	23	to	to	ADP
dpc-4095	3	24	other	other	ADJ
dpc-4095	3	25	causes	cause	NOUN
dpc-4095	3	26	.	.	PUNCT
dpc-4095	4	1	dermatol	dermatol	NOUN
dpc-4095	4	2	pract	pract	PROPN
dpc-4095	4	3	concept	concept	NOUN
dpc-4095	4	4	.	.	PUNCT
dpc-4095	5	1	2024;14(3):e2024170	2024;14(3):e2024170	X
dpc-4095	5	2	.	.	PUNCT
dpc-4095	5	3	doi	doi	PROPN
dpc-4095	5	4	:	:	PUNCT
dpc-4095	5	5	https://doi.org/10.5826/dpc.1403a170	https://doi.org/10.5826/dpc.1403a170	PROPN
dpc-4095	5	6	accepted	accept	VERB
dpc-4095	5	7	:	:	PUNCT
dpc-4095	5	8	march	march	PROPN
dpc-4095	5	9	13	13	NUM
dpc-4095	5	10	,	,	PUNCT
dpc-4095	5	11	2024	2024	NUM
dpc-4095	5	12	;	;	PUNCT
dpc-4095	5	13	published	publish	VERB
dpc-4095	5	14	:	:	PUNCT
dpc-4095	6	1	july	july	PROPN
dpc-4095	6	2	2024	2024	NUM
dpc-4095	6	3	copyright	copyright	NOUN
dpc-4095	6	4	:	:	PUNCT
dpc-4095	6	5	©	©	PROPN
dpc-4095	6	6	2024	2024	NUM
dpc-4095	6	7	kazan	kazan	PROPN
dpc-4095	6	8	et	et	PROPN
dpc-4095	6	9	al	al	PROPN
dpc-4095	6	10	.	.	PUNCT
dpc-4095	7	1	this	this	PRON
dpc-4095	7	2	is	be	AUX
dpc-4095	7	3	an	an	DET
dpc-4095	7	4	open	open	ADJ
dpc-4095	7	5	-	-	PUNCT
dpc-4095	7	6	access	access	NOUN
dpc-4095	7	7	article	article	NOUN
dpc-4095	7	8	distributed	distribute	VERB
dpc-4095	7	9	under	under	ADP
dpc-4095	7	10	the	the	DET
dpc-4095	7	11	terms	term	NOUN
dpc-4095	7	12	of	of	ADP
dpc-4095	7	13	the	the	DET
dpc-4095	7	14	creative	creative	ADJ
dpc-4095	7	15	commons	common	NOUN
dpc-4095	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-4095	7	17	license	license	NOUN
dpc-4095	7	18	(	(	PUNCT
dpc-4095	7	19	by	by	ADP
dpc-4095	7	20	-	-	PUNCT
dpc-4095	7	21	nc-4.0	nc-4.0	NOUN
dpc-4095	7	22	)	)	PUNCT
dpc-4095	7	23	,	,	PUNCT
dpc-4095	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-4095	7	25	,	,	PUNCT
dpc-4095	7	26	which	which	PRON
dpc-4095	7	27	permits	permit	VERB
dpc-4095	7	28	unrestricted	unrestricted	ADJ
dpc-4095	7	29	noncommercial	noncommercial	ADJ
dpc-4095	7	30	use	use	NOUN
dpc-4095	7	31	,	,	PUNCT
dpc-4095	7	32	distribution	distribution	NOUN
dpc-4095	7	33	,	,	PUNCT
dpc-4095	7	34	and	and	CCONJ
dpc-4095	7	35	reproduction	reproduction	NOUN
dpc-4095	7	36	in	in	ADP
dpc-4095	7	37	any	any	DET
dpc-4095	7	38	medium	medium	NOUN
dpc-4095	7	39	,	,	PUNCT
dpc-4095	7	40	provided	provide	VERB
dpc-4095	7	41	the	the	DET
dpc-4095	7	42	original	original	ADJ
dpc-4095	7	43	authors	author	NOUN
dpc-4095	7	44	and	and	CCONJ
dpc-4095	7	45	source	source	NOUN
dpc-4095	7	46	are	be	AUX
dpc-4095	7	47	credited	credit	VERB
dpc-4095	7	48	.	.	PUNCT
dpc-4095	8	1	funding	funding	NOUN
dpc-4095	8	2	:	:	PUNCT
dpc-4095	8	3	none	none	NOUN
dpc-4095	8	4	.	.	PUNCT
dpc-4095	9	1	competing	compete	VERB
dpc-4095	9	2	interests	interest	NOUN
dpc-4095	9	3	:	:	PUNCT
dpc-4095	9	4	none	none	NOUN
dpc-4095	9	5	.	.	PUNCT
dpc-4095	10	1	authorship	authorship	NOUN
dpc-4095	10	2	:	:	PUNCT
dpc-4095	10	3	all	all	DET
dpc-4095	10	4	authors	author	NOUN
dpc-4095	10	5	have	have	AUX
dpc-4095	10	6	contributed	contribute	VERB
dpc-4095	10	7	significantly	significantly	ADV
dpc-4095	10	8	to	to	ADP
dpc-4095	10	9	this	this	DET
dpc-4095	10	10	publication	publication	NOUN
dpc-4095	10	11	.	.	PUNCT
dpc-4095	11	1	corresponding	correspond	VERB
dpc-4095	11	2	author	author	NOUN
dpc-4095	11	3	:	:	PUNCT
dpc-4095	11	4	didem	didem	PROPN
dpc-4095	11	5	kazan	kazan	PROPN
dpc-4095	11	6	,	,	PUNCT
dpc-4095	11	7	kutahya	kutahya	PROPN
dpc-4095	11	8	health	health	PROPN
dpc-4095	11	9	science	science	PROPN
dpc-4095	11	10	university	university	PROPN
dpc-4095	11	11	,	,	PUNCT
dpc-4095	11	12	evliya	evliya	NOUN
dpc-4095	11	13	celebi	celebi	NOUN
dpc-4095	11	14	training	training	NOUN
dpc-4095	11	15	and	and	CCONJ
dpc-4095	11	16	research	research	NOUN
dpc-4095	11	17	hospital	hospital	NOUN
dpc-4095	11	18	,	,	PUNCT
dpc-4095	11	19	dermatology	dermatology	NOUN
dpc-4095	11	20	and	and	CCONJ
dpc-4095	11	21	venerology	venerology	NOUN
dpc-4095	11	22	clinic	clinic	PROPN
dpc-4095	11	23	,	,	PUNCT
dpc-4095	11	24	kütahya	kütahya	PROPN
dpc-4095	11	25	;	;	PUNCT
dpc-4095	11	26	istanbul	istanbul	PROPN
dpc-4095	11	27	arel	arel	PROPN
dpc-4095	11	28	university	university	PROPN
dpc-4095	11	29	,	,	PUNCT
dpc-4095	11	30	department	department	NOUN
dpc-4095	11	31	of	of	ADP
dpc-4095	11	32	dermatology	dermatology	NOUN
dpc-4095	11	33	and	and	CCONJ
dpc-4095	11	34	venerology	venerology	NOUN
dpc-4095	11	35	,	,	PUNCT
dpc-4095	11	36	istanbul	istanbul	PROPN
dpc-4095	11	37	,	,	PUNCT
dpc-4095	11	38	turkey	turkey	PROPN
dpc-4095	11	39	.	.	PUNCT
dpc-4095	12	1	bussiness	bussiness	PROPN
dpc-4095	12	2	tel	tel	PROPN
dpc-4095	12	3	:	:	PUNCT
dpc-4095	12	4	+902742236053	+902742236053	NUM
dpc-4095	12	5	,	,	PUNCT
dpc-4095	12	6	e	e	NOUN
dpc-4095	12	7	-	-	NOUN
dpc-4095	12	8	mail	mail	NOUN
dpc-4095	12	9	:	:	PUNCT
dpc-4095	12	10	didem.senses_343@hotmail.com	didem.senses_343@hotmail.com	PROPN
dpc-4095	12	11	introduction	introduction	NOUN
dpc-4095	12	12	:	:	PUNCT
dpc-4095	12	13	telogen	telogen	NOUN
dpc-4095	12	14	effluvium	effluvium	NOUN
dpc-4095	12	15	(	(	PUNCT
dpc-4095	12	16	te	te	PROPN
dpc-4095	12	17	)	)	PUNCT
dpc-4095	12	18	is	be	AUX
dpc-4095	12	19	a	a	DET
dpc-4095	12	20	common	common	ADJ
dpc-4095	12	21	type	type	NOUN
dpc-4095	12	22	of	of	ADP
dpc-4095	12	23	non	non	ADJ
dpc-4095	12	24	-	-	ADJ
dpc-4095	12	25	cicatricial	cicatricial	ADJ
dpc-4095	12	26	alopecia	alopecia	NOUN
dpc-4095	12	27	,	,	PUNCT
dpc-4095	12	28	and	and	CCONJ
dpc-4095	12	29	it	it	PRON
dpc-4095	12	30	is	be	AUX
dpc-4095	12	31	reported	report	VERB
dpc-4095	12	32	frequently	frequently	ADV
dpc-4095	12	33	in	in	ADP
dpc-4095	12	34	patients	patient	NOUN
dpc-4095	12	35	with	with	ADP
dpc-4095	12	36	sars	sar	NOUN
dpc-4095	12	37	-	-	PUNCT
dpc-4095	12	38	cov-2	cov-2	PART
dpc-4095	12	39	infection	infection	NOUN
dpc-4095	12	40	.	.	PUNCT
dpc-4095	13	1	objectives	objective	NOUN
dpc-4095	13	2	:	:	PUNCT
dpc-4095	13	3	herein	herein	NOUN
dpc-4095	13	4	,	,	PUNCT
dpc-4095	13	5	we	we	PRON
dpc-4095	13	6	aimed	aim	VERB
dpc-4095	13	7	to	to	PART
dpc-4095	13	8	examine	examine	VERB
dpc-4095	13	9	the	the	DET
dpc-4095	13	10	demographic	demographic	ADJ
dpc-4095	13	11	,	,	PUNCT
dpc-4095	13	12	dermoscopic	dermoscopic	NOUN
dpc-4095	13	13	,	,	PUNCT
dpc-4095	13	14	and	and	CCONJ
dpc-4095	13	15	laboratory	laboratory	NOUN
dpc-4095	13	16	features	feature	NOUN
dpc-4095	13	17	of	of	ADP
dpc-4095	13	18	the	the	DET
dpc-4095	13	19	patients	patient	NOUN
dpc-4095	13	20	with	with	ADP
dpc-4095	13	21	sars	sar	NOUN
dpc-4095	13	22	-	-	PUNCT
dpc-4095	13	23	cov-2	cov-2	NOUN
dpc-4095	13	24	associated	associate	VERB
dpc-4095	13	25	te	te	PROPN
dpc-4095	13	26	(	(	PUNCT
dpc-4095	13	27	cate	cate	PROPN
dpc-4095	13	28	)	)	PUNCT
dpc-4095	13	29	and	and	CCONJ
dpc-4095	13	30	compare	compare	VERB
dpc-4095	13	31	them	they	PRON
dpc-4095	13	32	with	with	ADP
dpc-4095	13	33	te	te	PROPN
dpc-4095	13	34	due	due	ADP
dpc-4095	13	35	to	to	ADP
dpc-4095	13	36	other	other	ADJ
dpc-4095	13	37	causes	cause	NOUN
dpc-4095	13	38	(	(	PUNCT
dpc-4095	13	39	tedoc	tedoc	NOUN
dpc-4095	13	40	)	)	PUNCT
dpc-4095	13	41	according	accord	VERB
dpc-4095	13	42	to	to	ADP
dpc-4095	13	43	these	these	DET
dpc-4095	13	44	features	feature	NOUN
dpc-4095	13	45	.	.	PUNCT
dpc-4095	14	1	methods	method	NOUN
dpc-4095	14	2	:	:	PUNCT
dpc-4095	14	3	in	in	ADP
dpc-4095	14	4	this	this	DET
dpc-4095	14	5	retrospective	retrospective	ADJ
dpc-4095	14	6	case	case	NOUN
dpc-4095	14	7	-	-	PUNCT
dpc-4095	14	8	control	control	NOUN
dpc-4095	14	9	study	study	NOUN
dpc-4095	14	10	we	we	PRON
dpc-4095	14	11	evaluated	evaluate	VERB
dpc-4095	14	12	the	the	DET
dpc-4095	14	13	patients	patient	NOUN
dpc-4095	14	14	who	who	PRON
dpc-4095	14	15	were	be	AUX
dpc-4095	14	16	diagnosed	diagnose	VERB
dpc-4095	14	17	with	with	ADP
dpc-4095	14	18	te	te	PROPN
dpc-4095	14	19	and	and	CCONJ
dpc-4095	14	20	were	be	AUX
dpc-4095	14	21	above	above	ADP
dpc-4095	14	22	18	18	NUM
dpc-4095	14	23	years	year	NOUN
dpc-4095	14	24	of	of	ADP
dpc-4095	14	25	age	age	NOUN
dpc-4095	14	26	between	between	ADP
dpc-4095	14	27	april	april	PROPN
dpc-4095	14	28	and	and	CCONJ
dpc-4095	14	29	june	june	PROPN
dpc-4095	14	30	2022	2022	NUM
dpc-4095	14	31	.	.	PUNCT
dpc-4095	15	1	the	the	DET
dpc-4095	15	2	patients	patient	NOUN
dpc-4095	15	3	were	be	AUX
dpc-4095	15	4	divided	divide	VERB
dpc-4095	15	5	into	into	ADP
dpc-4095	15	6	two	two	NUM
dpc-4095	15	7	groups	group	NOUN
dpc-4095	15	8	based	base	VERB
dpc-4095	15	9	on	on	ADP
dpc-4095	15	10	their	their	PRON
dpc-4095	15	11	medical	medical	ADJ
dpc-4095	15	12	history	history	NOUN
dpc-4095	15	13	and	and	CCONJ
dpc-4095	15	14	sars	sar	NOUN
dpc-4095	15	15	-	-	PUNCT
dpc-4095	15	16	cov-2	cov-2	NOUN
dpc-4095	15	17	pcr	pcr	NOUN
dpc-4095	15	18	positivity	positivity	NOUN
dpc-4095	15	19	.	.	PUNCT
dpc-4095	16	1	the	the	DET
dpc-4095	16	2	first	first	ADJ
dpc-4095	16	3	group	group	NOUN
dpc-4095	16	4	included	include	VERB
dpc-4095	16	5	patients	patient	NOUN
dpc-4095	16	6	with	with	ADP
dpc-4095	16	7	cate	cate	NOUN
dpc-4095	16	8	and	and	CCONJ
dpc-4095	16	9	positive	positive	ADJ
dpc-4095	16	10	sars	sar	NOUN
dpc-4095	16	11	-	-	PUNCT
dpc-4095	16	12	cov-2	cov-2	NOUN
dpc-4095	16	13	pcr	pcr	ADJ
dpc-4095	16	14	test	test	NOUN
dpc-4095	16	15	results	result	NOUN
dpc-4095	16	16	in	in	ADP
dpc-4095	16	17	the	the	DET
dpc-4095	16	18	last	last	ADJ
dpc-4095	16	19	3	3	NUM
dpc-4095	16	20	months	month	NOUN
dpc-4095	16	21	.	.	PUNCT
dpc-4095	17	1	the	the	DET
dpc-4095	17	2	second	second	ADJ
dpc-4095	17	3	group	group	NOUN
dpc-4095	17	4	consisted	consist	VERB
dpc-4095	17	5	of	of	ADP
dpc-4095	17	6	patients	patient	NOUN
dpc-4095	17	7	with	with	ADP
dpc-4095	17	8	tedoc	tedoc	NOUN
dpc-4095	17	9	.	.	PUNCT
dpc-4095	18	1	patients	patient	NOUN
dpc-4095	18	2	gender	gender	NOUN
dpc-4095	18	3	,	,	PUNCT
dpc-4095	18	4	age	age	NOUN
dpc-4095	18	5	,	,	PUNCT
dpc-4095	18	6	disease	disease	NOUN
dpc-4095	18	7	duration	duration	NOUN
dpc-4095	18	8	,	,	PUNCT
dpc-4095	18	9	additional	additional	ADJ
dpc-4095	18	10	systemic	systemic	ADJ
dpc-4095	18	11	disease	disease	NOUN
dpc-4095	18	12	,	,	PUNCT
dpc-4095	18	13	dermoscopic	dermoscopic	NOUN
dpc-4095	18	14	findings	finding	NOUN
dpc-4095	18	15	,	,	PUNCT
dpc-4095	18	16	and	and	CCONJ
dpc-4095	18	17	laboratory	laboratory	NOUN
dpc-4095	18	18	results	result	NOUN
dpc-4095	18	19	were	be	AUX
dpc-4095	18	20	recorded	record	VERB
dpc-4095	18	21	.	.	PUNCT
dpc-4095	19	1	results	result	NOUN
dpc-4095	19	2	:	:	PUNCT
dpc-4095	19	3	a	a	DET
dpc-4095	19	4	total	total	NOUN
dpc-4095	19	5	of	of	ADP
dpc-4095	19	6	92	92	NUM
dpc-4095	19	7	patients	patient	NOUN
dpc-4095	19	8	,	,	PUNCT
dpc-4095	19	9	86	86	NUM
dpc-4095	19	10	(	(	PUNCT
dpc-4095	19	11	93.5	93.5	NUM
dpc-4095	19	12	%	%	NOUN
dpc-4095	19	13	)	)	PUNCT
dpc-4095	19	14	females	female	NOUN
dpc-4095	19	15	,	,	PUNCT
dpc-4095	19	16	and	and	CCONJ
dpc-4095	19	17	6	6	NUM
dpc-4095	19	18	(	(	PUNCT
dpc-4095	19	19	6.5	6.5	NUM
dpc-4095	19	20	%	%	NOUN
dpc-4095	19	21	)	)	PUNCT
dpc-4095	19	22	males	male	NOUN
dpc-4095	19	23	,	,	PUNCT
dpc-4095	19	24	were	be	AUX
dpc-4095	19	25	included	include	VERB
dpc-4095	19	26	in	in	ADP
dpc-4095	19	27	the	the	DET
dpc-4095	19	28	study	study	NOUN
dpc-4095	19	29	.	.	PUNCT
dpc-4095	20	1	cate	cate	PROPN
dpc-4095	20	2	was	be	AUX
dpc-4095	20	3	detected	detect	VERB
dpc-4095	20	4	in	in	ADP
dpc-4095	20	5	52	52	NUM
dpc-4095	20	6	(	(	PUNCT
dpc-4095	20	7	56.5	56.5	NUM
dpc-4095	20	8	%	%	NOUN
dpc-4095	20	9	)	)	PUNCT
dpc-4095	20	10	patients	patient	NOUN
dpc-4095	20	11	whereas	whereas	SCONJ
dpc-4095	20	12	40	40	NUM
dpc-4095	20	13	(	(	PUNCT
dpc-4095	20	14	44.5	44.5	NUM
dpc-4095	20	15	%	%	NOUN
dpc-4095	20	16	)	)	PUNCT
dpc-4095	20	17	patients	patient	NOUN
dpc-4095	20	18	had	have	VERB
dpc-4095	20	19	tedoc	tedoc	ADJ
dpc-4095	20	20	.	.	PUNCT
dpc-4095	21	1	the	the	DET
dpc-4095	21	2	mean	mean	ADJ
dpc-4095	21	3	time	time	NOUN
dpc-4095	21	4	between	between	ADP
dpc-4095	21	5	the	the	DET
dpc-4095	21	6	onset	onset	NOUN
dpc-4095	21	7	of	of	ADP
dpc-4095	21	8	sars	sar	NOUN
dpc-4095	21	9	-	-	PUNCT
dpc-4095	21	10	cov-2	cov-2	PART
dpc-4095	21	11	infection	infection	NOUN
dpc-4095	21	12	and	and	CCONJ
dpc-4095	21	13	hair	hair	NOUN
dpc-4095	21	14	loss	loss	NOUN
dpc-4095	21	15	complaint	complaint	NOUN
dpc-4095	21	16	was	be	AUX
dpc-4095	21	17	calculated	calculate	VERB
dpc-4095	21	18	as	as	ADP
dpc-4095	21	19	64.8	64.8	NUM
dpc-4095	21	20	+	+	NUM
dpc-4095	21	21	25.6	25.6	NUM
dpc-4095	21	22	days	day	NOUN
dpc-4095	21	23	,	,	PUNCT
dpc-4095	21	24	and	and	CCONJ
dpc-4095	21	25	this	this	DET
dpc-4095	21	26	time	time	NOUN
dpc-4095	21	27	was	be	AUX
dpc-4095	21	28	significantly	significantly	ADV
dpc-4095	21	29	shorter	short	ADJ
dpc-4095	21	30	than	than	ADP
dpc-4095	21	31	patients	patient	NOUN
dpc-4095	21	32	with	with	ADP
dpc-4095	21	33	tedoc	tedoc	NOUN
dpc-4095	21	34	(	(	PUNCT
dpc-4095	21	35	p	p	X
dpc-4095	21	36	=	=	NOUN
dpc-4095	21	37	0.003	0.003	NUM
dpc-4095	21	38	)	)	PUNCT
dpc-4095	21	39	.	.	PUNCT
dpc-4095	22	1	the	the	DET
dpc-4095	22	2	dermoscopic	dermoscopic	ADJ
dpc-4095	22	3	evaluation	evaluation	NOUN
dpc-4095	22	4	showed	show	VERB
dpc-4095	22	5	that	that	SCONJ
dpc-4095	22	6	empty	empty	ADJ
dpc-4095	22	7	follicular	follicular	ADJ
dpc-4095	22	8	openings	opening	NOUN
dpc-4095	22	9	and	and	CCONJ
dpc-4095	22	10	yellow	yellow	ADJ
dpc-4095	22	11	dots	dot	NOUN
dpc-4095	22	12	were	be	AUX
dpc-4095	22	13	statistically	statistically	ADV
dpc-4095	22	14	higher	high	ADJ
dpc-4095	22	15	in	in	ADP
dpc-4095	22	16	patients	patient	NOUN
dpc-4095	22	17	with	with	ADP
dpc-4095	22	18	cate	cate	NOUN
dpc-4095	22	19	,	,	PUNCT
dpc-4095	22	20	whereas	whereas	SCONJ
dpc-4095	22	21	short	short	ADJ
dpc-4095	22	22	regrowing	regrowing	NOUN
dpc-4095	22	23	hair	hair	NOUN
dpc-4095	22	24	were	be	AUX
dpc-4095	22	25	markedly	markedly	ADV
dpc-4095	22	26	higher	high	ADJ
dpc-4095	22	27	in	in	ADP
dpc-4095	22	28	patients	patient	NOUN
dpc-4095	22	29	with	with	ADP
dpc-4095	22	30	tedoc	tedoc	NOUN
dpc-4095	22	31	(	(	PUNCT
dpc-4095	22	32	p	p	NOUN
dpc-4095	22	33	=	=	NOUN
dpc-4095	22	34	0.001	0.001	NUM
dpc-4095	22	35	,	,	PUNCT
dpc-4095	22	36	p	p	NOUN
dpc-4095	22	37	=	=	NOUN
dpc-4095	22	38	0.001	0.001	NUM
dpc-4095	22	39	,	,	PUNCT
dpc-4095	22	40	and	and	CCONJ
dpc-4095	22	41	p	p	NOUN
dpc-4095	22	42	=	=	NOUN
dpc-4095	22	43	0.001	0.001	NUM
dpc-4095	22	44	,	,	PUNCT
dpc-4095	22	45	respectively	respectively	ADV
dpc-4095	22	46	)	)	PUNCT
dpc-4095	22	47	conclusions	conclusion	NOUN
dpc-4095	22	48	:	:	PUNCT
dpc-4095	22	49	cate	cate	PROPN
dpc-4095	22	50	is	be	AUX
dpc-4095	22	51	characterized	characterize	VERB
dpc-4095	22	52	by	by	ADP
dpc-4095	22	53	excessive	excessive	ADJ
dpc-4095	22	54	hair	hair	NOUN
dpc-4095	22	55	-	-	PUNCT
dpc-4095	22	56	shedding	shedding	NOUN
dpc-4095	22	57	that	that	PRON
dpc-4095	22	58	begins	begin	VERB
dpc-4095	22	59	sooner	soon	ADV
dpc-4095	22	60	after	after	ADP
dpc-4095	22	61	infection	infection	NOUN
dpc-4095	22	62	than	than	ADP
dpc-4095	22	63	classic	classic	ADJ
dpc-4095	22	64	te	te	PROPN
dpc-4095	22	65	.	.	PUNCT
dpc-4095	22	66	dermoscopic	dermoscopic	PROPN
dpc-4095	22	67	findings	finding	NOUN
dpc-4095	22	68	can	can	AUX
dpc-4095	22	69	assist	assist	VERB
dpc-4095	22	70	clinicians	clinician	NOUN
dpc-4095	22	71	in	in	ADP
dpc-4095	22	72	diagnosis	diagnosis	NOUN
dpc-4095	22	73	.	.	PUNCT
dpc-4095	23	1	abstract	abstract	ADJ
dpc-4095	23	2	2	2	NUM
dpc-4095	23	3	original	original	ADJ
dpc-4095	23	4	article|	article|	NOUN
dpc-4095	23	5	dermatol	dermatol	ADJ
dpc-4095	23	6	pract	pract	PROPN
dpc-4095	23	7	concept	concept	NOUN
dpc-4095	23	8	.	.	PUNCT
dpc-4095	24	1	2024;14(3):e2024170	2024;14(3):e2024170	NUM
dpc-4095	24	2	introduction	introduction	NOUN
dpc-4095	24	3	telogen	telogen	NOUN
dpc-4095	24	4	effluvium	effluvium	NOUN
dpc-4095	24	5	(	(	PUNCT
dpc-4095	24	6	te	te	PROPN
dpc-4095	24	7	)	)	PUNCT
dpc-4095	24	8	is	be	AUX
dpc-4095	24	9	a	a	DET
dpc-4095	24	10	type	type	NOUN
dpc-4095	24	11	of	of	ADP
dpc-4095	24	12	diffuse	diffuse	ADJ
dpc-4095	24	13	non	non	ADJ
dpc-4095	24	14	-	-	ADJ
dpc-4095	24	15	cicatricial	cicatricial	ADJ
dpc-4095	24	16	alopecia	alopecia	NOUN
dpc-4095	24	17	that	that	PRON
dpc-4095	24	18	develops	develop	VERB
dpc-4095	24	19	as	as	ADP
dpc-4095	24	20	a	a	DET
dpc-4095	24	21	result	result	NOUN
dpc-4095	24	22	of	of	ADP
dpc-4095	24	23	a	a	DET
dpc-4095	24	24	disturbance	disturbance	NOUN
dpc-4095	24	25	in	in	ADP
dpc-4095	24	26	the	the	DET
dpc-4095	24	27	growth	growth	NOUN
dpc-4095	24	28	cycle	cycle	NOUN
dpc-4095	24	29	of	of	ADP
dpc-4095	24	30	the	the	DET
dpc-4095	24	31	hair	hair	NOUN
dpc-4095	24	32	follicle	follicle	VERB
dpc-4095	24	33	.	.	PUNCT
dpc-4095	25	1	there	there	PRON
dpc-4095	25	2	are	be	VERB
dpc-4095	25	3	five	five	NUM
dpc-4095	25	4	functional	functional	ADJ
dpc-4095	25	5	types	type	NOUN
dpc-4095	25	6	of	of	ADP
dpc-4095	25	7	te	te	PROPN
dpc-4095	25	8	,	,	PUNCT
dpc-4095	25	9	which	which	PRON
dpc-4095	25	10	are	be	AUX
dpc-4095	25	11	classified	classify	VERB
dpc-4095	25	12	according	accord	VERB
dpc-4095	25	13	to	to	ADP
dpc-4095	25	14	alterations	alteration	NOUN
dpc-4095	25	15	in	in	ADP
dpc-4095	25	16	specific	specific	ADJ
dpc-4095	25	17	phases	phase	NOUN
dpc-4095	25	18	of	of	ADP
dpc-4095	25	19	the	the	DET
dpc-4095	25	20	follicular	follicular	ADJ
dpc-4095	25	21	cycle	cycle	NOUN
dpc-4095	25	22	:	:	PUNCT
dpc-4095	25	23	immediate	immediate	ADJ
dpc-4095	25	24	or	or	CCONJ
dpc-4095	25	25	delayed	delay	VERB
dpc-4095	25	26	anagen	anagen	NOUN
dpc-4095	25	27	release	release	NOUN
dpc-4095	25	28	,	,	PUNCT
dpc-4095	25	29	short	short	ADJ
dpc-4095	25	30	anagen	anagen	NOUN
dpc-4095	25	31	syndrome	syndrome	NOUN
dpc-4095	25	32	,	,	PUNCT
dpc-4095	25	33	and	and	CCONJ
dpc-4095	25	34	rapid	rapid	ADJ
dpc-4095	25	35	or	or	CCONJ
dpc-4095	25	36	delayed	delay	VERB
dpc-4095	25	37	telogen	telogen	NOUN
dpc-4095	25	38	release	release	NOUN
dpc-4095	25	39	.	.	PUNCT
dpc-4095	26	1	this	this	DET
dpc-4095	26	2	results	result	NOUN
dpc-4095	26	3	in	in	ADP
dpc-4095	26	4	intense	intense	ADJ
dpc-4095	26	5	hair	hair	NOUN
dpc-4095	26	6	shedding	shedding	NOUN
dpc-4095	26	7	,	,	PUNCT
dpc-4095	26	8	which	which	PRON
dpc-4095	26	9	can	can	AUX
dpc-4095	26	10	be	be	AUX
dpc-4095	26	11	acute	acute	ADJ
dpc-4095	26	12	or	or	CCONJ
dpc-4095	26	13	chronic	chronic	ADJ
dpc-4095	26	14	.	.	PUNCT
dpc-4095	27	1	acute	acute	PROPN
dpc-4095	27	2	te	te	PROPN
dpc-4095	27	3	usually	usually	ADV
dpc-4095	27	4	resolves	resolve	NOUN
dpc-4095	27	5	within	within	ADP
dpc-4095	27	6	3	3	NUM
dpc-4095	27	7	-	-	SYM
dpc-4095	27	8	6	6	NUM
dpc-4095	27	9	months	month	NOUN
dpc-4095	27	10	,	,	PUNCT
dpc-4095	27	11	while	while	SCONJ
dpc-4095	27	12	chronic	chronic	ADJ
dpc-4095	27	13	te	te	PROPN
dpc-4095	27	14	persists	persist	VERB
dpc-4095	27	15	for	for	ADP
dpc-4095	27	16	more	more	ADJ
dpc-4095	27	17	than	than	ADP
dpc-4095	27	18	6	6	NUM
dpc-4095	27	19	months	month	NOUN
dpc-4095	27	20	.	.	PUNCT
dpc-4095	28	1	te	te	PROPN
dpc-4095	28	2	is	be	AUX
dpc-4095	28	3	often	often	ADV
dpc-4095	28	4	triggered	trigger	VERB
dpc-4095	28	5	by	by	ADP
dpc-4095	28	6	underlying	underlie	VERB
dpc-4095	28	7	emotional	emotional	ADJ
dpc-4095	28	8	stress	stress	NOUN
dpc-4095	28	9	,	,	PUNCT
dpc-4095	28	10	febrile	febrile	NOUN
dpc-4095	28	11	illness	illness	NOUN
dpc-4095	28	12	,	,	PUNCT
dpc-4095	28	13	the	the	DET
dpc-4095	28	14	postpartum	postpartum	NOUN
dpc-4095	28	15	period	period	NOUN
dpc-4095	28	16	,	,	PUNCT
dpc-4095	28	17	weight	weight	NOUN
dpc-4095	28	18	loss	loss	NOUN
dpc-4095	28	19	,	,	PUNCT
dpc-4095	28	20	systemic	systemic	ADJ
dpc-4095	28	21	disease	disease	NOUN
dpc-4095	28	22	,	,	PUNCT
dpc-4095	28	23	systemic	systemic	ADJ
dpc-4095	28	24	drug	drug	NOUN
dpc-4095	28	25	use	use	NOUN
dpc-4095	28	26	,	,	PUNCT
dpc-4095	28	27	or	or	CCONJ
dpc-4095	28	28	surgery	surgery	NOUN
dpc-4095	28	29	[	[	X
dpc-4095	28	30	1	1	NUM
dpc-4095	28	31	]	]	PUNCT
dpc-4095	28	32	.	.	PUNCT
dpc-4095	29	1	numerous	numerous	ADJ
dpc-4095	29	2	studies	study	NOUN
dpc-4095	29	3	reported	report	VERB
dpc-4095	29	4	many	many	ADJ
dpc-4095	29	5	patients	patient	NOUN
dpc-4095	29	6	with	with	ADP
dpc-4095	29	7	te	te	PROPN
dpc-4095	29	8	after	after	ADP
dpc-4095	29	9	sars	sars	NOUN
dpc-4095	29	10	-	-	PUNCT
dpc-4095	29	11	cov-2	cov-2	PART
dpc-4095	29	12	infection	infection	NOUN
dpc-4095	29	13	and	and	CCONJ
dpc-4095	29	14	as	as	ADV
dpc-4095	29	15	well	well	ADV
dpc-4095	29	16	as	as	ADP
dpc-4095	29	17	after	after	ADP
dpc-4095	29	18	receiving	receive	VERB
dpc-4095	29	19	its	its	PRON
dpc-4095	29	20	vaccines	vaccine	NOUN
dpc-4095	29	21	[	[	X
dpc-4095	29	22	2	2	NUM
dpc-4095	29	23	-	-	SYM
dpc-4095	29	24	4	4	NUM
dpc-4095	29	25	]	]	PUNCT
dpc-4095	29	26	.	.	PUNCT
dpc-4095	30	1	the	the	DET
dpc-4095	30	2	development	development	NOUN
dpc-4095	30	3	of	of	ADP
dpc-4095	30	4	te	te	PROPN
dpc-4095	30	5	has	have	AUX
dpc-4095	30	6	been	be	AUX
dpc-4095	30	7	linked	link	VERB
dpc-4095	30	8	to	to	ADP
dpc-4095	30	9	the	the	DET
dpc-4095	30	10	release	release	NOUN
dpc-4095	30	11	of	of	ADP
dpc-4095	30	12	proinflammatory	proinflammatory	ADJ
dpc-4095	30	13	cytokines	cytokine	NOUN
dpc-4095	30	14	due	due	ADJ
dpc-4095	30	15	to	to	ADP
dpc-4095	30	16	systemic	systemic	ADJ
dpc-4095	30	17	inflammation	inflammation	NOUN
dpc-4095	30	18	,	,	PUNCT
dpc-4095	30	19	the	the	DET
dpc-4095	30	20	occlusion	occlusion	NOUN
dpc-4095	30	21	of	of	ADP
dpc-4095	30	22	the	the	DET
dpc-4095	30	23	vascular	vascular	ADJ
dpc-4095	30	24	system	system	NOUN
dpc-4095	30	25	of	of	ADP
dpc-4095	30	26	the	the	DET
dpc-4095	30	27	hair	hair	NOUN
dpc-4095	30	28	follicle	follicle	VERB
dpc-4095	30	29	,	,	PUNCT
dpc-4095	30	30	and	and	CCONJ
dpc-4095	30	31	direct	direct	ADJ
dpc-4095	30	32	infection	infection	NOUN
dpc-4095	30	33	of	of	ADP
dpc-4095	30	34	the	the	DET
dpc-4095	30	35	hair	hair	NOUN
dpc-4095	30	36	follicle	follicle	NOUN
dpc-4095	30	37	by	by	ADP
dpc-4095	30	38	the	the	DET
dpc-4095	30	39	virus	virus	NOUN
dpc-4095	31	1	[	[	X
dpc-4095	31	2	5	5	NUM
dpc-4095	31	3	-	-	SYM
dpc-4095	31	4	7	7	NUM
dpc-4095	31	5	]	]	PUNCT
dpc-4095	31	6	.	.	PUNCT
dpc-4095	32	1	emotional	emotional	ADJ
dpc-4095	32	2	and	and	CCONJ
dpc-4095	32	3	psychological	psychological	ADJ
dpc-4095	32	4	stress	stress	NOUN
dpc-4095	32	5	,	,	PUNCT
dpc-4095	32	6	fever	fever	NOUN
dpc-4095	32	7	,	,	PUNCT
dpc-4095	32	8	weight	weight	NOUN
dpc-4095	32	9	loss	loss	NOUN
dpc-4095	32	10	,	,	PUNCT
dpc-4095	32	11	nutritional	nutritional	ADJ
dpc-4095	32	12	deficiency	deficiency	NOUN
dpc-4095	32	13	,	,	PUNCT
dpc-4095	32	14	and	and	CCONJ
dpc-4095	32	15	systemic	systemic	ADJ
dpc-4095	32	16	medications	medication	NOUN
dpc-4095	32	17	may	may	AUX
dpc-4095	32	18	also	also	ADV
dpc-4095	32	19	increase	increase	VERB
dpc-4095	32	20	the	the	DET
dpc-4095	32	21	prevalence	prevalence	NOUN
dpc-4095	32	22	and	and	CCONJ
dpc-4095	32	23	severity	severity	NOUN
dpc-4095	32	24	of	of	ADP
dpc-4095	32	25	te	te	PROPN
dpc-4095	32	26	during	during	ADP
dpc-4095	32	27	sars	sar	NOUN
dpc-4095	32	28	-	-	PUNCT
dpc-4095	32	29	cov-2	cov-2	PART
dpc-4095	32	30	infection	infection	NOUN
dpc-4095	32	31	[	[	X
dpc-4095	32	32	8	8	NUM
dpc-4095	32	33	]	]	PUNCT
dpc-4095	32	34	.	.	PUNCT
dpc-4095	33	1	objectives	objective	NOUN
dpc-4095	33	2	in	in	ADP
dpc-4095	33	3	this	this	DET
dpc-4095	33	4	study	study	NOUN
dpc-4095	33	5	,	,	PUNCT
dpc-4095	33	6	we	we	PRON
dpc-4095	33	7	planned	plan	VERB
dpc-4095	33	8	to	to	PART
dpc-4095	33	9	examine	examine	VERB
dpc-4095	33	10	the	the	DET
dpc-4095	33	11	demographic	demographic	ADJ
dpc-4095	33	12	,	,	PUNCT
dpc-4095	33	13	dermoscopic	dermoscopic	NOUN
dpc-4095	33	14	,	,	PUNCT
dpc-4095	33	15	and	and	CCONJ
dpc-4095	33	16	laboratory	laboratory	NOUN
dpc-4095	33	17	features	feature	NOUN
dpc-4095	33	18	of	of	ADP
dpc-4095	33	19	the	the	DET
dpc-4095	33	20	patients	patient	NOUN
dpc-4095	33	21	with	with	ADP
dpc-4095	33	22	sars	sar	NOUN
dpc-4095	33	23	-	-	PUNCT
dpc-4095	33	24	cov-2	cov-2	NOUN
dpc-4095	33	25	-associated	-associated	ADJ
dpc-4095	33	26	te	te	PROPN
dpc-4095	33	27	(	(	PUNCT
dpc-4095	33	28	cate	cate	PROPN
dpc-4095	33	29	)	)	PUNCT
dpc-4095	33	30	and	and	CCONJ
dpc-4095	33	31	compare	compare	VERB
dpc-4095	33	32	them	they	PRON
dpc-4095	33	33	with	with	ADP
dpc-4095	33	34	te	te	PROPN
dpc-4095	33	35	due	due	ADP
dpc-4095	33	36	to	to	ADP
dpc-4095	33	37	other	other	ADJ
dpc-4095	33	38	causes	cause	NOUN
dpc-4095	33	39	(	(	PUNCT
dpc-4095	33	40	tedoc	tedoc	NOUN
dpc-4095	33	41	)	)	PUNCT
dpc-4095	33	42	according	accord	VERB
dpc-4095	33	43	to	to	ADP
dpc-4095	33	44	these	these	DET
dpc-4095	33	45	features	feature	NOUN
dpc-4095	33	46	.	.	PUNCT
dpc-4095	34	1	methods	method	NOUN
dpc-4095	34	2	this	this	DET
dpc-4095	34	3	study	study	NOUN
dpc-4095	34	4	is	be	AUX
dpc-4095	34	5	a	a	DET
dpc-4095	34	6	descriptive	descriptive	ADJ
dpc-4095	34	7	,	,	PUNCT
dpc-4095	34	8	retrospective	retrospective	ADJ
dpc-4095	34	9	and	and	CCONJ
dpc-4095	34	10	case	case	NOUN
dpc-4095	34	11	-	-	PUNCT
dpc-4095	34	12	control	control	NOUN
dpc-4095	34	13	study	study	NOUN
dpc-4095	34	14	.	.	PUNCT
dpc-4095	35	1	it	it	PRON
dpc-4095	35	2	was	be	AUX
dpc-4095	35	3	conducted	conduct	VERB
dpc-4095	35	4	in	in	ADP
dpc-4095	35	5	a	a	DET
dpc-4095	35	6	tertiary	tertiary	ADJ
dpc-4095	35	7	dermatology	dermatology	NOUN
dpc-4095	35	8	center	center	NOUN
dpc-4095	35	9	after	after	ADP
dpc-4095	35	10	approval	approval	NOUN
dpc-4095	35	11	from	from	ADP
dpc-4095	35	12	the	the	DET
dpc-4095	35	13	ethics	ethic	NOUN
dpc-4095	35	14	committee	committee	PROPN
dpc-4095	35	15	according	accord	VERB
dpc-4095	35	16	to	to	ADP
dpc-4095	35	17	the	the	DET
dpc-4095	35	18	declaration	declaration	NOUN
dpc-4095	35	19	of	of	ADP
dpc-4095	35	20	helsinki	helsinki	PROPN
dpc-4095	35	21	(	(	PUNCT
dpc-4095	35	22	approval	approval	NOUN
dpc-4095	35	23	date	date	NOUN
dpc-4095	35	24	:	:	PUNCT
dpc-4095	35	25	august	august	PROPN
dpc-4095	35	26	2023	2023	NUM
dpc-4095	35	27	,	,	PUNCT
dpc-4095	35	28	approval	approval	NOUN
dpc-4095	35	29	number:2023/09	number:2023/09	NOUN
dpc-4095	35	30	-	-	SYM
dpc-4095	35	31	31	31	NUM
dpc-4095	35	32	)	)	PUNCT
dpc-4095	35	33	.	.	PUNCT
dpc-4095	36	1	study	study	NOUN
dpc-4095	36	2	population	population	NOUN
dpc-4095	36	3	the	the	DET
dpc-4095	36	4	study	study	NOUN
dpc-4095	36	5	included	include	VERB
dpc-4095	36	6	patients	patient	NOUN
dpc-4095	36	7	who	who	PRON
dpc-4095	36	8	visited	visit	VERB
dpc-4095	36	9	our	our	PRON
dpc-4095	36	10	dermatology	dermatology	NOUN
dpc-4095	36	11	clinic	clinic	NOUN
dpc-4095	36	12	between	between	ADP
dpc-4095	36	13	april	april	PROPN
dpc-4095	36	14	and	and	CCONJ
dpc-4095	36	15	june	june	PROPN
dpc-4095	36	16	2022	2022	NUM
dpc-4095	36	17	due	due	ADP
dpc-4095	36	18	to	to	ADP
dpc-4095	36	19	excessive	excessive	ADJ
dpc-4095	36	20	hair	hair	NOUN
dpc-4095	36	21	loss	loss	NOUN
dpc-4095	36	22	,	,	PUNCT
dpc-4095	36	23	had	have	VERB
dpc-4095	36	24	a	a	DET
dpc-4095	36	25	positive	positive	ADJ
dpc-4095	36	26	hair	hair	NOUN
dpc-4095	36	27	-	-	PUNCT
dpc-4095	36	28	pulling	pull	VERB
dpc-4095	36	29	test	test	NOUN
dpc-4095	36	30	,	,	PUNCT
dpc-4095	36	31	were	be	AUX
dpc-4095	36	32	diagnosed	diagnose	VERB
dpc-4095	36	33	with	with	ADP
dpc-4095	36	34	te	te	PROPN
dpc-4095	36	35	based	base	VERB
dpc-4095	36	36	on	on	ADP
dpc-4095	36	37	the	the	DET
dpc-4095	36	38	clinic	clinic	NOUN
dpc-4095	36	39	and	and	CCONJ
dpc-4095	36	40	dermoscopic	dermoscopic	NOUN
dpc-4095	36	41	features	feature	NOUN
dpc-4095	36	42	,	,	PUNCT
dpc-4095	36	43	and	and	CCONJ
dpc-4095	36	44	were	be	AUX
dpc-4095	36	45	over	over	ADP
dpc-4095	36	46	18	18	NUM
dpc-4095	36	47	years	year	NOUN
dpc-4095	36	48	old	old	ADJ
dpc-4095	36	49	.	.	PUNCT
dpc-4095	37	1	the	the	DET
dpc-4095	37	2	patients	patient	NOUN
dpc-4095	37	3	reported	report	VERB
dpc-4095	37	4	that	that	SCONJ
dpc-4095	37	5	their	their	PRON
dpc-4095	37	6	hair	hair	NOUN
dpc-4095	37	7	loss	loss	NOUN
dpc-4095	37	8	started	start	VERB
dpc-4095	37	9	after	after	ADP
dpc-4095	37	10	contracting	contract	VERB
dpc-4095	37	11	sars	sar	NOUN
dpc-4095	37	12	-	-	PUNCT
dpc-4095	37	13	cov-2	cov-2	PART
dpc-4095	37	14	infection	infection	NOUN
dpc-4095	37	15	and	and	CCONJ
dpc-4095	37	16	had	have	VERB
dpc-4095	37	17	sars	sar	NOUN
dpc-4095	37	18	-	-	PUNCT
dpc-4095	37	19	cov-2	cov-2	NOUN
dpc-4095	37	20	pcr	pcr	NOUN
dpc-4095	37	21	positivity	positivity	NOUN
dpc-4095	37	22	in	in	ADP
dpc-4095	37	23	the	the	DET
dpc-4095	37	24	last	last	ADJ
dpc-4095	37	25	3	3	NUM
dpc-4095	37	26	months	month	NOUN
dpc-4095	37	27	in	in	ADP
dpc-4095	37	28	our	our	PRON
dpc-4095	37	29	hospital	hospital	NOUN
dpc-4095	37	30	recording	recording	NOUN
dpc-4095	37	31	system	system	NOUN
dpc-4095	37	32	were	be	AUX
dpc-4095	37	33	categorized	categorize	VERB
dpc-4095	37	34	as	as	ADP
dpc-4095	37	35	cate	cate	NOUN
dpc-4095	37	36	,	,	PUNCT
dpc-4095	37	37	on	on	ADP
dpc-4095	37	38	the	the	DET
dpc-4095	37	39	other	other	ADJ
dpc-4095	37	40	hand	hand	NOUN
dpc-4095	37	41	,	,	PUNCT
dpc-4095	37	42	patients	patient	NOUN
dpc-4095	37	43	who	who	PRON
dpc-4095	37	44	did	do	AUX
dpc-4095	37	45	not	not	PART
dpc-4095	37	46	link	link	VERB
dpc-4095	37	47	their	their	PRON
dpc-4095	37	48	hair	hair	NOUN
dpc-4095	37	49	loss	loss	NOUN
dpc-4095	37	50	to	to	ADP
dpc-4095	37	51	sars	sar	NOUN
dpc-4095	37	52	-	-	PUNCT
dpc-4095	37	53	cov-2	cov-2	PART
dpc-4095	37	54	infection	infection	NOUN
dpc-4095	37	55	and	and	CCONJ
dpc-4095	37	56	had	have	VERB
dpc-4095	37	57	no	no	DET
dpc-4095	37	58	records	record	NOUN
dpc-4095	37	59	of	of	ADP
dpc-4095	37	60	sars	sar	NOUN
dpc-4095	37	61	-	-	PUNCT
dpc-4095	37	62	cov-2	cov-2	NOUN
dpc-4095	37	63	positivity	positivity	NOUN
dpc-4095	37	64	in	in	ADP
dpc-4095	37	65	the	the	DET
dpc-4095	37	66	last	last	ADJ
dpc-4095	37	67	three	three	NUM
dpc-4095	37	68	months	month	NOUN
dpc-4095	37	69	were	be	AUX
dpc-4095	37	70	classified	classify	VERB
dpc-4095	37	71	as	as	ADP
dpc-4095	37	72	te	te	PROPN
dpc-4095	37	73	due	due	ADP
dpc-4095	37	74	to	to	ADP
dpc-4095	37	75	other	other	ADJ
dpc-4095	37	76	causes	cause	NOUN
dpc-4095	37	77	(	(	PUNCT
dpc-4095	37	78	tedoc	tedoc	NOUN
dpc-4095	37	79	)	)	PUNCT
dpc-4095	37	80	.	.	PUNCT
dpc-4095	38	1	all	all	DET
dpc-4095	38	2	patients	patient	NOUN
dpc-4095	38	3	provided	provide	VERB
dpc-4095	38	4	informed	informed	ADJ
dpc-4095	38	5	consent	consent	NOUN
dpc-4095	38	6	forms	form	NOUN
dpc-4095	38	7	before	before	ADP
dpc-4095	38	8	participating	participate	VERB
dpc-4095	38	9	in	in	ADP
dpc-4095	38	10	the	the	DET
dpc-4095	38	11	study	study	NOUN
dpc-4095	38	12	.	.	PUNCT
dpc-4095	39	1	data	datum	NOUN
dpc-4095	39	2	collection	collection	NOUN
dpc-4095	39	3	patients	patient	NOUN
dpc-4095	39	4	gender	gender	NOUN
dpc-4095	39	5	,	,	PUNCT
dpc-4095	39	6	age	age	NOUN
dpc-4095	39	7	,	,	PUNCT
dpc-4095	39	8	disease	disease	NOUN
dpc-4095	39	9	duration	duration	NOUN
dpc-4095	39	10	,	,	PUNCT
dpc-4095	39	11	accompanying	accompany	VERB
dpc-4095	39	12	systemic	systemic	ADJ
dpc-4095	39	13	disease	disease	NOUN
dpc-4095	39	14	,	,	PUNCT
dpc-4095	39	15	dermoscopic	dermoscopic	NOUN
dpc-4095	39	16	findings	finding	NOUN
dpc-4095	39	17	,	,	PUNCT
dpc-4095	39	18	and	and	CCONJ
dpc-4095	39	19	laboratory	laboratory	NOUN
dpc-4095	39	20	results	result	NOUN
dpc-4095	39	21	were	be	AUX
dpc-4095	39	22	recorded	record	VERB
dpc-4095	39	23	.	.	PUNCT
dpc-4095	40	1	all	all	DET
dpc-4095	40	2	dermoscopic	dermoscopic	ADJ
dpc-4095	40	3	examinations	examination	NOUN
dpc-4095	40	4	were	be	AUX
dpc-4095	40	5	performed	perform	VERB
dpc-4095	40	6	using	use	VERB
dpc-4095	40	7	a	a	DET
dpc-4095	40	8	hand	hand	NOUN
dpc-4095	40	9	-	-	PUNCT
dpc-4095	40	10	held	hold	VERB
dpc-4095	40	11	dermoscop	dermoscop	NOUN
dpc-4095	40	12	(	(	PUNCT
dpc-4095	40	13	plusmed	plusme	VERB
dpc-4095	40	14	)	)	PUNCT
dpc-4095	40	15	and	and	CCONJ
dpc-4095	40	16	data	datum	NOUN
dpc-4095	40	17	were	be	AUX
dpc-4095	40	18	collected	collect	VERB
dpc-4095	40	19	from	from	ADP
dpc-4095	40	20	hospital	hospital	NOUN
dpc-4095	40	21	records	record	NOUN
dpc-4095	40	22	.	.	PUNCT
dpc-4095	41	1	statistical	statistical	ADJ
dpc-4095	41	2	analysis	analysis	NOUN
dpc-4095	41	3	statistical	statistical	ADJ
dpc-4095	41	4	analysis	analysis	NOUN
dpc-4095	41	5	was	be	AUX
dpc-4095	41	6	done	do	VERB
dpc-4095	41	7	with	with	ADP
dpc-4095	41	8	the	the	DET
dpc-4095	41	9	ibm	ibm	PROPN
dpc-4095	41	10	spss	spss	PROPN
dpc-4095	41	11	20.0	20.0	NUM
dpc-4095	41	12	(	(	PUNCT
dpc-4095	41	13	ibm	ibm	PROPN
dpc-4095	41	14	corp	corp	PROPN
dpc-4095	41	15	.	.	PROPN
dpc-4095	41	16	)	)	PUNCT
dpc-4095	41	17	package	package	NOUN
dpc-4095	41	18	program	program	NOUN
dpc-4095	41	19	.	.	PUNCT
dpc-4095	42	1	numerical	numerical	PROPN
dpc-4095	42	2	variables	variable	NOUN
dpc-4095	42	3	were	be	AUX
dpc-4095	42	4	given	give	VERB
dpc-4095	42	5	as	as	ADP
dpc-4095	42	6	mean	mean	PROPN
dpc-4095	42	7	±	±	NUM
dpc-4095	42	8	standard	standard	ADJ
dpc-4095	42	9	deviation	deviation	NOUN
dpc-4095	42	10	or	or	CCONJ
dpc-4095	42	11	median	median	NOUN
dpc-4095	42	12	(	(	PUNCT
dpc-4095	42	13	25th-75th	25th-75th	NUM
dpc-4095	42	14	percentile	percentile	NOUN
dpc-4095	42	15	)	)	PUNCT
dpc-4095	42	16	.	.	PUNCT
dpc-4095	43	1	categorical	categorical	ADJ
dpc-4095	43	2	variables	variable	NOUN
dpc-4095	43	3	were	be	AUX
dpc-4095	43	4	given	give	VERB
dpc-4095	43	5	as	as	ADP
dpc-4095	43	6	frequency	frequency	NOUN
dpc-4095	43	7	(	(	PUNCT
dpc-4095	43	8	percentage	percentage	NOUN
dpc-4095	43	9	)	)	PUNCT
dpc-4095	43	10	.	.	PUNCT
dpc-4095	44	1	relationships	relationship	NOUN
dpc-4095	44	2	between	between	ADP
dpc-4095	44	3	categorical	categorical	ADJ
dpc-4095	44	4	variables	variable	NOUN
dpc-4095	44	5	were	be	AUX
dpc-4095	44	6	evaluated	evaluate	VERB
dpc-4095	44	7	by	by	ADP
dpc-4095	44	8	chi	chi	ADJ
dpc-4095	44	9	-	-	PUNCT
dpc-4095	44	10	square	square	NOUN
dpc-4095	44	11	analysis	analysis	NOUN
dpc-4095	44	12	.	.	PUNCT
dpc-4095	45	1	two	two	NUM
dpc-4095	45	2	samples	sample	NOUN
dpc-4095	45	3	student	student	NOUN
dpc-4095	45	4	t	t	PROPN
dpc-4095	45	5	-	-	PUNCT
dpc-4095	45	6	test	test	NOUN
dpc-4095	45	7	was	be	AUX
dpc-4095	45	8	used	use	VERB
dpc-4095	45	9	to	to	PART
dpc-4095	45	10	compare	compare	VERB
dpc-4095	45	11	mean	mean	ADJ
dpc-4095	45	12	values	value	NOUN
dpc-4095	45	13	of	of	ADP
dpc-4095	45	14	normally	normally	ADV
dpc-4095	45	15	distributed	distribute	VERB
dpc-4095	45	16	quantitative	quantitative	ADJ
dpc-4095	45	17	variables	variable	NOUN
dpc-4095	45	18	.	.	PUNCT
dpc-4095	46	1	in	in	ADP
dpc-4095	46	2	the	the	DET
dpc-4095	46	3	testing	testing	NOUN
dpc-4095	46	4	of	of	ADP
dpc-4095	46	5	two	two	NUM
dpc-4095	46	6	-	-	PUNCT
dpc-4095	46	7	sided	sided	ADJ
dpc-4095	46	8	hypotheses	hypothesis	NOUN
dpc-4095	46	9	,	,	PUNCT
dpc-4095	46	10	p	p	X
dpc-4095	46	11	<	<	X
dpc-4095	46	12	0.05	0.05	NUM
dpc-4095	46	13	was	be	AUX
dpc-4095	46	14	considered	consider	VERB
dpc-4095	46	15	sufficient	sufficient	ADJ
dpc-4095	46	16	for	for	ADP
dpc-4095	46	17	statistical	statistical	ADJ
dpc-4095	46	18	significance	significance	NOUN
dpc-4095	46	19	.	.	PUNCT
dpc-4095	47	1	results	result	VERB
dpc-4095	47	2	a	a	DET
dpc-4095	47	3	total	total	NOUN
dpc-4095	47	4	of	of	ADP
dpc-4095	47	5	92	92	NUM
dpc-4095	47	6	patients	patient	NOUN
dpc-4095	47	7	,	,	PUNCT
dpc-4095	47	8	86	86	NUM
dpc-4095	47	9	(	(	PUNCT
dpc-4095	47	10	93.5	93.5	NUM
dpc-4095	47	11	%	%	NOUN
dpc-4095	47	12	)	)	PUNCT
dpc-4095	47	13	females	female	NOUN
dpc-4095	47	14	,	,	PUNCT
dpc-4095	47	15	and	and	CCONJ
dpc-4095	47	16	6	6	NUM
dpc-4095	47	17	(	(	PUNCT
dpc-4095	47	18	6.5	6.5	NUM
dpc-4095	47	19	%	%	NOUN
dpc-4095	47	20	)	)	PUNCT
dpc-4095	47	21	males	male	NOUN
dpc-4095	47	22	,	,	PUNCT
dpc-4095	47	23	were	be	AUX
dpc-4095	47	24	included	include	VERB
dpc-4095	47	25	in	in	ADP
dpc-4095	47	26	the	the	DET
dpc-4095	47	27	study	study	NOUN
dpc-4095	47	28	.	.	PUNCT
dpc-4095	48	1	previous	previous	ADJ
dpc-4095	48	2	sars	sar	NOUN
dpc-4095	48	3	-	-	PUNCT
dpc-4095	48	4	cov-2	cov-2	NOUN
dpc-4095	48	5	infection	infection	NOUN
dpc-4095	48	6	before	before	SCONJ
dpc-4095	48	7	hair	hair	NOUN
dpc-4095	48	8	shedding	shed	VERB
dpc-4095	48	9	was	be	AUX
dpc-4095	48	10	detected	detect	VERB
dpc-4095	48	11	in	in	ADP
dpc-4095	48	12	52	52	NUM
dpc-4095	48	13	(	(	PUNCT
dpc-4095	48	14	56.5	56.5	NUM
dpc-4095	48	15	%	%	NOUN
dpc-4095	48	16	)	)	PUNCT
dpc-4095	48	17	patients	patient	NOUN
dpc-4095	48	18	whereas	whereas	SCONJ
dpc-4095	48	19	40	40	NUM
dpc-4095	48	20	(	(	PUNCT
dpc-4095	48	21	44.5	44.5	NUM
dpc-4095	48	22	%	%	NOUN
dpc-4095	48	23	)	)	PUNCT
dpc-4095	48	24	patients	patient	NOUN
dpc-4095	48	25	had	have	VERB
dpc-4095	48	26	tedoc	tedoc	ADJ
dpc-4095	48	27	.	.	PUNCT
dpc-4095	49	1	female	female	ADJ
dpc-4095	49	2	dominance	dominance	NOUN
dpc-4095	49	3	was	be	AUX
dpc-4095	49	4	detected	detect	VERB
dpc-4095	49	5	in	in	ADP
dpc-4095	49	6	both	both	DET
dpc-4095	49	7	groups	group	NOUN
dpc-4095	49	8	,	,	PUNCT
dpc-4095	49	9	however	however	ADV
dpc-4095	49	10	,	,	PUNCT
dpc-4095	49	11	there	there	PRON
dpc-4095	49	12	was	be	VERB
dpc-4095	49	13	no	no	DET
dpc-4095	49	14	statistically	statistically	ADV
dpc-4095	49	15	significant	significant	ADJ
dpc-4095	49	16	difference	difference	NOUN
dpc-4095	49	17	between	between	ADP
dpc-4095	49	18	the	the	DET
dpc-4095	49	19	groups	group	NOUN
dpc-4095	49	20	(	(	PUNCT
dpc-4095	49	21	p	p	X
dpc-4095	49	22	=	=	NOUN
dpc-4095	49	23	0.197	0.197	NUM
dpc-4095	49	24	)	)	PUNCT
dpc-4095	49	25	.	.	PUNCT
dpc-4095	50	1	the	the	DET
dpc-4095	50	2	mean	mean	ADJ
dpc-4095	50	3	age	age	NOUN
dpc-4095	50	4	of	of	ADP
dpc-4095	50	5	the	the	DET
dpc-4095	50	6	patients	patient	NOUN
dpc-4095	50	7	with	with	ADP
dpc-4095	50	8	cate	cate	PROPN
dpc-4095	50	9	was	be	AUX
dpc-4095	50	10	30.3	30.3	NUM
dpc-4095	50	11	+	+	CCONJ
dpc-4095	50	12	10.7	10.7	NUM
dpc-4095	50	13	years	year	NOUN
dpc-4095	50	14	.	.	PUNCT
dpc-4095	51	1	the	the	DET
dpc-4095	51	2	mean	mean	ADJ
dpc-4095	51	3	duration	duration	NOUN
dpc-4095	51	4	of	of	ADP
dpc-4095	51	5	the	the	DET
dpc-4095	51	6	disease	disease	NOUN
dpc-4095	51	7	was	be	AUX
dpc-4095	51	8	102.5	102.5	NUM
dpc-4095	51	9	+	+	NUM
dpc-4095	51	10	35.2	35.2	NUM
dpc-4095	51	11	days	day	NOUN
dpc-4095	51	12	.	.	PUNCT
dpc-4095	52	1	as	as	ADP
dpc-4095	52	2	a	a	DET
dpc-4095	52	3	result	result	NOUN
dpc-4095	52	4	of	of	ADP
dpc-4095	52	5	that	that	PRON
dpc-4095	52	6	,	,	PUNCT
dpc-4095	52	7	acute	acute	PROPN
dpc-4095	52	8	te	te	PROPN
dpc-4095	52	9	was	be	AUX
dpc-4095	52	10	found	find	VERB
dpc-4095	52	11	to	to	PART
dpc-4095	52	12	be	be	AUX
dpc-4095	52	13	higher	high	ADJ
dpc-4095	52	14	in	in	ADP
dpc-4095	52	15	patients	patient	NOUN
dpc-4095	52	16	with	with	ADP
dpc-4095	52	17	cate	cate	NOUN
dpc-4095	52	18	(	(	PUNCT
dpc-4095	52	19	p	p	NOUN
dpc-4095	52	20	=	=	NOUN
dpc-4095	52	21	0.001	0.001	NUM
dpc-4095	52	22	)	)	PUNCT
dpc-4095	52	23	.	.	PUNCT
dpc-4095	53	1	in	in	ADP
dpc-4095	53	2	terms	term	NOUN
dpc-4095	53	3	of	of	ADP
dpc-4095	53	4	the	the	DET
dpc-4095	53	5	mean	mean	ADJ
dpc-4095	53	6	age	age	NOUN
dpc-4095	53	7	of	of	ADP
dpc-4095	53	8	the	the	DET
dpc-4095	53	9	patients	patient	NOUN
dpc-4095	53	10	and	and	CCONJ
dpc-4095	53	11	the	the	DET
dpc-4095	53	12	mean	mean	ADJ
dpc-4095	53	13	duration	duration	NOUN
dpc-4095	53	14	of	of	ADP
dpc-4095	53	15	the	the	DET
dpc-4095	53	16	disease	disease	NOUN
dpc-4095	53	17	,	,	PUNCT
dpc-4095	53	18	there	there	PRON
dpc-4095	53	19	was	be	VERB
dpc-4095	53	20	no	no	DET
dpc-4095	53	21	significant	significant	ADJ
dpc-4095	53	22	difference	difference	NOUN
dpc-4095	53	23	between	between	ADP
dpc-4095	53	24	the	the	DET
dpc-4095	53	25	groups	group	NOUN
dpc-4095	53	26	(	(	PUNCT
dpc-4095	53	27	p	p	X
dpc-4095	53	28	=	=	NOUN
dpc-4095	53	29	0.888	0.888	NUM
dpc-4095	53	30	,	,	PUNCT
dpc-4095	53	31	p	p	NOUN
dpc-4095	53	32	=	=	NOUN
dpc-4095	53	33	0.077	0.077	NUM
dpc-4095	53	34	,	,	PUNCT
dpc-4095	53	35	respectively	respectively	ADV
dpc-4095	53	36	)	)	PUNCT
dpc-4095	53	37	.	.	PUNCT
dpc-4095	54	1	however	however	ADV
dpc-4095	54	2	,	,	PUNCT
dpc-4095	54	3	the	the	DET
dpc-4095	54	4	mean	mean	ADJ
dpc-4095	54	5	time	time	NOUN
dpc-4095	54	6	between	between	ADP
dpc-4095	54	7	the	the	DET
dpc-4095	54	8	onset	onset	NOUN
dpc-4095	54	9	of	of	ADP
dpc-4095	54	10	trigger	trigger	NOUN
dpc-4095	54	11	and	and	CCONJ
dpc-4095	54	12	hair	hair	NOUN
dpc-4095	54	13	loss	loss	NOUN
dpc-4095	54	14	complaint	complaint	NOUN
dpc-4095	54	15	was	be	AUX
dpc-4095	54	16	calculated	calculate	VERB
dpc-4095	54	17	as	as	ADP
dpc-4095	54	18	64.8	64.8	NUM
dpc-4095	54	19	+	+	NUM
dpc-4095	54	20	25.6	25.6	NUM
dpc-4095	54	21	days	day	NOUN
dpc-4095	54	22	,	,	PUNCT
dpc-4095	54	23	and	and	CCONJ
dpc-4095	54	24	this	this	DET
dpc-4095	54	25	time	time	NOUN
dpc-4095	54	26	was	be	AUX
dpc-4095	54	27	markedly	markedly	ADV
dpc-4095	54	28	shorter	short	ADJ
dpc-4095	54	29	than	than	ADP
dpc-4095	54	30	patients	patient	NOUN
dpc-4095	54	31	with	with	ADP
dpc-4095	54	32	tedoc	tedoc	NOUN
dpc-4095	54	33	(	(	PUNCT
dpc-4095	54	34	p	p	X
dpc-4095	54	35	=	=	NOUN
dpc-4095	54	36	0.003	0.003	NUM
dpc-4095	54	37	)	)	PUNCT
dpc-4095	54	38	.	.	PUNCT
dpc-4095	55	1	evaluation	evaluation	NOUN
dpc-4095	55	2	of	of	ADP
dpc-4095	55	3	the	the	DET
dpc-4095	55	4	additional	additional	ADJ
dpc-4095	55	5	systemic	systemic	ADJ
dpc-4095	55	6	diseases	disease	NOUN
dpc-4095	55	7	revealed	reveal	VERB
dpc-4095	55	8	that	that	SCONJ
dpc-4095	55	9	2	2	NUM
dpc-4095	55	10	(	(	PUNCT
dpc-4095	55	11	3.8	3.8	NUM
dpc-4095	55	12	%	%	NOUN
dpc-4095	55	13	)	)	PUNCT
dpc-4095	55	14	patients	patient	NOUN
dpc-4095	55	15	had	have	VERB
dpc-4095	55	16	hypertension	hypertension	NOUN
dpc-4095	55	17	in	in	ADP
dpc-4095	55	18	patients	patient	NOUN
dpc-4095	55	19	with	with	ADP
dpc-4095	55	20	cate	cate	NOUN
dpc-4095	55	21	,	,	PUNCT
dpc-4095	55	22	whereas	whereas	SCONJ
dpc-4095	55	23	4	4	NUM
dpc-4095	55	24	(	(	PUNCT
dpc-4095	55	25	10	10	NUM
dpc-4095	55	26	%	%	NOUN
dpc-4095	55	27	)	)	PUNCT
dpc-4095	55	28	patients	patient	NOUN
dpc-4095	55	29	had	have	VERB
dpc-4095	55	30	hashimoto	hashimoto	NOUN
dpc-4095	55	31	thyroiditis	thyroiditis	NOUN
dpc-4095	55	32	,	,	PUNCT
dpc-4095	55	33	3	3	NUM
dpc-4095	55	34	(	(	PUNCT
dpc-4095	55	35	7.5	7.5	NUM
dpc-4095	55	36	%	%	NOUN
dpc-4095	55	37	)	)	PUNCT
dpc-4095	55	38	patients	patient	NOUN
dpc-4095	55	39	had	have	VERB
dpc-4095	55	40	diabetes	diabetes	NOUN
dpc-4095	55	41	mellitus	mellitus	NOUN
dpc-4095	55	42	,	,	PUNCT
dpc-4095	55	43	and	and	CCONJ
dpc-4095	55	44	1	1	NUM
dpc-4095	55	45	(	(	PUNCT
dpc-4095	55	46	2.5	2.5	NUM
dpc-4095	55	47	%	%	NOUN
dpc-4095	55	48	)	)	PUNCT
dpc-4095	55	49	patient	patient	NOUN
dpc-4095	55	50	had	have	VERB
dpc-4095	55	51	chronic	chronic	ADJ
dpc-4095	55	52	hepatitis	hepatitis	NOUN
dpc-4095	55	53	due	due	ADP
dpc-4095	55	54	to	to	ADP
dpc-4095	55	55	hepatitis	hepatitis	PROPN
dpc-4095	55	56	b	b	PROPN
dpc-4095	55	57	virus	virus	NOUN
dpc-4095	55	58	in	in	ADP
dpc-4095	55	59	patients	patient	NOUN
dpc-4095	55	60	with	with	ADP
dpc-4095	55	61	tedoc	tedoc	NOUN
dpc-4095	55	62	,	,	PUNCT
dpc-4095	55	63	and	and	CCONJ
dpc-4095	55	64	there	there	PRON
dpc-4095	55	65	was	be	VERB
dpc-4095	55	66	no	no	DET
dpc-4095	55	67	statistically	statistically	ADV
dpc-4095	55	68	significant	significant	ADJ
dpc-4095	55	69	difference	difference	NOUN
dpc-4095	55	70	between	between	ADP
dpc-4095	55	71	the	the	DET
dpc-4095	55	72	groups	group	NOUN
dpc-4095	55	73	(	(	PUNCT
dpc-4095	55	74	p	p	X
dpc-4095	55	75	=	=	NOUN
dpc-4095	55	76	0.073	0.073	NUM
dpc-4095	55	77	)	)	PUNCT
dpc-4095	55	78	.	.	PUNCT
dpc-4095	56	1	reduced	reduce	VERB
dpc-4095	56	2	hair	hair	NOUN
dpc-4095	56	3	density	density	NOUN
dpc-4095	56	4	was	be	AUX
dpc-4095	56	5	detected	detect	VERB
dpc-4095	56	6	in	in	ADP
dpc-4095	56	7	all	all	DET
dpc-4095	56	8	patients	patient	NOUN
dpc-4095	56	9	with	with	ADP
dpc-4095	56	10	cate	cate	NOUN
dpc-4095	56	11	and/or	and/or	CCONJ
dpc-4095	56	12	tedoc	tedoc	NOUN
dpc-4095	56	13	.	.	PUNCT
dpc-4095	57	1	after	after	ADP
dpc-4095	57	2	evaluating	evaluate	VERB
dpc-4095	57	3	in	in	ADP
dpc-4095	57	4	terms	term	NOUN
dpc-4095	57	5	of	of	ADP
dpc-4095	57	6	the	the	DET
dpc-4095	57	7	difference	difference	NOUN
dpc-4095	57	8	in	in	ADP
dpc-4095	57	9	dermoscopic	dermoscopic	ADJ
dpc-4095	57	10	examination	examination	NOUN
dpc-4095	57	11	,	,	PUNCT
dpc-4095	57	12	empty	empty	ADJ
dpc-4095	57	13	follicular	follicular	ADJ
dpc-4095	57	14	openings	opening	NOUN
dpc-4095	57	15	and	and	CCONJ
dpc-4095	57	16	yellow	yellow	ADJ
dpc-4095	57	17	dots	dot	NOUN
dpc-4095	57	18	were	be	AUX
dpc-4095	57	19	significantly	significantly	ADV
dpc-4095	57	20	higher	high	ADJ
dpc-4095	57	21	in	in	ADP
dpc-4095	57	22	patients	patient	NOUN
dpc-4095	57	23	with	with	ADP
dpc-4095	57	24	cate	cate	NOUN
dpc-4095	57	25	(	(	PUNCT
dpc-4095	57	26	respectively	respectively	ADV
dpc-4095	57	27	p	p	NOUN
dpc-4095	57	28	=	=	NOUN
dpc-4095	57	29	0.001	0.001	NUM
dpc-4095	57	30	and	and	CCONJ
dpc-4095	57	31	p	p	NOUN
dpc-4095	57	32	=	=	NOUN
dpc-4095	57	33	0.001	0.001	NUM
dpc-4095	57	34	)	)	PUNCT
dpc-4095	57	35	,	,	PUNCT
dpc-4095	57	36	whereas	whereas	SCONJ
dpc-4095	57	37	original	original	ADJ
dpc-4095	57	38	article	article	NOUN
dpc-4095	57	39	|	|	ADV
dpc-4095	57	40	dermatol	dermatol	ADJ
dpc-4095	57	41	pract	pract	NOUN
dpc-4095	57	42	concept	concept	NOUN
dpc-4095	57	43	.	.	PUNCT
dpc-4095	58	1	2024;14(3):e2024170	2024;14(3):e2024170	NUM
dpc-4095	58	2	3	3	NUM
dpc-4095	58	3	short	short	ADJ
dpc-4095	58	4	regrowing	regrow	VERB
dpc-4095	58	5	hair	hair	NOUN
dpc-4095	58	6	were	be	AUX
dpc-4095	58	7	higher	high	ADJ
dpc-4095	58	8	in	in	ADP
dpc-4095	58	9	patients	patient	NOUN
dpc-4095	58	10	with	with	ADP
dpc-4095	58	11	tedoc	tedoc	NOUN
dpc-4095	58	12	(	(	PUNCT
dpc-4095	58	13	p	p	NOUN
dpc-4095	58	14	=	=	NOUN
dpc-4095	58	15	0.001	0.001	NUM
dpc-4095	58	16	)	)	PUNCT
dpc-4095	58	17	.	.	PUNCT
dpc-4095	59	1	iron	iron	NOUN
dpc-4095	59	2	deficiency	deficiency	NOUN
dpc-4095	59	3	was	be	AUX
dpc-4095	59	4	the	the	DET
dpc-4095	59	5	most	most	ADV
dpc-4095	59	6	common	common	ADJ
dpc-4095	59	7	laboratory	laboratory	NOUN
dpc-4095	59	8	finding	finding	NOUN
dpc-4095	59	9	in	in	ADP
dpc-4095	59	10	54	54	NUM
dpc-4095	59	11	(	(	PUNCT
dpc-4095	59	12	58.6	58.6	NUM
dpc-4095	59	13	%	%	NOUN
dpc-4095	59	14	)	)	PUNCT
dpc-4095	59	15	of	of	ADP
dpc-4095	59	16	total	total	ADJ
dpc-4095	59	17	patients	patient	NOUN
dpc-4095	59	18	.	.	PUNCT
dpc-4095	60	1	among	among	ADP
dpc-4095	60	2	all	all	DET
dpc-4095	60	3	cate	cate	NOUN
dpc-4095	60	4	patients	patient	NOUN
dpc-4095	60	5	with	with	ADP
dpc-4095	60	6	accompanying	accompany	VERB
dpc-4095	60	7	anemia	anemia	NOUN
dpc-4095	60	8	,	,	PUNCT
dpc-4095	60	9	vitamin	vitamin	NOUN
dpc-4095	60	10	b12	b12	NOUN
dpc-4095	60	11	deficiency	deficiency	NOUN
dpc-4095	60	12	and	and	CCONJ
dpc-4095	60	13	25	25	NUM
dpc-4095	60	14	-	-	PUNCT
dpc-4095	60	15	oh	oh	NUM
dpc-4095	60	16	-	-	PUNCT
dpc-4095	60	17	vitamin	vitamin	NOUN
dpc-4095	60	18	d	d	NOUN
dpc-4095	60	19	deficiency	deficiency	NOUN
dpc-4095	60	20	,	,	PUNCT
dpc-4095	60	21	these	these	DET
dpc-4095	60	22	deficiencies	deficiency	NOUN
dpc-4095	60	23	were	be	AUX
dpc-4095	60	24	present	present	ADJ
dpc-4095	60	25	before	before	ADP
dpc-4095	60	26	sars	sar	NOUN
dpc-4095	60	27	-	-	PUNCT
dpc-4095	60	28	cov-2	cov-2	PART
dpc-4095	60	29	infection	infection	NOUN
dpc-4095	60	30	and	and	CCONJ
dpc-4095	60	31	were	be	AUX
dpc-4095	60	32	not	not	PART
dpc-4095	60	33	related	relate	VERB
dpc-4095	60	34	to	to	ADP
dpc-4095	60	35	hair	hair	NOUN
dpc-4095	60	36	loss	loss	NOUN
dpc-4095	60	37	.	.	PUNCT
dpc-4095	61	1	iron	iron	NOUN
dpc-4095	61	2	deficiency	deficiency	NOUN
dpc-4095	61	3	and	and	CCONJ
dpc-4095	61	4	hypothyroidism	hypothyroidism	NOUN
dpc-4095	61	5	were	be	AUX
dpc-4095	61	6	found	find	VERB
dpc-4095	61	7	statistically	statistically	ADV
dpc-4095	61	8	higher	high	ADJ
dpc-4095	61	9	in	in	ADP
dpc-4095	61	10	patients	patient	NOUN
dpc-4095	61	11	with	with	ADP
dpc-4095	61	12	tedoc	tedoc	NOUN
dpc-4095	61	13	(	(	PUNCT
dpc-4095	61	14	p	p	X
dpc-4095	61	15	=	=	NOUN
dpc-4095	61	16	0.005	0.005	NUM
dpc-4095	61	17	,	,	PUNCT
dpc-4095	61	18	p	p	NOUN
dpc-4095	61	19	=	=	NOUN
dpc-4095	61	20	0.03	0.03	NUM
dpc-4095	61	21	,	,	PUNCT
dpc-4095	61	22	respectively	respectively	ADV
dpc-4095	61	23	)	)	PUNCT
dpc-4095	61	24	conclusions	conclusion	NOUN
dpc-4095	61	25	in	in	ADP
dpc-4095	61	26	this	this	DET
dpc-4095	61	27	study	study	NOUN
dpc-4095	61	28	,	,	PUNCT
dpc-4095	61	29	we	we	PRON
dpc-4095	61	30	retrospectively	retrospectively	ADV
dpc-4095	61	31	evaluated	evaluate	VERB
dpc-4095	61	32	92	92	NUM
dpc-4095	61	33	patients	patient	NOUN
dpc-4095	61	34	with	with	ADP
dpc-4095	61	35	te	te	PROPN
dpc-4095	61	36	between	between	ADP
dpc-4095	61	37	april	april	PROPN
dpc-4095	61	38	and	and	CCONJ
dpc-4095	61	39	june	june	PROPN
dpc-4095	61	40	2022	2022	NUM
dpc-4095	61	41	.	.	PUNCT
dpc-4095	62	1	among	among	ADP
dpc-4095	62	2	92	92	NUM
dpc-4095	62	3	patients	patient	NOUN
dpc-4095	62	4	,	,	PUNCT
dpc-4095	62	5	52	52	NUM
dpc-4095	62	6	(	(	PUNCT
dpc-4095	62	7	56.5	56.5	NUM
dpc-4095	62	8	%	%	NOUN
dpc-4095	62	9	)	)	PUNCT
dpc-4095	62	10	had	have	VERB
dpc-4095	62	11	cate	cate	NOUN
dpc-4095	62	12	and	and	CCONJ
dpc-4095	62	13	40	40	NUM
dpc-4095	62	14	(	(	PUNCT
dpc-4095	62	15	44.5	44.5	NUM
dpc-4095	62	16	%	%	NOUN
dpc-4095	62	17	)	)	PUNCT
dpc-4095	62	18	had	have	VERB
dpc-4095	62	19	tedoc	tedoc	ADJ
dpc-4095	62	20	.	.	PUNCT
dpc-4095	63	1	the	the	DET
dpc-4095	63	2	mean	mean	ADJ
dpc-4095	63	3	time	time	NOUN
dpc-4095	63	4	between	between	ADP
dpc-4095	63	5	the	the	DET
dpc-4095	63	6	onset	onset	NOUN
dpc-4095	63	7	of	of	ADP
dpc-4095	63	8	trigger	trigger	NOUN
dpc-4095	63	9	and	and	CCONJ
dpc-4095	63	10	hair	hair	NOUN
dpc-4095	63	11	loss	loss	NOUN
dpc-4095	63	12	complaint	complaint	NOUN
dpc-4095	63	13	was	be	AUX
dpc-4095	63	14	statistically	statistically	ADV
dpc-4095	63	15	shorter	short	ADJ
dpc-4095	63	16	in	in	ADP
dpc-4095	63	17	patients	patient	NOUN
dpc-4095	63	18	with	with	ADP
dpc-4095	63	19	cate	cate	NOUN
dpc-4095	63	20	than	than	ADP
dpc-4095	63	21	patients	patient	NOUN
dpc-4095	63	22	with	with	ADP
dpc-4095	63	23	tedoc	tedoc	NOUN
dpc-4095	63	24	.	.	PUNCT
dpc-4095	64	1	we	we	PRON
dpc-4095	64	2	found	find	VERB
dpc-4095	64	3	empty	empty	ADJ
dpc-4095	64	4	follicular	follicular	ADJ
dpc-4095	64	5	openings	opening	NOUN
dpc-4095	64	6	and	and	CCONJ
dpc-4095	64	7	yellow	yellow	ADJ
dpc-4095	64	8	dots	dot	NOUN
dpc-4095	64	9	significantly	significantly	ADV
dpc-4095	64	10	higher	higher	ADV
dpc-4095	64	11	in	in	ADP
dpc-4095	64	12	patients	patient	NOUN
dpc-4095	64	13	with	with	ADP
dpc-4095	64	14	cate	cate	NOUN
dpc-4095	64	15	,	,	PUNCT
dpc-4095	64	16	whereas	whereas	SCONJ
dpc-4095	64	17	short	short	ADJ
dpc-4095	64	18	regrowing	regrow	VERB
dpc-4095	64	19	hair	hair	NOUN
dpc-4095	64	20	markedly	markedly	ADV
dpc-4095	64	21	higher	higher	ADV
dpc-4095	64	22	in	in	ADP
dpc-4095	64	23	patients	patient	NOUN
dpc-4095	64	24	with	with	ADP
dpc-4095	64	25	tedoc	tedoc	PROPN
dpc-4095	64	26	.	.	PUNCT
dpc-4095	65	1	iron	iron	NOUN
dpc-4095	65	2	deficiency	deficiency	NOUN
dpc-4095	65	3	and	and	CCONJ
dpc-4095	65	4	hypothyroidism	hypothyroidism	NOUN
dpc-4095	65	5	were	be	AUX
dpc-4095	65	6	also	also	ADV
dpc-4095	65	7	higher	high	ADJ
dpc-4095	65	8	in	in	ADP
dpc-4095	65	9	patients	patient	NOUN
dpc-4095	65	10	with	with	ADP
dpc-4095	65	11	tedoc	tedoc	NOUN
dpc-4095	65	12	.	.	PUNCT
dpc-4095	66	1	te	te	PROPN
dpc-4095	66	2	was	be	AUX
dpc-4095	66	3	reported	report	VERB
dpc-4095	66	4	as	as	ADP
dpc-4095	66	5	the	the	DET
dpc-4095	66	6	most	most	ADV
dpc-4095	66	7	common	common	ADJ
dpc-4095	66	8	hair	hair	NOUN
dpc-4095	66	9	disease	disease	NOUN
dpc-4095	66	10	in	in	ADP
dpc-4095	66	11	patients	patient	NOUN
dpc-4095	66	12	with	with	ADP
dpc-4095	66	13	sars	sar	NOUN
dpc-4095	66	14	-	-	PUNCT
dpc-4095	66	15	cov-2	cov-2	PART
dpc-4095	66	16	infection	infection	NOUN
dpc-4095	66	17	in	in	ADP
dpc-4095	66	18	many	many	ADJ
dpc-4095	66	19	studies	study	NOUN
dpc-4095	66	20	in	in	ADP
dpc-4095	66	21	the	the	DET
dpc-4095	66	22	literature	literature	NOUN
dpc-4095	66	23	[	[	X
dpc-4095	66	24	5	5	NUM
dpc-4095	66	25	-	-	SYM
dpc-4095	66	26	7	7	NUM
dpc-4095	66	27	]	]	PUNCT
dpc-4095	66	28	.	.	PUNCT
dpc-4095	67	1	the	the	DET
dpc-4095	67	2	main	main	ADJ
dpc-4095	67	3	pathogenesis	pathogenesis	NOUN
dpc-4095	67	4	of	of	ADP
dpc-4095	67	5	cate	cate	NOUN
dpc-4095	67	6	was	be	AUX
dpc-4095	67	7	still	still	ADV
dpc-4095	67	8	not	not	PART
dpc-4095	67	9	fully	fully	ADV
dpc-4095	67	10	understood	understand	VERB
dpc-4095	67	11	,	,	PUNCT
dpc-4095	67	12	however	however	ADV
dpc-4095	67	13	,	,	PUNCT
dpc-4095	67	14	several	several	ADJ
dpc-4095	67	15	factors	factor	NOUN
dpc-4095	67	16	were	be	AUX
dpc-4095	67	17	implicated	implicate	VERB
dpc-4095	67	18	.	.	PUNCT
dpc-4095	68	1	recent	recent	ADJ
dpc-4095	68	2	studies	study	NOUN
dpc-4095	68	3	reported	report	VERB
dpc-4095	68	4	that	that	SCONJ
dpc-4095	68	5	proinflammatory	proinflammatory	ADJ
dpc-4095	68	6	cytokines	cytokine	NOUN
dpc-4095	68	7	such	such	ADJ
dpc-4095	68	8	as	as	ADP
dpc-4095	68	9	interleukin	interleukin	NOUN
dpc-4095	68	10	1β	1β	NOUN
dpc-4095	68	11	,	,	PUNCT
dpc-4095	68	12	interleukin	interleukin	NOUN
dpc-4095	68	13	6	6	NUM
dpc-4095	68	14	,	,	PUNCT
dpc-4095	68	15	tumor	tumor	NOUN
dpc-4095	68	16	necrosis	necrosis	NOUN
dpc-4095	68	17	factor	factor	NOUN
dpc-4095	68	18	α	α	NOUN
dpc-4095	68	19	,	,	PUNCT
dpc-4095	68	20	type	type	NOUN
dpc-4095	68	21	1	1	NUM
dpc-4095	68	22	and	and	CCONJ
dpc-4095	68	23	type	type	NOUN
dpc-4095	68	24	2	2	NUM
dpc-4095	68	25	interferon	interferon	NOUN
dpc-4095	68	26	,	,	PUNCT
dpc-4095	68	27	and	and	CCONJ
dpc-4095	68	28	metalloproteinases	metalloproteinase	NOUN
dpc-4095	68	29	1	1	NUM
dpc-4095	68	30	and	and	CCONJ
dpc-4095	68	31	3	3	NUM
dpc-4095	68	32	affect	affect	VERB
dpc-4095	68	33	matrix	matrix	NOUN
dpc-4095	68	34	cells	cell	NOUN
dpc-4095	68	35	of	of	ADP
dpc-4095	68	36	the	the	DET
dpc-4095	68	37	follicle	follicle	NOUN
dpc-4095	68	38	[	[	X
dpc-4095	68	39	7	7	NUM
dpc-4095	68	40	-	-	SYM
dpc-4095	68	41	9	9	NUM
dpc-4095	68	42	]	]	PUNCT
dpc-4095	68	43	.	.	PUNCT
dpc-4095	69	1	metalloproteinases	metalloproteinase	NOUN
dpc-4095	69	2	1	1	NUM
dpc-4095	69	3	and	and	CCONJ
dpc-4095	69	4	3	3	NUM
dpc-4095	69	5	,	,	PUNCT
dpc-4095	69	6	and	and	CCONJ
dpc-4095	69	7	interleukin	interleukin	NOUN
dpc-4095	69	8	1β	1β	NUM
dpc-4095	69	9	inhibit	inhibit	NOUN
dpc-4095	69	10	hair	hair	NOUN
dpc-4095	69	11	follicle	follicle	NOUN
dpc-4095	69	12	growth	growth	NOUN
dpc-4095	69	13	,	,	PUNCT
dpc-4095	69	14	and	and	CCONJ
dpc-4095	69	15	interleukin	interleukin	NOUN
dpc-4095	69	16	6	6	NUM
dpc-4095	69	17	induces	induce	VERB
dpc-4095	69	18	the	the	DET
dpc-4095	69	19	catagen	catagen	NOUN
dpc-4095	69	20	phase	phase	NOUN
dpc-4095	69	21	[	[	X
dpc-4095	69	22	10,11	10,11	NOUN
dpc-4095	69	23	]	]	PUNCT
dpc-4095	69	24	.	.	PUNCT
dpc-4095	70	1	in	in	ADP
dpc-4095	70	2	addition	addition	NOUN
dpc-4095	70	3	,	,	PUNCT
dpc-4095	70	4	this	this	DET
dpc-4095	70	5	systemic	systemic	ADJ
dpc-4095	70	6	cytokine	cytokine	NOUN
dpc-4095	70	7	storm	storm	NOUN
dpc-4095	70	8	may	may	AUX
dpc-4095	70	9	mediate	mediate	VERB
dpc-4095	70	10	microvascular	microvascular	ADJ
dpc-4095	70	11	inflammation	inflammation	NOUN
dpc-4095	70	12	and	and	CCONJ
dpc-4095	70	13	the	the	DET
dpc-4095	70	14	activation	activation	NOUN
dpc-4095	70	15	of	of	ADP
dpc-4095	70	16	the	the	DET
dpc-4095	70	17	coagulation	coagulation	NOUN
dpc-4095	70	18	cascade	cascade	NOUN
dpc-4095	70	19	and	and	CCONJ
dpc-4095	70	20	decrease	decrease	VERB
dpc-4095	70	21	the	the	DET
dpc-4095	70	22	concentration	concentration	NOUN
dpc-4095	70	23	of	of	ADP
dpc-4095	70	24	anticoagulant	anticoagulant	ADJ
dpc-4095	70	25	proteins	protein	NOUN
dpc-4095	70	26	.	.	PUNCT
dpc-4095	71	1	this	this	DET
dpc-4095	71	2	process	process	NOUN
dpc-4095	71	3	may	may	AUX
dpc-4095	71	4	end	end	VERB
dpc-4095	71	5	with	with	ADP
dpc-4095	71	6	capillary	capillary	ADJ
dpc-4095	71	7	thrombosis	thrombosis	NOUN
dpc-4095	71	8	and	and	CCONJ
dpc-4095	71	9	dermal	dermal	ADJ
dpc-4095	71	10	fibrosis	fibrosis	NOUN
dpc-4095	71	11	[	[	X
dpc-4095	71	12	12	12	NUM
dpc-4095	71	13	-	-	SYM
dpc-4095	71	14	14	14	NUM
dpc-4095	71	15	]	]	PUNCT
dpc-4095	71	16	.	.	PUNCT
dpc-4095	72	1	another	another	DET
dpc-4095	72	2	hypothesized	hypothesize	VERB
dpc-4095	72	3	mechanism	mechanism	NOUN
dpc-4095	72	4	was	be	AUX
dpc-4095	72	5	fcγ	fcγ	NOUN
dpc-4095	72	6	-	-	PUNCT
dpc-4095	72	7	mediated	mediate	VERB
dpc-4095	72	8	virus	virus	NOUN
dpc-4095	72	9	entry	entry	NOUN
dpc-4095	72	10	into	into	ADP
dpc-4095	72	11	the	the	DET
dpc-4095	72	12	host	host	NOUN
dpc-4095	72	13	cells	cell	NOUN
dpc-4095	72	14	because	because	SCONJ
dpc-4095	72	15	of	of	ADP
dpc-4095	72	16	non	non	ADJ
dpc-4095	72	17	-	-	ADJ
dpc-4095	72	18	neutralizing	neutralizing	ADJ
dpc-4095	72	19	virus	virus	NOUN
dpc-4095	72	20	-	-	PUNCT
dpc-4095	72	21	specific	specific	ADJ
dpc-4095	72	22	antibodies	antibody	NOUN
dpc-4095	72	23	(	(	PUNCT
dpc-4095	72	24	nab	nab	NOUN
dpc-4095	72	25	)	)	PUNCT
dpc-4095	73	1	[	[	X
dpc-4095	73	2	15	15	NUM
dpc-4095	73	3	]	]	PUNCT
dpc-4095	73	4	.	.	PUNCT
dpc-4095	74	1	therefore	therefore	ADV
dpc-4095	74	2	,	,	PUNCT
dpc-4095	74	3	cate	cate	PROPN
dpc-4095	74	4	develops	develop	VERB
dpc-4095	74	5	because	because	SCONJ
dpc-4095	74	6	of	of	ADP
dpc-4095	74	7	the	the	DET
dpc-4095	74	8	early	early	ADJ
dpc-4095	74	9	-	-	PUNCT
dpc-4095	74	10	onset	onset	NOUN
dpc-4095	74	11	telogen	telogen	NOUN
dpc-4095	74	12	phase	phase	NOUN
dpc-4095	74	13	,	,	PUNCT
dpc-4095	74	14	namely	namely	ADV
dpc-4095	74	15	,	,	PUNCT
dpc-4095	74	16	dystrophic	dystrophic	ADJ
dpc-4095	74	17	anagen	anagen	NOUN
dpc-4095	74	18	effluvium	effluvium	NOUN
dpc-4095	74	19	.	.	PUNCT
dpc-4095	75	1	thus	thus	ADV
dpc-4095	75	2	,	,	PUNCT
dpc-4095	75	3	patients	patient	NOUN
dpc-4095	75	4	with	with	ADP
dpc-4095	75	5	cate	cate	PROPN
dpc-4095	75	6	have	have	VERB
dpc-4095	75	7	a	a	DET
dpc-4095	75	8	shorter	short	ADJ
dpc-4095	75	9	time	time	NOUN
dpc-4095	75	10	of	of	ADP
dpc-4095	75	11	onset	onset	NOUN
dpc-4095	75	12	,	,	PUNCT
dpc-4095	75	13	typically	typically	ADV
dpc-4095	75	14	1–2	1–2	NUM
dpc-4095	75	15	months	month	NOUN
dpc-4095	75	16	instead	instead	ADV
dpc-4095	75	17	of	of	ADP
dpc-4095	75	18	3	3	NUM
dpc-4095	75	19	months	month	NOUN
dpc-4095	75	20	compared	compare	VERB
dpc-4095	75	21	with	with	ADP
dpc-4095	75	22	tedoc	tedoc	PRON
dpc-4095	75	23	[	[	X
dpc-4095	75	24	16	16	NUM
dpc-4095	75	25	]	]	PUNCT
dpc-4095	75	26	.	.	PUNCT
dpc-4095	76	1	in	in	ADP
dpc-4095	76	2	our	our	PRON
dpc-4095	76	3	study	study	NOUN
dpc-4095	76	4	,	,	PUNCT
dpc-4095	76	5	we	we	PRON
dpc-4095	76	6	found	find	VERB
dpc-4095	76	7	shorter	short	ADJ
dpc-4095	76	8	time	time	NOUN
dpc-4095	76	9	between	between	ADP
dpc-4095	76	10	the	the	DET
dpc-4095	76	11	onset	onset	NOUN
dpc-4095	76	12	of	of	ADP
dpc-4095	76	13	trigger	trigger	NOUN
dpc-4095	76	14	and	and	CCONJ
dpc-4095	76	15	hair	hair	NOUN
dpc-4095	76	16	loss	loss	NOUN
dpc-4095	76	17	complaint	complaint	NOUN
dpc-4095	76	18	in	in	ADP
dpc-4095	76	19	patients	patient	NOUN
dpc-4095	76	20	with	with	ADP
dpc-4095	76	21	cate	cate	NOUN
dpc-4095	76	22	than	than	ADP
dpc-4095	76	23	in	in	ADP
dpc-4095	76	24	patients	patient	NOUN
dpc-4095	76	25	with	with	ADP
dpc-4095	76	26	tedoc	tedoc	PROPN
dpc-4095	76	27	.	.	PUNCT
dpc-4095	77	1	common	common	ADJ
dpc-4095	77	2	dermoscopic	dermoscopic	ADJ
dpc-4095	77	3	findings	finding	NOUN
dpc-4095	77	4	of	of	ADP
dpc-4095	77	5	the	the	DET
dpc-4095	77	6	patients	patient	NOUN
dpc-4095	77	7	with	with	ADP
dpc-4095	77	8	te	te	PROPN
dpc-4095	77	9	are	be	AUX
dpc-4095	77	10	reduced	reduce	VERB
dpc-4095	77	11	hair	hair	NOUN
dpc-4095	77	12	density	density	NOUN
dpc-4095	77	13	,	,	PUNCT
dpc-4095	77	14	one	one	NUM
dpc-4095	77	15	emerging	emerge	VERB
dpc-4095	77	16	hair	hair	NOUN
dpc-4095	77	17	on	on	ADP
dpc-4095	77	18	the	the	DET
dpc-4095	77	19	follicle	follicle	NOUN
dpc-4095	77	20	,	,	PUNCT
dpc-4095	77	21	etc	etc	X
dpc-4095	78	1	[	[	X
dpc-4095	78	2	17	17	NUM
dpc-4095	78	3	]	]	PUNCT
dpc-4095	78	4	.	.	PUNCT
dpc-4095	79	1	unfortunately	unfortunately	ADV
dpc-4095	79	2	,	,	PUNCT
dpc-4095	79	3	these	these	DET
dpc-4095	79	4	findings	finding	NOUN
dpc-4095	79	5	were	be	AUX
dpc-4095	79	6	not	not	PART
dpc-4095	79	7	specific	specific	ADJ
dpc-4095	79	8	and	and	CCONJ
dpc-4095	79	9	could	could	AUX
dpc-4095	79	10	be	be	AUX
dpc-4095	79	11	seen	see	VERB
dpc-4095	79	12	in	in	ADP
dpc-4095	79	13	cate	cate	PROPN
dpc-4095	79	14	and/or	and/or	CCONJ
dpc-4095	79	15	tedoc.[18	tedoc.[18	PROPN
dpc-4095	79	16	]	]	PUNCT
dpc-4095	79	17	however	however	ADV
dpc-4095	79	18	,	,	PUNCT
dpc-4095	79	19	lv	lv	PROPN
dpc-4095	79	20	et	et	NOUN
dpc-4095	79	21	al	al	PROPN
dpc-4095	79	22	reported	report	VERB
dpc-4095	79	23	a	a	DET
dpc-4095	79	24	case	case	NOUN
dpc-4095	79	25	with	with	ADP
dpc-4095	79	26	cate	cate	NOUN
dpc-4095	79	27	had	have	VERB
dpc-4095	79	28	scalp	scalp	NOUN
dpc-4095	79	29	capillary	capillary	ADJ
dpc-4095	79	30	ectasia	ectasia	NOUN
dpc-4095	79	31	without	without	ADP
dpc-4095	79	32	any	any	DET
dpc-4095	79	33	inflammatory	inflammatory	ADJ
dpc-4095	79	34	scalp	scalp	NOUN
dpc-4095	79	35	disease	disease	NOUN
dpc-4095	79	36	because	because	SCONJ
dpc-4095	79	37	of	of	ADP
dpc-4095	79	38	medium	medium	NOUN
dpc-4095	79	39	to	to	ADP
dpc-4095	79	40	small	small	ADJ
dpc-4095	79	41	vessel	vessel	NOUN
dpc-4095	79	42	dilatation	dilatation	NOUN
dpc-4095	79	43	due	due	ADP
dpc-4095	79	44	to	to	ADP
dpc-4095	79	45	the	the	DET
dpc-4095	79	46	inflammatory	inflammatory	ADJ
dpc-4095	79	47	stimulus	stimulus	NOUN
dpc-4095	79	48	of	of	ADP
dpc-4095	79	49	sars	sar	NOUN
dpc-4095	79	50	-	-	PUNCT
dpc-4095	79	51	cov-2	cov-2	NOUN
dpc-4095	79	52	.	.	PUNCT
dpc-4095	80	1	[	[	X
dpc-4095	80	2	19	19	NUM
dpc-4095	80	3	]	]	PUNCT
dpc-4095	80	4	.	.	PUNCT
dpc-4095	81	1	they	they	PRON
dpc-4095	81	2	also	also	ADV
dpc-4095	81	3	declared	declare	VERB
dpc-4095	81	4	that	that	SCONJ
dpc-4095	81	5	this	this	DET
dpc-4095	81	6	dermoscopic	dermoscopic	NOUN
dpc-4095	81	7	finding	finding	NOUN
dpc-4095	81	8	was	be	AUX
dpc-4095	81	9	regressed	regress	VERB
dpc-4095	81	10	at	at	ADP
dpc-4095	81	11	3rd	3rd	ADJ
dpc-4095	81	12	month	month	NOUN
dpc-4095	81	13	of	of	ADP
dpc-4095	81	14	control	control	NOUN
dpc-4095	81	15	.	.	PUNCT
dpc-4095	82	1	saber	saber	PROPN
dpc-4095	82	2	et	et	PROPN
dpc-4095	82	3	al	al	PROPN
dpc-4095	82	4	.	.	PROPN
dpc-4095	82	5	suggested	suggest	VERB
dpc-4095	82	6	scalp	scalp	NOUN
dpc-4095	82	7	capillary	capillary	ADJ
dpc-4095	82	8	ectasia	ectasia	NOUN
dpc-4095	82	9	as	as	ADP
dpc-4095	82	10	a	a	DET
dpc-4095	82	11	trichoscopic	trichoscopic	NOUN
dpc-4095	82	12	sign	sign	NOUN
dpc-4095	82	13	and	and	CCONJ
dpc-4095	82	14	a	a	DET
dpc-4095	82	15	diagnostic	diagnostic	ADJ
dpc-4095	82	16	clue	clue	NOUN
dpc-4095	82	17	for	for	ADP
dpc-4095	82	18	patients	patient	NOUN
dpc-4095	82	19	with	with	ADP
dpc-4095	82	20	cate	cate	NOUN
dpc-4095	82	21	[	[	X
dpc-4095	82	22	20	20	NUM
dpc-4095	82	23	]	]	PUNCT
dpc-4095	82	24	.	.	PUNCT
dpc-4095	83	1	we	we	PRON
dpc-4095	83	2	did	do	AUX
dpc-4095	83	3	not	not	PART
dpc-4095	83	4	observe	observe	VERB
dpc-4095	83	5	this	this	DET
dpc-4095	83	6	dermoscopic	dermoscopic	NOUN
dpc-4095	83	7	finding	finding	NOUN
dpc-4095	83	8	in	in	ADP
dpc-4095	83	9	our	our	PRON
dpc-4095	83	10	patients	patient	NOUN
dpc-4095	83	11	with	with	ADP
dpc-4095	83	12	cate	cate	NOUN
dpc-4095	83	13	because	because	SCONJ
dpc-4095	83	14	our	our	PRON
dpc-4095	83	15	patients	patient	NOUN
dpc-4095	83	16	applied	apply	VERB
dpc-4095	83	17	to	to	ADP
dpc-4095	83	18	the	the	DET
dpc-4095	83	19	hospital	hospital	NOUN
dpc-4095	83	20	when	when	SCONJ
dpc-4095	83	21	the	the	DET
dpc-4095	83	22	mean	mean	ADJ
dpc-4095	83	23	disease	disease	NOUN
dpc-4095	83	24	duration	duration	NOUN
dpc-4095	83	25	was	be	AUX
dpc-4095	83	26	102.5	102.5	NUM
dpc-4095	83	27	+	+	NUM
dpc-4095	83	28	35.2	35.2	NUM
dpc-4095	83	29	days	day	NOUN
dpc-4095	83	30	.	.	PUNCT
dpc-4095	84	1	however	however	ADV
dpc-4095	84	2	,	,	PUNCT
dpc-4095	84	3	empty	empty	ADJ
dpc-4095	84	4	follicular	follicular	ADJ
dpc-4095	84	5	openings	opening	NOUN
dpc-4095	84	6	and	and	CCONJ
dpc-4095	84	7	yellow	yellow	ADJ
dpc-4095	84	8	dots	dot	NOUN
dpc-4095	84	9	were	be	AUX
dpc-4095	84	10	statistically	statistically	ADV
dpc-4095	84	11	higher	high	ADJ
dpc-4095	84	12	in	in	ADP
dpc-4095	84	13	patients	patient	NOUN
dpc-4095	84	14	with	with	ADP
dpc-4095	84	15	cate	cate	NOUN
dpc-4095	84	16	,	,	PUNCT
dpc-4095	84	17	whereas	whereas	SCONJ
dpc-4095	84	18	short	short	ADJ
dpc-4095	84	19	regrowing	regrowing	NOUN
dpc-4095	84	20	hair	hair	NOUN
dpc-4095	84	21	were	be	AUX
dpc-4095	84	22	significantly	significantly	ADV
dpc-4095	84	23	higher	high	ADJ
dpc-4095	84	24	in	in	ADP
dpc-4095	84	25	patients	patient	NOUN
dpc-4095	84	26	with	with	ADP
dpc-4095	84	27	tedoc	tedoc	NOUN
dpc-4095	84	28	.	.	PUNCT
dpc-4095	85	1	this	this	DET
dpc-4095	85	2	result	result	NOUN
dpc-4095	85	3	could	could	AUX
dpc-4095	85	4	be	be	AUX
dpc-4095	85	5	explained	explain	VERB
dpc-4095	85	6	by	by	ADP
dpc-4095	85	7	the	the	DET
dpc-4095	85	8	fact	fact	NOUN
dpc-4095	85	9	that	that	SCONJ
dpc-4095	85	10	cate	cate	PROPN
dpc-4095	85	11	patients	patient	NOUN
dpc-4095	85	12	were	be	AUX
dpc-4095	85	13	more	more	ADV
dpc-4095	85	14	in	in	ADP
dpc-4095	85	15	acute	acute	NOUN
dpc-4095	85	16	te	te	ADP
dpc-4095	85	17	,	,	PUNCT
dpc-4095	85	18	while	while	SCONJ
dpc-4095	85	19	tedoc	tedoc	ADJ
dpc-4095	85	20	patients	patient	NOUN
dpc-4095	85	21	were	be	AUX
dpc-4095	85	22	more	more	ADV
dpc-4095	85	23	in	in	ADP
dpc-4095	85	24	chronic	chronic	NOUN
dpc-4095	85	25	te	te	PROPN
dpc-4095	85	26	.	.	PUNCT
dpc-4095	86	1	because	because	SCONJ
dpc-4095	86	2	of	of	ADP
dpc-4095	86	3	having	have	VERB
dpc-4095	86	4	more	more	ADV
dpc-4095	86	5	stressful	stressful	ADJ
dpc-4095	86	6	events	event	NOUN
dpc-4095	86	7	such	such	ADJ
dpc-4095	86	8	as	as	ADP
dpc-4095	86	9	delivery	delivery	NOUN
dpc-4095	86	10	,	,	PUNCT
dpc-4095	86	11	abortion	abortion	NOUN
dpc-4095	86	12	,	,	PUNCT
dpc-4095	86	13	lactation	lactation	NOUN
dpc-4095	86	14	,	,	PUNCT
dpc-4095	86	15	etc	etc	X
dpc-4095	86	16	,	,	PUNCT
dpc-4095	86	17	te	te	PROPN
dpc-4095	86	18	is	be	AUX
dpc-4095	86	19	more	more	ADV
dpc-4095	86	20	commonly	commonly	ADV
dpc-4095	86	21	seen	see	VERB
dpc-4095	86	22	in	in	ADP
dpc-4095	86	23	table	table	NOUN
dpc-4095	86	24	1	1	NUM
dpc-4095	86	25	.	.	PUNCT
dpc-4095	86	26	demografic	demografic	ADJ
dpc-4095	86	27	features	feature	NOUN
dpc-4095	86	28	of	of	ADP
dpc-4095	86	29	the	the	DET
dpc-4095	86	30	patients	patient	NOUN
dpc-4095	86	31	demografic	demografic	VERB
dpc-4095	86	32	features	feature	NOUN
dpc-4095	86	33	of	of	ADP
dpc-4095	86	34	the	the	DET
dpc-4095	86	35	patients	patient	NOUN
dpc-4095	86	36	sars	sar	NOUN
dpc-4095	86	37	-	-	PUNCT
dpc-4095	86	38	cov-2	cov-2	NOUN
dpc-4095	86	39	associated	associate	VERB
dpc-4095	86	40	te	te	ADP
dpc-4095	86	41	n	n	PROPN
dpc-4095	86	42	=	=	SYM
dpc-4095	86	43	52	52	NUM
dpc-4095	86	44	(	(	PUNCT
dpc-4095	86	45	%	%	INTJ
dpc-4095	86	46	)	)	PUNCT
dpc-4095	87	1	te	te	ADP
dpc-4095	87	2	due	due	ADP
dpc-4095	87	3	to	to	ADP
dpc-4095	87	4	other	other	ADJ
dpc-4095	87	5	causes	cause	NOUN
dpc-4095	87	6	n	n	NOUN
dpc-4095	87	7	=	=	SYM
dpc-4095	87	8	40	40	NUM
dpc-4095	87	9	(	(	PUNCT
dpc-4095	87	10	%	%	NOUN
dpc-4095	87	11	)	)	PUNCT
dpc-4095	87	12	p	p	NOUN
dpc-4095	87	13	value	value	NOUN
dpc-4095	87	14	gender	gender	NOUN
dpc-4095	87	15	female	female	ADJ
dpc-4095	87	16	male	male	NOUN
dpc-4095	87	17	46	46	NUM
dpc-4095	87	18	(	(	PUNCT
dpc-4095	87	19	88.5	88.5	NUM
dpc-4095	87	20	%	%	NOUN
dpc-4095	87	21	)	)	PUNCT
dpc-4095	87	22	6	6	NUM
dpc-4095	87	23	(	(	PUNCT
dpc-4095	87	24	11.5	11.5	NUM
dpc-4095	87	25	%	%	NOUN
dpc-4095	87	26	)	)	PUNCT
dpc-4095	87	27	37(92.5	37(92.5	NUM
dpc-4095	87	28	%	%	NOUN
dpc-4095	87	29	)	)	PUNCT
dpc-4095	87	30	3	3	NUM
dpc-4095	87	31	(	(	PUNCT
dpc-4095	87	32	7.5	7.5	NUM
dpc-4095	87	33	%	%	NOUN
dpc-4095	87	34	)	)	PUNCT
dpc-4095	87	35	0.197	0.197	NUM
dpc-4095	87	36	mean	mean	NOUN
dpc-4095	87	37	age	age	NOUN
dpc-4095	87	38	of	of	ADP
dpc-4095	87	39	the	the	DET
dpc-4095	87	40	patients	patient	NOUN
dpc-4095	87	41	(	(	PUNCT
dpc-4095	87	42	+	+	NUM
dpc-4095	87	43	sd	sd	NOUN
dpc-4095	87	44	)	)	PUNCT
dpc-4095	87	45	(	(	PUNCT
dpc-4095	87	46	year	year	NOUN
dpc-4095	87	47	)	)	PUNCT
dpc-4095	87	48	30.3	30.3	NUM
dpc-4095	88	1	+	+	CCONJ
dpc-4095	88	2	10.7	10.7	NUM
dpc-4095	88	3	27.9	27.9	NUM
dpc-4095	88	4	+	+	CCONJ
dpc-4095	88	5	10.7	10.7	NUM
dpc-4095	88	6	0.888	0.888	NUM
dpc-4095	88	7	mean	mean	NOUN
dpc-4095	88	8	duration	duration	NOUN
dpc-4095	88	9	of	of	ADP
dpc-4095	88	10	disease	disease	NOUN
dpc-4095	88	11	(	(	PUNCT
dpc-4095	88	12	+	+	NUM
dpc-4095	88	13	sd	sd	NOUN
dpc-4095	88	14	)	)	PUNCT
dpc-4095	88	15	(	(	PUNCT
dpc-4095	88	16	day	day	NOUN
dpc-4095	88	17	)	)	PUNCT
dpc-4095	88	18	102.5	102.5	NUM
dpc-4095	89	1	+	+	NUM
dpc-4095	89	2	35.2	35.2	NUM
dpc-4095	89	3	249.7	249.7	NUM
dpc-4095	89	4	+	+	CCONJ
dpc-4095	89	5	109.3	109.3	NUM
dpc-4095	89	6	0.077	0.077	NUM
dpc-4095	89	7	mean	mean	ADJ
dpc-4095	89	8	time	time	NOUN
dpc-4095	89	9	between	between	ADP
dpc-4095	89	10	the	the	DET
dpc-4095	89	11	onset	onset	NOUN
dpc-4095	89	12	of	of	ADP
dpc-4095	89	13	trigger	trigger	NOUN
dpc-4095	89	14	and	and	CCONJ
dpc-4095	89	15	hair	hair	NOUN
dpc-4095	89	16	loss	loss	NOUN
dpc-4095	89	17	complaint	complaint	NOUN
dpc-4095	89	18	(	(	PUNCT
dpc-4095	89	19	day	day	NOUN
dpc-4095	89	20	)	)	PUNCT
dpc-4095	89	21	64.8	64.8	NUM
dpc-4095	90	1	+	+	NUM
dpc-4095	90	2	25.6	25.6	NUM
dpc-4095	90	3	133.5	133.5	NUM
dpc-4095	90	4	+	+	NUM
dpc-4095	90	5	5.8	5.8	NUM
dpc-4095	90	6	0.003	0.003	NUM
dpc-4095	90	7	acute	acute	NOUN
dpc-4095	90	8	te	te	ADP
dpc-4095	90	9	chronic	chronic	NOUN
dpc-4095	90	10	te	te	ADP
dpc-4095	90	11	48	48	NUM
dpc-4095	90	12	(	(	PUNCT
dpc-4095	90	13	92.3	92.3	NUM
dpc-4095	90	14	%	%	NOUN
dpc-4095	90	15	)	)	PUNCT
dpc-4095	90	16	4	4	NUM
dpc-4095	90	17	(	(	PUNCT
dpc-4095	90	18	7.7	7.7	NUM
dpc-4095	90	19	%	%	NOUN
dpc-4095	90	20	)	)	PUNCT
dpc-4095	90	21	19	19	NUM
dpc-4095	90	22	(	(	PUNCT
dpc-4095	90	23	47.5	47.5	NUM
dpc-4095	90	24	%	%	NOUN
dpc-4095	90	25	)	)	PUNCT
dpc-4095	90	26	21	21	NUM
dpc-4095	90	27	(	(	PUNCT
dpc-4095	90	28	52.5	52.5	NUM
dpc-4095	90	29	%	%	NOUN
dpc-4095	90	30	)	)	PUNCT
dpc-4095	90	31	0.001	0.001	NUM
dpc-4095	90	32	accompanying	accompany	VERB
dpc-4095	90	33	systemic	systemic	ADJ
dpc-4095	90	34	disease	disease	NOUN
dpc-4095	90	35	present	present	ADJ
dpc-4095	90	36	absent	absent	ADJ
dpc-4095	90	37	3	3	NUM
dpc-4095	90	38	(	(	PUNCT
dpc-4095	90	39	5.8	5.8	NUM
dpc-4095	90	40	%	%	NOUN
dpc-4095	90	41	)	)	PUNCT
dpc-4095	90	42	49	49	NUM
dpc-4095	90	43	(	(	PUNCT
dpc-4095	90	44	94.2	94.2	NUM
dpc-4095	90	45	%	%	NOUN
dpc-4095	90	46	)	)	PUNCT
dpc-4095	90	47	7	7	NUM
dpc-4095	90	48	(	(	PUNCT
dpc-4095	90	49	17.5	17.5	NUM
dpc-4095	90	50	%	%	NOUN
dpc-4095	90	51	)	)	PUNCT
dpc-4095	90	52	33	33	NUM
dpc-4095	90	53	(	(	PUNCT
dpc-4095	90	54	82.5	82.5	NUM
dpc-4095	90	55	%	%	NOUN
dpc-4095	90	56	)	)	PUNCT
dpc-4095	90	57	0.073	0.073	NUM
dpc-4095	90	58	sd	sd	NOUN
dpc-4095	90	59	=	=	SYM
dpc-4095	90	60	standard	standard	ADJ
dpc-4095	90	61	deviation	deviation	NOUN
dpc-4095	90	62	;	;	PUNCT
dpc-4095	90	63	te	te	PROPN
dpc-4095	90	64	=	=	PUNCT
dpc-4095	90	65	telogen	telogen	NOUN
dpc-4095	90	66	effluvium	effluvium	NOUN
dpc-4095	90	67	.	.	PUNCT
dpc-4095	91	1	4	4	NUM
dpc-4095	91	2	original	original	ADJ
dpc-4095	91	3	article|	article|	NOUN
dpc-4095	91	4	dermatol	dermatol	ADJ
dpc-4095	91	5	pract	pract	PROPN
dpc-4095	91	6	concept	concept	NOUN
dpc-4095	91	7	.	.	PUNCT
dpc-4095	92	1	2024;14(3):e2024170	2024;14(3):e2024170	DET
dpc-4095	92	2	cate	cate	NOUN
dpc-4095	92	3	is	be	AUX
dpc-4095	92	4	characterized	characterize	VERB
dpc-4095	92	5	by	by	ADP
dpc-4095	92	6	excessive	excessive	ADJ
dpc-4095	92	7	hair	hair	NOUN
dpc-4095	92	8	loss	loss	NOUN
dpc-4095	92	9	,	,	PUNCT
dpc-4095	92	10	positive	positive	ADJ
dpc-4095	92	11	hair	hair	NOUN
dpc-4095	92	12	pull	pull	VERB
dpc-4095	92	13	test	test	NOUN
dpc-4095	92	14	,	,	PUNCT
dpc-4095	92	15	not	not	PART
dpc-4095	92	16	having	have	VERB
dpc-4095	92	17	anisotrichosis	anisotrichosis	PRON
dpc-4095	92	18	in	in	ADP
dpc-4095	92	19	dermoscopic	dermoscopic	NOUN
dpc-4095	92	20	examination	examination	NOUN
dpc-4095	92	21	and	and	CCONJ
dpc-4095	92	22	not	not	PART
dpc-4095	92	23	having	have	VERB
dpc-4095	92	24	underlying	underlie	VERB
dpc-4095	92	25	other	other	ADJ
dpc-4095	92	26	common	common	ADJ
dpc-4095	92	27	te	te	PROPN
dpc-4095	92	28	causes	cause	NOUN
dpc-4095	92	29	.	.	PUNCT
dpc-4095	93	1	however	however	ADV
dpc-4095	93	2	,	,	PUNCT
dpc-4095	93	3	lots	lot	NOUN
dpc-4095	93	4	of	of	ADP
dpc-4095	93	5	patients	patient	NOUN
dpc-4095	93	6	could	could	AUX
dpc-4095	93	7	have	have	VERB
dpc-4095	93	8	systemic	systemic	ADJ
dpc-4095	93	9	comorbidities	comorbiditie	NOUN
dpc-4095	93	10	and	and	CCONJ
dpc-4095	93	11	sars	sar	NOUN
dpc-4095	93	12	-	-	PUNCT
dpc-4095	93	13	cov-2	cov-2	PART
dpc-4095	93	14	infection	infection	NOUN
dpc-4095	93	15	at	at	ADP
dpc-4095	93	16	the	the	DET
dpc-4095	93	17	same	same	ADJ
dpc-4095	93	18	time	time	NOUN
dpc-4095	93	19	.	.	PUNCT
dpc-4095	94	1	they	they	PRON
dpc-4095	94	2	could	could	AUX
dpc-4095	94	3	also	also	ADV
dpc-4095	94	4	have	have	VERB
dpc-4095	94	5	cate	cate	NOUN
dpc-4095	94	6	after	after	ADP
dpc-4095	94	7	infection	infection	NOUN
dpc-4095	94	8	.	.	PUNCT
dpc-4095	95	1	at	at	ADP
dpc-4095	95	2	this	this	DET
dpc-4095	95	3	situation	situation	NOUN
dpc-4095	95	4	,	,	PUNCT
dpc-4095	95	5	the	the	DET
dpc-4095	95	6	exact	exact	ADJ
dpc-4095	95	7	time	time	NOUN
dpc-4095	95	8	of	of	ADP
dpc-4095	95	9	the	the	DET
dpc-4095	95	10	onset	onset	NOUN
dpc-4095	95	11	of	of	ADP
dpc-4095	95	12	the	the	DET
dpc-4095	95	13	complaint	complaint	NOUN
dpc-4095	95	14	was	be	AUX
dpc-4095	95	15	taken	take	VERB
dpc-4095	95	16	as	as	ADP
dpc-4095	95	17	basis	basis	NOUN
dpc-4095	95	18	.	.	PUNCT
dpc-4095	96	1	if	if	SCONJ
dpc-4095	96	2	the	the	DET
dpc-4095	96	3	complaints	complaint	NOUN
dpc-4095	96	4	started	start	VERB
dpc-4095	96	5	after	after	ADP
dpc-4095	96	6	sars	sar	NOUN
dpc-4095	96	7	-	-	PUNCT
dpc-4095	96	8	cov-2	cov-2	PART
dpc-4095	96	9	infection	infection	NOUN
dpc-4095	96	10	immediately	immediately	ADV
dpc-4095	96	11	,	,	PUNCT
dpc-4095	96	12	it	it	PRON
dpc-4095	96	13	is	be	AUX
dpc-4095	96	14	categorized	categorize	VERB
dpc-4095	96	15	as	as	ADP
dpc-4095	96	16	cate	cate	NOUN
dpc-4095	96	17	[	[	X
dpc-4095	96	18	23	23	NUM
dpc-4095	96	19	]	]	PUNCT
dpc-4095	96	20	.	.	PUNCT
dpc-4095	97	1	in	in	ADP
dpc-4095	97	2	our	our	PRON
dpc-4095	97	3	study	study	NOUN
dpc-4095	97	4	,	,	PUNCT
dpc-4095	97	5	24	24	NUM
dpc-4095	97	6	(	(	PUNCT
dpc-4095	97	7	46.2	46.2	NUM
dpc-4095	97	8	%	%	NOUN
dpc-4095	97	9	)	)	PUNCT
dpc-4095	97	10	patients	patient	NOUN
dpc-4095	97	11	had	have	VERB
dpc-4095	97	12	iron	iron	NOUN
dpc-4095	97	13	deficiency	deficiency	NOUN
dpc-4095	97	14	,	,	PUNCT
dpc-4095	97	15	14	14	NUM
dpc-4095	97	16	(	(	PUNCT
dpc-4095	97	17	26.9	26.9	NUM
dpc-4095	97	18	%	%	NOUN
dpc-4095	97	19	)	)	PUNCT
dpc-4095	97	20	patients	patient	NOUN
dpc-4095	97	21	had	have	VERB
dpc-4095	97	22	vitamin	vitamin	NOUN
dpc-4095	97	23	b12	b12	NOUN
dpc-4095	97	24	deficiency	deficiency	NOUN
dpc-4095	97	25	,	,	PUNCT
dpc-4095	97	26	and	and	CCONJ
dpc-4095	97	27	10	10	NUM
dpc-4095	97	28	(	(	PUNCT
dpc-4095	97	29	19.2	19.2	NUM
dpc-4095	97	30	%	%	NOUN
dpc-4095	97	31	)	)	PUNCT
dpc-4095	97	32	patients	patient	NOUN
dpc-4095	97	33	had	have	VERB
dpc-4095	97	34	25	25	NUM
dpc-4095	97	35	-	-	PUNCT
dpc-4095	97	36	oh	oh	NUM
dpc-4095	97	37	-	-	PUNCT
dpc-4095	97	38	vitamin	vitamin	NOUN
dpc-4095	97	39	d	d	NOUN
dpc-4095	97	40	deficiency	deficiency	NOUN
dpc-4095	97	41	in	in	ADP
dpc-4095	97	42	cate	cate	PROPN
dpc-4095	97	43	group	group	NOUN
dpc-4095	97	44	.	.	PUNCT
dpc-4095	98	1	however	however	ADV
dpc-4095	98	2	,	,	PUNCT
dpc-4095	98	3	statistical	statistical	ADJ
dpc-4095	98	4	analysis	analysis	NOUN
dpc-4095	98	5	showed	show	VERB
dpc-4095	98	6	that	that	SCONJ
dpc-4095	98	7	tedoc	tedoc	ADJ
dpc-4095	98	8	patients	patient	NOUN
dpc-4095	98	9	had	have	VERB
dpc-4095	98	10	significantly	significantly	ADV
dpc-4095	98	11	more	more	ADJ
dpc-4095	98	12	iron	iron	NOUN
dpc-4095	98	13	and	and	CCONJ
dpc-4095	98	14	vitamin	vitamin	NOUN
dpc-4095	98	15	b12	b12	NOUN
dpc-4095	98	16	deficiency	deficiency	NOUN
dpc-4095	98	17	.	.	PUNCT
dpc-4095	99	1	therefore	therefore	ADV
dpc-4095	99	2	,	,	PUNCT
dpc-4095	99	3	we	we	PRON
dpc-4095	99	4	should	should	AUX
dpc-4095	99	5	think	think	VERB
dpc-4095	99	6	that	that	SCONJ
dpc-4095	99	7	patients	patient	NOUN
dpc-4095	99	8	prone	prone	ADJ
dpc-4095	99	9	to	to	ADP
dpc-4095	99	10	the	the	DET
dpc-4095	99	11	development	development	NOUN
dpc-4095	99	12	of	of	ADP
dpc-4095	99	13	te	te	PROPN
dpc-4095	99	14	could	could	AUX
dpc-4095	99	15	facilitate	facilitate	VERB
dpc-4095	99	16	the	the	DET
dpc-4095	99	17	development	development	NOUN
dpc-4095	99	18	of	of	ADP
dpc-4095	99	19	cate	cate	PROPN
dpc-4095	99	20	.	.	PUNCT
dpc-4095	100	1	females	female	NOUN
dpc-4095	100	2	.	.	PUNCT
dpc-4095	101	1	in	in	ADP
dpc-4095	101	2	addition	addition	NOUN
dpc-4095	101	3	,	,	PUNCT
dpc-4095	101	4	females	female	NOUN
dpc-4095	101	5	are	be	AUX
dpc-4095	101	6	prone	prone	ADJ
dpc-4095	101	7	to	to	PART
dpc-4095	101	8	be	be	AUX
dpc-4095	101	9	more	more	ADV
dpc-4095	101	10	affected	affect	VERB
dpc-4095	101	11	emotionally	emotionally	ADV
dpc-4095	101	12	by	by	ADP
dpc-4095	101	13	hair	hair	NOUN
dpc-4095	101	14	shedding	shedding	NOUN
dpc-4095	101	15	,	,	PUNCT
dpc-4095	101	16	and	and	CCONJ
dpc-4095	101	17	having	have	VERB
dpc-4095	101	18	longer	long	ADJ
dpc-4095	101	19	hair	hair	NOUN
dpc-4095	101	20	makes	make	VERB
dpc-4095	101	21	them	they	PRON
dpc-4095	101	22	think	think	VERB
dpc-4095	101	23	of	of	ADP
dpc-4095	101	24	having	have	VERB
dpc-4095	101	25	more	more	ADJ
dpc-4095	101	26	hair	hair	NOUN
dpc-4095	101	27	loss	loss	NOUN
dpc-4095	101	28	.	.	PUNCT
dpc-4095	102	1	therefore	therefore	ADV
dpc-4095	102	2	,	,	PUNCT
dpc-4095	102	3	they	they	PRON
dpc-4095	102	4	are	be	AUX
dpc-4095	102	5	more	more	ADV
dpc-4095	102	6	likely	likely	ADJ
dpc-4095	102	7	to	to	PART
dpc-4095	102	8	seek	seek	VERB
dpc-4095	102	9	medical	medical	ADJ
dpc-4095	102	10	attention	attention	NOUN
dpc-4095	102	11	[	[	X
dpc-4095	102	12	21	21	NUM
dpc-4095	102	13	]	]	PUNCT
dpc-4095	102	14	.	.	PUNCT
dpc-4095	103	1	numerous	numerous	ADJ
dpc-4095	103	2	studies	study	NOUN
dpc-4095	103	3	in	in	ADP
dpc-4095	103	4	the	the	DET
dpc-4095	103	5	literature	literature	NOUN
dpc-4095	103	6	also	also	ADV
dpc-4095	103	7	reported	report	VERB
dpc-4095	103	8	female	female	ADJ
dpc-4095	103	9	dominance	dominance	NOUN
dpc-4095	103	10	in	in	ADP
dpc-4095	103	11	patients	patient	NOUN
dpc-4095	103	12	with	with	ADP
dpc-4095	103	13	cate	cate	NOUN
dpc-4095	103	14	[	[	X
dpc-4095	103	15	2,5	2,5	NUM
dpc-4095	103	16	-	-	SYM
dpc-4095	103	17	8	8	NUM
dpc-4095	103	18	]	]	PUNCT
dpc-4095	103	19	.	.	PUNCT
dpc-4095	104	1	we	we	PRON
dpc-4095	104	2	also	also	ADV
dpc-4095	104	3	found	find	VERB
dpc-4095	104	4	female	female	ADJ
dpc-4095	104	5	dominance	dominance	NOUN
dpc-4095	104	6	in	in	ADP
dpc-4095	104	7	both	both	DET
dpc-4095	104	8	groups	group	NOUN
dpc-4095	104	9	in	in	ADP
dpc-4095	104	10	our	our	PRON
dpc-4095	104	11	study	study	NOUN
dpc-4095	104	12	.	.	PUNCT
dpc-4095	105	1	however	however	ADV
dpc-4095	105	2	,	,	PUNCT
dpc-4095	105	3	the	the	DET
dpc-4095	105	4	exact	exact	ADJ
dpc-4095	105	5	mechanism	mechanism	NOUN
dpc-4095	105	6	under	under	ADP
dpc-4095	105	7	this	this	DET
dpc-4095	105	8	situation	situation	NOUN
dpc-4095	105	9	was	be	AUX
dpc-4095	105	10	still	still	ADV
dpc-4095	105	11	not	not	PART
dpc-4095	105	12	understood	understand	VERB
dpc-4095	105	13	.	.	PUNCT
dpc-4095	106	1	estrogens	estrogen	NOUN
dpc-4095	106	2	and	and	CCONJ
dpc-4095	106	3	progesterone	progesterone	NOUN
dpc-4095	106	4	are	be	AUX
dpc-4095	106	5	known	know	VERB
dpc-4095	106	6	to	to	PART
dpc-4095	106	7	be	be	AUX
dpc-4095	106	8	immunomodulatory	immunomodulatory	ADJ
dpc-4095	106	9	,	,	PUNCT
dpc-4095	106	10	anti	anti	ADJ
dpc-4095	106	11	-	-	ADJ
dpc-4095	106	12	inflammatory	inflammatory	ADJ
dpc-4095	106	13	,	,	PUNCT
dpc-4095	106	14	and	and	CCONJ
dpc-4095	106	15	work	work	VERB
dpc-4095	106	16	protectively	protectively	ADV
dpc-4095	106	17	at	at	ADP
dpc-4095	106	18	hair	hair	NOUN
dpc-4095	106	19	follicles	follicle	NOUN
dpc-4095	106	20	.	.	PUNCT
dpc-4095	107	1	the	the	DET
dpc-4095	107	2	reduction	reduction	NOUN
dpc-4095	107	3	of	of	ADP
dpc-4095	107	4	estrogen	estrogen	NOUN
dpc-4095	107	5	and	and	CCONJ
dpc-4095	107	6	progesterone	progesterone	NOUN
dpc-4095	107	7	levels	level	NOUN
dpc-4095	107	8	at	at	ADP
dpc-4095	107	9	blood	blood	NOUN
dpc-4095	107	10	due	due	ADP
dpc-4095	107	11	to	to	ADP
dpc-4095	107	12	systemic	systemic	ADJ
dpc-4095	107	13	inflammation	inflammation	NOUN
dpc-4095	107	14	could	could	AUX
dpc-4095	107	15	cause	cause	VERB
dpc-4095	107	16	hair	hair	NOUN
dpc-4095	107	17	loss	loss	NOUN
dpc-4095	107	18	in	in	ADP
dpc-4095	107	19	female	female	ADJ
dpc-4095	107	20	patients	patient	NOUN
dpc-4095	107	21	with	with	ADP
dpc-4095	107	22	sars	sar	NOUN
dpc-4095	107	23	-	-	PUNCT
dpc-4095	107	24	cov-2	cov-2	NOUN
dpc-4095	107	25	[	[	NOUN
dpc-4095	107	26	22	22	NUM
dpc-4095	107	27	]	]	PUNCT
dpc-4095	107	28	.	.	PUNCT
dpc-4095	108	1	however	however	ADV
dpc-4095	108	2	,	,	PUNCT
dpc-4095	108	3	we	we	PRON
dpc-4095	108	4	need	need	VERB
dpc-4095	108	5	further	further	ADJ
dpc-4095	108	6	studies	study	NOUN
dpc-4095	108	7	to	to	PART
dpc-4095	108	8	enlighten	enlighten	VERB
dpc-4095	108	9	the	the	DET
dpc-4095	108	10	relationship	relationship	NOUN
dpc-4095	108	11	between	between	ADP
dpc-4095	108	12	hair	hair	NOUN
dpc-4095	108	13	loss	loss	NOUN
dpc-4095	108	14	and	and	CCONJ
dpc-4095	108	15	sars	sar	NOUN
dpc-4095	108	16	-	-	PUNCT
dpc-4095	108	17	cov-2	cov-2	NOUN
dpc-4095	108	18	.	.	NOUN
dpc-4095	108	19	table	table	NOUN
dpc-4095	108	20	2	2	NUM
dpc-4095	108	21	.	.	PUNCT
dpc-4095	108	22	dermoscopic	dermoscopic	NOUN
dpc-4095	108	23	features	feature	NOUN
dpc-4095	108	24	of	of	ADP
dpc-4095	108	25	the	the	DET
dpc-4095	108	26	patients	patient	NOUN
dpc-4095	108	27	dermoscopic	dermoscopic	VERB
dpc-4095	108	28	findings	finding	NOUN
dpc-4095	108	29	sars	sar	NOUN
dpc-4095	108	30	-	-	PUNCT
dpc-4095	108	31	cov-2	cov-2	NOUN
dpc-4095	108	32	associated	associate	VERB
dpc-4095	108	33	te	te	ADP
dpc-4095	108	34	n	n	PROPN
dpc-4095	108	35	=	=	SYM
dpc-4095	108	36	52	52	NUM
dpc-4095	108	37	(	(	PUNCT
dpc-4095	108	38	%	%	INTJ
dpc-4095	108	39	)	)	PUNCT
dpc-4095	109	1	te	te	ADP
dpc-4095	109	2	due	due	ADP
dpc-4095	109	3	to	to	ADP
dpc-4095	109	4	other	other	ADJ
dpc-4095	109	5	causes	cause	NOUN
dpc-4095	109	6	n	n	NOUN
dpc-4095	109	7	=	=	SYM
dpc-4095	109	8	40	40	NUM
dpc-4095	109	9	(	(	PUNCT
dpc-4095	109	10	%	%	NOUN
dpc-4095	109	11	)	)	PUNCT
dpc-4095	109	12	p	p	NOUN
dpc-4095	109	13	value	value	NOUN
dpc-4095	109	14	empty	empty	ADJ
dpc-4095	109	15	follicular	follicular	ADJ
dpc-4095	109	16	opening	opening	NOUN
dpc-4095	109	17	present	present	NOUN
dpc-4095	109	18	absent	absent	ADJ
dpc-4095	109	19	40	40	NUM
dpc-4095	109	20	(	(	PUNCT
dpc-4095	109	21	76.9	76.9	NUM
dpc-4095	109	22	%	%	NOUN
dpc-4095	109	23	)	)	PUNCT
dpc-4095	109	24	12	12	NUM
dpc-4095	109	25	(	(	PUNCT
dpc-4095	109	26	23.1	23.1	NUM
dpc-4095	109	27	%	%	NOUN
dpc-4095	109	28	)	)	PUNCT
dpc-4095	109	29	4	4	NUM
dpc-4095	109	30	(	(	PUNCT
dpc-4095	109	31	10	10	NUM
dpc-4095	109	32	%	%	NOUN
dpc-4095	109	33	)	)	PUNCT
dpc-4095	109	34	36	36	NUM
dpc-4095	109	35	(	(	PUNCT
dpc-4095	109	36	90	90	NUM
dpc-4095	109	37	%	%	NOUN
dpc-4095	109	38	)	)	PUNCT
dpc-4095	109	39	0.001	0.001	NUM
dpc-4095	109	40	yellow	yellow	ADJ
dpc-4095	109	41	dots	dot	NOUN
dpc-4095	109	42	present	present	VERB
dpc-4095	109	43	absent	absent	ADJ
dpc-4095	109	44	29	29	NUM
dpc-4095	109	45	(	(	PUNCT
dpc-4095	109	46	55.8	55.8	NUM
dpc-4095	109	47	%	%	NOUN
dpc-4095	109	48	)	)	PUNCT
dpc-4095	109	49	23	23	NUM
dpc-4095	109	50	(	(	PUNCT
dpc-4095	109	51	44.2	44.2	NUM
dpc-4095	109	52	%	%	NOUN
dpc-4095	109	53	)	)	PUNCT
dpc-4095	109	54	3	3	NUM
dpc-4095	109	55	(	(	PUNCT
dpc-4095	109	56	7.5	7.5	NUM
dpc-4095	109	57	%	%	NOUN
dpc-4095	109	58	)	)	PUNCT
dpc-4095	109	59	37	37	NUM
dpc-4095	109	60	(	(	PUNCT
dpc-4095	109	61	92.5	92.5	NUM
dpc-4095	109	62	%	%	NOUN
dpc-4095	109	63	)	)	PUNCT
dpc-4095	109	64	0.001	0.001	NUM
dpc-4095	109	65	short	short	ADJ
dpc-4095	109	66	regrowing	regrow	VERB
dpc-4095	109	67	hair	hair	NOUN
dpc-4095	109	68	present	present	ADJ
dpc-4095	109	69	absent	absent	ADJ
dpc-4095	109	70	10	10	NUM
dpc-4095	109	71	(	(	PUNCT
dpc-4095	109	72	10.2	10.2	NUM
dpc-4095	109	73	%	%	NOUN
dpc-4095	109	74	)	)	PUNCT
dpc-4095	109	75	42	42	NUM
dpc-4095	109	76	(	(	PUNCT
dpc-4095	109	77	80.8	80.8	NUM
dpc-4095	109	78	%	%	NOUN
dpc-4095	109	79	)	)	PUNCT
dpc-4095	109	80	30	30	NUM
dpc-4095	109	81	(	(	PUNCT
dpc-4095	109	82	75	75	NUM
dpc-4095	109	83	%	%	NOUN
dpc-4095	109	84	)	)	PUNCT
dpc-4095	109	85	10	10	NUM
dpc-4095	109	86	(	(	PUNCT
dpc-4095	109	87	25	25	NUM
dpc-4095	109	88	%	%	NOUN
dpc-4095	109	89	)	)	PUNCT
dpc-4095	109	90	0.001	0.001	NUM
dpc-4095	109	91	one	one	NUM
dpc-4095	109	92	emerging	emerge	VERB
dpc-4095	109	93	hair	hair	NOUN
dpc-4095	109	94	shaft	shaft	NOUN
dpc-4095	109	95	on	on	ADP
dpc-4095	109	96	the	the	DET
dpc-4095	109	97	follicle	follicle	NOUN
dpc-4095	109	98	present	present	NOUN
dpc-4095	109	99	absent	absent	ADJ
dpc-4095	109	100	8	8	NUM
dpc-4095	109	101	(	(	PUNCT
dpc-4095	109	102	15.4	15.4	NUM
dpc-4095	109	103	%	%	NOUN
dpc-4095	109	104	)	)	PUNCT
dpc-4095	109	105	44	44	NUM
dpc-4095	109	106	(	(	PUNCT
dpc-4095	109	107	84.6	84.6	NUM
dpc-4095	109	108	%	%	NOUN
dpc-4095	109	109	)	)	PUNCT
dpc-4095	109	110	8	8	NUM
dpc-4095	109	111	(	(	PUNCT
dpc-4095	109	112	20	20	NUM
dpc-4095	109	113	%	%	NOUN
dpc-4095	109	114	)	)	PUNCT
dpc-4095	109	115	32	32	NUM
dpc-4095	109	116	(	(	PUNCT
dpc-4095	109	117	80	80	NUM
dpc-4095	109	118	%	%	NOUN
dpc-4095	109	119	)	)	PUNCT
dpc-4095	110	1	0.563	0.563	NUM
dpc-4095	110	2	te	te	ADP
dpc-4095	110	3	=	=	PUNCT
dpc-4095	110	4	telogen	telogen	NOUN
dpc-4095	110	5	effluvium	effluvium	NOUN
dpc-4095	110	6	.	.	PUNCT
dpc-4095	110	7	table	table	NOUN
dpc-4095	111	1	3	3	NUM
dpc-4095	111	2	.	.	PUNCT
dpc-4095	111	3	laboratory	laboratory	NOUN
dpc-4095	111	4	findings	finding	NOUN
dpc-4095	111	5	of	of	ADP
dpc-4095	111	6	the	the	DET
dpc-4095	111	7	patients	patient	NOUN
dpc-4095	111	8	laboratory	laboratory	PROPN
dpc-4095	111	9	findings	finding	VERB
dpc-4095	111	10	sars	sar	NOUN
dpc-4095	111	11	-	-	PUNCT
dpc-4095	111	12	cov-2	cov-2	NOUN
dpc-4095	111	13	associated	associate	VERB
dpc-4095	111	14	te	te	ADP
dpc-4095	111	15	n	n	PROPN
dpc-4095	111	16	=	=	SYM
dpc-4095	111	17	52	52	NUM
dpc-4095	111	18	(	(	PUNCT
dpc-4095	111	19	%	%	INTJ
dpc-4095	111	20	)	)	PUNCT
dpc-4095	112	1	te	te	ADP
dpc-4095	112	2	due	due	ADP
dpc-4095	112	3	to	to	ADP
dpc-4095	112	4	other	other	ADJ
dpc-4095	112	5	causes	cause	NOUN
dpc-4095	112	6	n	n	NOUN
dpc-4095	112	7	=	=	SYM
dpc-4095	112	8	40	40	NUM
dpc-4095	112	9	(	(	PUNCT
dpc-4095	112	10	%	%	NOUN
dpc-4095	112	11	)	)	PUNCT
dpc-4095	112	12	p	p	NOUN
dpc-4095	112	13	value	value	NOUN
dpc-4095	112	14	iron	iron	NOUN
dpc-4095	112	15	deficiency	deficiency	NOUN
dpc-4095	112	16	present	present	ADJ
dpc-4095	112	17	absent	absent	ADJ
dpc-4095	112	18	24	24	NUM
dpc-4095	112	19	(	(	PUNCT
dpc-4095	112	20	46.2	46.2	NUM
dpc-4095	112	21	%	%	NOUN
dpc-4095	112	22	)	)	PUNCT
dpc-4095	112	23	28	28	NUM
dpc-4095	112	24	(	(	PUNCT
dpc-4095	112	25	53.8	53.8	NUM
dpc-4095	112	26	%	%	NOUN
dpc-4095	112	27	)	)	PUNCT
dpc-4095	112	28	30	30	NUM
dpc-4095	112	29	(	(	PUNCT
dpc-4095	112	30	75	75	NUM
dpc-4095	112	31	%	%	NOUN
dpc-4095	112	32	)	)	PUNCT
dpc-4095	112	33	10	10	NUM
dpc-4095	112	34	(	(	PUNCT
dpc-4095	112	35	25	25	NUM
dpc-4095	112	36	%	%	NOUN
dpc-4095	112	37	)	)	PUNCT
dpc-4095	112	38	0.005	0.005	NUM
dpc-4095	112	39	hypothyroditis	hypothyroditis	NOUN
dpc-4095	112	40	present	present	ADJ
dpc-4095	112	41	absent	absent	ADJ
dpc-4095	112	42	0	0	NUM
dpc-4095	112	43	52	52	NUM
dpc-4095	112	44	(	(	PUNCT
dpc-4095	112	45	100	100	NUM
dpc-4095	112	46	%	%	NOUN
dpc-4095	112	47	)	)	PUNCT
dpc-4095	112	48	4	4	NUM
dpc-4095	112	49	(	(	PUNCT
dpc-4095	112	50	10	10	NUM
dpc-4095	112	51	%	%	NOUN
dpc-4095	112	52	)	)	PUNCT
dpc-4095	112	53	36	36	NUM
dpc-4095	112	54	(	(	PUNCT
dpc-4095	112	55	90	90	NUM
dpc-4095	112	56	%	%	NOUN
dpc-4095	112	57	)	)	PUNCT
dpc-4095	112	58	0.033	0.033	NUM
dpc-4095	112	59	vitamin	vitamin	NOUN
dpc-4095	112	60	b12	b12	NOUN
dpc-4095	112	61	deficiency	deficiency	NOUN
dpc-4095	112	62	present	present	ADJ
dpc-4095	112	63	absent	absent	ADJ
dpc-4095	112	64	14	14	NUM
dpc-4095	112	65	(	(	PUNCT
dpc-4095	112	66	26.9	26.9	NUM
dpc-4095	112	67	%	%	NOUN
dpc-4095	112	68	)	)	PUNCT
dpc-4095	112	69	38	38	NUM
dpc-4095	112	70	(	(	PUNCT
dpc-4095	112	71	73.1	73.1	NUM
dpc-4095	112	72	%	%	NOUN
dpc-4095	112	73	)	)	PUNCT
dpc-4095	112	74	11	11	NUM
dpc-4095	112	75	(	(	PUNCT
dpc-4095	112	76	27.5	27.5	NUM
dpc-4095	112	77	%	%	NOUN
dpc-4095	112	78	)	)	PUNCT
dpc-4095	112	79	29	29	NUM
dpc-4095	112	80	(	(	PUNCT
dpc-4095	112	81	72.5	72.5	NUM
dpc-4095	112	82	%	%	NOUN
dpc-4095	112	83	)	)	PUNCT
dpc-4095	112	84	0.951	0.951	NUM
dpc-4095	112	85	25	25	NUM
dpc-4095	112	86	-	-	PUNCT
dpc-4095	112	87	oh	oh	NUM
dpc-4095	112	88	-	-	PUNCT
dpc-4095	112	89	vitamin	vitamin	NOUN
dpc-4095	112	90	d	d	NOUN
dpc-4095	112	91	deficiency	deficiency	NOUN
dpc-4095	112	92	present	present	NOUN
dpc-4095	112	93	absent	absent	ADJ
dpc-4095	112	94	10	10	NUM
dpc-4095	112	95	(	(	PUNCT
dpc-4095	112	96	19.2	19.2	NUM
dpc-4095	112	97	%	%	NOUN
dpc-4095	112	98	)	)	PUNCT
dpc-4095	112	99	42	42	NUM
dpc-4095	112	100	(	(	PUNCT
dpc-4095	112	101	80.8	80.8	NUM
dpc-4095	112	102	%	%	NOUN
dpc-4095	112	103	)	)	PUNCT
dpc-4095	112	104	8	8	NUM
dpc-4095	112	105	(	(	PUNCT
dpc-4095	112	106	20	20	NUM
dpc-4095	112	107	%	%	NOUN
dpc-4095	112	108	)	)	PUNCT
dpc-4095	112	109	32	32	NUM
dpc-4095	112	110	(	(	PUNCT
dpc-4095	112	111	80	80	NUM
dpc-4095	112	112	%	%	NOUN
dpc-4095	112	113	)	)	PUNCT
dpc-4095	112	114	0.927	0.927	NUM
dpc-4095	112	115	folic	folic	ADJ
dpc-4095	112	116	acid	acid	NOUN
dpc-4095	112	117	deficiency	deficiency	NOUN
dpc-4095	112	118	present	present	ADJ
dpc-4095	112	119	absent	absent	ADJ
dpc-4095	112	120	0	0	NUM
dpc-4095	112	121	52(100	52(100	NUM
dpc-4095	112	122	%	%	NOUN
dpc-4095	112	123	)	)	PUNCT
dpc-4095	112	124	2	2	NUM
dpc-4095	112	125	(	(	PUNCT
dpc-4095	112	126	5	5	NUM
dpc-4095	112	127	%	%	NOUN
dpc-4095	112	128	)	)	PUNCT
dpc-4095	112	129	38	38	NUM
dpc-4095	112	130	(	(	PUNCT
dpc-4095	112	131	95	95	NUM
dpc-4095	112	132	%	%	NOUN
dpc-4095	112	133	)	)	PUNCT
dpc-4095	112	134	0.186	0.186	NUM
dpc-4095	112	135	te	te	PROPN
dpc-4095	112	136	=	=	SYM
dpc-4095	112	137	telogen	telogen	NOUN
dpc-4095	112	138	effluvium	effluvium	NOUN
dpc-4095	112	139	.	.	PUNCT
dpc-4095	113	1	original	original	ADJ
dpc-4095	113	2	article	article	NOUN
dpc-4095	113	3	|	|	ADV
dpc-4095	113	4	dermatol	dermatol	ADJ
dpc-4095	113	5	pract	pract	NOUN
dpc-4095	113	6	concept	concept	NOUN
dpc-4095	113	7	.	.	PUNCT
dpc-4095	114	1	2024;14(3):e2024170	2024;14(3):e2024170	NUM
dpc-4095	114	2	5	5	NUM
dpc-4095	114	3	10	10	NUM
dpc-4095	114	4	.	.	PUNCT
dpc-4095	115	1	xiong	xiong	PROPN
dpc-4095	115	2	y	y	PROPN
dpc-4095	115	3	,	,	PUNCT
dpc-4095	115	4	harmon	harmon	PROPN
dpc-4095	115	5	cs	cs	PROPN
dpc-4095	115	6	.	.	PROPN
dpc-4095	116	1	interleukin-1beta	interleukin-1beta	PROPN
dpc-4095	116	2	is	be	AUX
dpc-4095	116	3	differentially	differentially	ADV
dpc-4095	116	4	expressed	express	VERB
dpc-4095	116	5	by	by	ADP
dpc-4095	116	6	human	human	ADJ
dpc-4095	116	7	dermal	dermal	NOUN
dpc-4095	116	8	papilla	papilla	NOUN
dpc-4095	116	9	cells	cell	NOUN
dpc-4095	116	10	in	in	ADP
dpc-4095	116	11	response	response	NOUN
dpc-4095	116	12	to	to	ADP
dpc-4095	116	13	pkc	pkc	NOUN
dpc-4095	116	14	activation	activation	NOUN
dpc-4095	116	15	and	and	CCONJ
dpc-4095	116	16	is	be	AUX
dpc-4095	116	17	a	a	DET
dpc-4095	116	18	potent	potent	ADJ
dpc-4095	116	19	inhibitor	inhibitor	NOUN
dpc-4095	116	20	of	of	ADP
dpc-4095	116	21	human	human	ADJ
dpc-4095	116	22	hair	hair	NOUN
dpc-4095	116	23	follicle	follicle	NOUN
dpc-4095	116	24	growth	growth	NOUN
dpc-4095	116	25	in	in	ADP
dpc-4095	116	26	organ	organ	NOUN
dpc-4095	116	27	culture	culture	NOUN
dpc-4095	116	28	.	.	PUNCT
dpc-4095	117	1	j	j	PROPN
dpc-4095	117	2	interferon	interferon	PROPN
dpc-4095	117	3	cytokine	cytokine	NOUN
dpc-4095	117	4	res	re	NOUN
dpc-4095	117	5	.	.	PUNCT
dpc-4095	118	1	1997;17(3):151	1997;17(3):151	NUM
dpc-4095	118	2	-	-	SYM
dpc-4095	118	3	157	157	NUM
dpc-4095	118	4	.	.	PUNCT
dpc-4095	119	1	doi	doi	NOUN
dpc-4095	119	2	:	:	PUNCT
dpc-4095	119	3	10.1089	10.1089	NUM
dpc-4095	119	4	/	/	SYM
dpc-4095	119	5	jir.1997.17.151	jir.1997.17.151	PROPN
dpc-4095	119	6	.	.	PUNCT
dpc-4095	120	1	pmid	pmid	NOUN
dpc-4095	120	2	:	:	PUNCT
dpc-4095	120	3	9085940	9085940	NUM
dpc-4095	120	4	.	.	PUNCT
dpc-4095	121	1	11	11	NUM
dpc-4095	121	2	.	.	PUNCT
dpc-4095	122	1	mandt	mandt	ADJ
dpc-4095	122	2	n	n	CCONJ
dpc-4095	122	3	,	,	PUNCT
dpc-4095	122	4	geilen	geilen	PROPN
dpc-4095	122	5	cc	cc	PROPN
dpc-4095	122	6	,	,	PUNCT
dpc-4095	122	7	wrobel	wrobel	PROPN
dpc-4095	122	8	a	a	PROPN
dpc-4095	122	9	,	,	PUNCT
dpc-4095	122	10	et	et	PROPN
dpc-4095	122	11	al	al	PROPN
dpc-4095	122	12	.	.	PUNCT
dpc-4095	123	1	interleukin-4	interleukin-4	NOUN
dpc-4095	123	2	induces	induce	VERB
dpc-4095	123	3	apoptosis	apoptosis	NOUN
dpc-4095	123	4	in	in	ADP
dpc-4095	123	5	cultured	cultured	ADJ
dpc-4095	123	6	human	human	ADJ
dpc-4095	123	7	follicular	follicular	ADJ
dpc-4095	123	8	keratinocytes	keratinocyte	NOUN
dpc-4095	123	9	,	,	PUNCT
dpc-4095	123	10	but	but	CCONJ
dpc-4095	123	11	not	not	PART
dpc-4095	123	12	in	in	ADP
dpc-4095	123	13	dermal	dermal	ADJ
dpc-4095	123	14	papilla	papilla	NOUN
dpc-4095	123	15	cells	cell	NOUN
dpc-4095	123	16	.	.	PUNCT
dpc-4095	124	1	eur	eur	PROPN
dpc-4095	124	2	j	j	PROPN
dpc-4095	124	3	dermatol	dermatol	NOUN
dpc-4095	124	4	.	.	PUNCT
dpc-4095	125	1	2002;12(5):432	2002;12(5):432	NUM
dpc-4095	125	2	-	-	PUNCT
dpc-4095	125	3	438	438	NUM
dpc-4095	125	4	.	.	PUNCT
dpc-4095	126	1	pmid	pmid	NOUN
dpc-4095	126	2	:	:	PUNCT
dpc-4095	126	3	12370129	12370129	NUM
dpc-4095	126	4	.	.	PUNCT
dpc-4095	127	1	12	12	NUM
dpc-4095	127	2	.	.	PUNCT
dpc-4095	127	3	rosei	rosei	PROPN
dpc-4095	127	4	ca	ca	PROPN
dpc-4095	127	5	,	,	PUNCT
dpc-4095	127	6	gaggero	gaggero	VERB
dpc-4095	127	7	a	a	PRON
dpc-4095	127	8	,	,	PUNCT
dpc-4095	127	9	famà	famà	NOUN
dpc-4095	127	10	f	f	X
dpc-4095	127	11	,	,	PUNCT
dpc-4095	127	12	et	et	PROPN
dpc-4095	127	13	al	al	PROPN
dpc-4095	127	14	.	.	PROPN
dpc-4095	128	1	skin	skin	NOUN
dpc-4095	128	2	capillary	capillary	ADJ
dpc-4095	128	3	alterations	alteration	NOUN
dpc-4095	128	4	in	in	ADP
dpc-4095	128	5	patients	patient	NOUN
dpc-4095	128	6	with	with	ADP
dpc-4095	128	7	acute	acute	ADJ
dpc-4095	128	8	sarscov2	sarscov2	NOUN
dpc-4095	128	9	infection	infection	NOUN
dpc-4095	128	10	.	.	PUNCT
dpc-4095	129	1	j	j	PROPN
dpc-4095	129	2	hypertens	hyperten	NOUN
dpc-4095	129	3	.	.	PUNCT
dpc-4095	130	1	2022;40(12):2385–93	2022;40(12):2385–93	NUM
dpc-4095	130	2	.	.	PUNCT
dpc-4095	131	1	doi	doi	NOUN
dpc-4095	131	2	:	:	PUNCT
dpc-4095	131	3	10.1097	10.1097	NUM
dpc-4095	131	4	/	/	SYM
dpc-4095	131	5	hjh.0000000000003271	hjh.0000000000003271	PROPN
dpc-4095	131	6	.	.	PUNCT
dpc-4095	132	1	epub	epub	NOUN
dpc-4095	132	2	2022	2022	NUM
dpc-4095	132	3	aug	aug	PROPN
dpc-4095	132	4	18	18	NUM
dpc-4095	132	5	.	.	PUNCT
dpc-4095	133	1	pmid	pmid	NOUN
dpc-4095	133	2	:	:	PUNCT
dpc-4095	133	3	35983856	35983856	NUM
dpc-4095	133	4	;	;	PUNCT
dpc-4095	133	5	pmcid	pmcid	NOUN
dpc-4095	133	6	:	:	PUNCT
dpc-4095	133	7	pmc9640263	pmc9640263	ADJ
dpc-4095	133	8	.	.	PUNCT
dpc-4095	134	1	13	13	NUM
dpc-4095	134	2	.	.	PUNCT
dpc-4095	134	3	michelini	michelini	PROPN
dpc-4095	134	4	s	s	SYM
dpc-4095	134	5	,	,	PUNCT
dpc-4095	134	6	caro	caro	NOUN
dpc-4095	134	7	g	g	PROPN
dpc-4095	134	8	,	,	PUNCT
dpc-4095	134	9	di	di	PROPN
dpc-4095	134	10	fraia	fraia	PROPN
dpc-4095	134	11	m	m	PROPN
dpc-4095	134	12	,	,	PUNCT
dpc-4095	134	13	et	et	PROPN
dpc-4095	134	14	al	al	PROPN
dpc-4095	134	15	.	.	PROPN
dpc-4095	134	16	telogen	telogen	PROPN
dpc-4095	134	17	effluvium	effluvium	NOUN
dpc-4095	134	18	in	in	ADP
dpc-4095	134	19	sars	sar	NOUN
dpc-4095	134	20	-	-	PUNCT
dpc-4095	134	21	cov-2	cov-2	PART
dpc-4095	134	22	infection	infection	NOUN
dpc-4095	134	23	:	:	PUNCT
dpc-4095	134	24	histological	histological	ADJ
dpc-4095	134	25	aspects	aspect	NOUN
dpc-4095	134	26	.	.	PUNCT
dpc-4095	135	1	j	j	PROPN
dpc-4095	135	2	eur	eur	PROPN
dpc-4095	135	3	acad	acad	PROPN
dpc-4095	135	4	dermatol	dermatol	NOUN
dpc-4095	135	5	venereol	venereol	NOUN
dpc-4095	135	6	.	.	PUNCT
dpc-4095	136	1	2023	2023	NUM
dpc-4095	136	2	;	;	PUNCT
dpc-4095	136	3	8:1–3	8:1–3	NUM
dpc-4095	136	4	.	.	PUNCT
dpc-4095	136	5	doi	doi	NOUN
dpc-4095	136	6	:	:	PUNCT
dpc-4095	136	7	10.1111	10.1111	NUM
dpc-4095	136	8	/	/	SYM
dpc-4095	136	9	jdv.19015	jdv.19015	PROPN
dpc-4095	136	10	.	.	PUNCT
dpc-4095	137	1	epub	epub	NOUN
dpc-4095	137	2	ahead	ahead	ADV
dpc-4095	137	3	of	of	ADP
dpc-4095	137	4	print	print	NOUN
dpc-4095	137	5	.	.	PUNCT
dpc-4095	138	1	pmid	pmid	NOUN
dpc-4095	138	2	:	:	PUNCT
dpc-4095	138	3	36883793	36883793	NUM
dpc-4095	138	4	.	.	PUNCT
dpc-4095	139	1	14	14	NUM
dpc-4095	139	2	.	.	PUNCT
dpc-4095	140	1	jose	jose	PROPN
dpc-4095	140	2	rj	rj	PROPN
dpc-4095	140	3	,	,	PUNCT
dpc-4095	140	4	manuel	manuel	PROPN
dpc-4095	140	5	a.	a.	PROPN
dpc-4095	140	6	covid-19	covid-19	PROPN
dpc-4095	140	7	cytokine	cytokine	NOUN
dpc-4095	140	8	storm	storm	NOUN
dpc-4095	140	9	:	:	PUNCT
dpc-4095	140	10	the	the	DET
dpc-4095	140	11	interplay	interplay	NOUN
dpc-4095	140	12	between	between	ADP
dpc-4095	140	13	inflammation	inflammation	NOUN
dpc-4095	140	14	and	and	CCONJ
dpc-4095	140	15	coagulation	coagulation	NOUN
dpc-4095	140	16	.	.	PUNCT
dpc-4095	141	1	lancet	lancet	PROPN
dpc-4095	141	2	respir	respir	VERB
dpc-4095	141	3	med	med	ADJ
dpc-4095	141	4	.	.	PUNCT
dpc-4095	142	1	2020;8(6):e46	2020;8(6):e46	PROPN
dpc-4095	142	2	-	-	PUNCT
dpc-4095	142	3	e47	e47	PROPN
dpc-4095	142	4	.	.	PUNCT
dpc-4095	143	1	doi:10.1016	doi:10.1016	PROPN
dpc-4095	143	2	/	/	SYM
dpc-4095	143	3	s2213	s2213	PROPN
dpc-4095	143	4	-	-	PUNCT
dpc-4095	143	5	2600(20)30216	2600(20)30216	NUM
dpc-4095	143	6	-	-	SYM
dpc-4095	143	7	2	2	NUM
dpc-4095	143	8	.	.	PUNCT
dpc-4095	144	1	epub	epub	NOUN
dpc-4095	144	2	2020	2020	NUM
dpc-4095	144	3	apr	apr	PROPN
dpc-4095	144	4	27	27	NUM
dpc-4095	144	5	.	.	PUNCT
dpc-4095	145	1	pmid	pmid	NOUN
dpc-4095	145	2	:	:	PUNCT
dpc-4095	145	3	32353251	32353251	NUM
dpc-4095	145	4	;	;	PUNCT
dpc-4095	145	5	pmcid	pmcid	PROPN
dpc-4095	145	6	:	:	PUNCT
dpc-4095	145	7	pmc7185942	pmc7185942	ADJ
dpc-4095	145	8	.	.	PUNCT
dpc-4095	146	1	15	15	NUM
dpc-4095	146	2	.	.	PUNCT
dpc-4095	146	3	rossi	rossi	PROPN
dpc-4095	146	4	a	a	DET
dpc-4095	146	5	,	,	PUNCT
dpc-4095	146	6	magri	magri	NOUN
dpc-4095	146	7	f	f	NOUN
dpc-4095	146	8	,	,	PUNCT
dpc-4095	146	9	sernicola	sernicola	PROPN
dpc-4095	146	10	a	a	PROPN
dpc-4095	146	11	,	,	PUNCT
dpc-4095	146	12	et	et	PROPN
dpc-4095	146	13	al	al	PROPN
dpc-4095	146	14	.	.	PROPN
dpc-4095	146	15	telogen	telogen	PROPN
dpc-4095	146	16	effluvium	effluvium	NOUN
dpc-4095	146	17	after	after	ADP
dpc-4095	146	18	sars	sar	NOUN
dpc-4095	146	19	-	-	PUNCT
dpc-4095	146	20	cov-2	cov-2	PART
dpc-4095	146	21	infection	infection	NOUN
dpc-4095	146	22	:	:	PUNCT
dpc-4095	146	23	a	a	DET
dpc-4095	146	24	series	series	NOUN
dpc-4095	146	25	of	of	ADP
dpc-4095	146	26	cases	case	NOUN
dpc-4095	146	27	and	and	CCONJ
dpc-4095	146	28	possible	possible	ADJ
dpc-4095	146	29	pathogenetic	pathogenetic	ADJ
dpc-4095	146	30	mechanisms	mechanism	NOUN
dpc-4095	146	31	.	.	PUNCT
dpc-4095	147	1	skin	skin	NOUN
dpc-4095	147	2	appendage	appendage	NOUN
dpc-4095	147	3	disord	disord	NOUN
dpc-4095	147	4	.	.	PUNCT
dpc-4095	148	1	2021;21(5):1–5	2021;21(5):1–5	X
dpc-4095	148	2	.	.	PUNCT
dpc-4095	149	1	doi	doi	NOUN
dpc-4095	149	2	:	:	PUNCT
dpc-4095	149	3	10.1159/000517223	10.1159/000517223	NUM
dpc-4095	149	4	.	.	PUNCT
dpc-4095	150	1	pmid	pmid	NOUN
dpc-4095	150	2	:	:	PUNCT
dpc-4095	150	3	34373830	34373830	NUM
dpc-4095	150	4	;	;	PUNCT
dpc-4095	150	5	pmcid	pmcid	ADJ
dpc-4095	150	6	:	:	PUNCT
dpc-4095	150	7	pmc8339054	pmc8339054	PROPN
dpc-4095	150	8	.	.	PUNCT
dpc-4095	151	1	16	16	NUM
dpc-4095	151	2	.	.	PUNCT
dpc-4095	151	3	rizzetto	rizzetto	PROPN
dpc-4095	151	4	g	g	PROPN
dpc-4095	151	5	,	,	PUNCT
dpc-4095	151	6	diotallevi	diotallevi	ADJ
dpc-4095	151	7	f	f	PROPN
dpc-4095	151	8	,	,	PUNCT
dpc-4095	151	9	campanati	campanati	PROPN
dpc-4095	151	10	a	a	X
dpc-4095	151	11	,	,	PUNCT
dpc-4095	151	12	et	et	PROPN
dpc-4095	151	13	al	al	PROPN
dpc-4095	151	14	.	.	PROPN
dpc-4095	151	15	telogen	telogen	PROPN
dpc-4095	151	16	effluvium	effluvium	NOUN
dpc-4095	151	17	related	relate	VERB
dpc-4095	151	18	to	to	PART
dpc-4095	151	19	post	post	VERB
dpc-4095	151	20	severe	severe	ADJ
dpc-4095	151	21	sars	sar	NOUN
dpc-4095	151	22	-	-	PUNCT
dpc-4095	151	23	cov-2	cov-2	PART
dpc-4095	151	24	infection	infection	NOUN
dpc-4095	151	25	:	:	PUNCT
dpc-4095	151	26	clinical	clinical	ADJ
dpc-4095	151	27	aspects	aspect	NOUN
dpc-4095	151	28	and	and	CCONJ
dpc-4095	151	29	our	our	PRON
dpc-4095	151	30	management	management	NOUN
dpc-4095	151	31	experience	experience	NOUN
dpc-4095	151	32	.	.	PUNCT
dpc-4095	152	1	dermatol	dermatol	NOUN
dpc-4095	152	2	ther	ther	ADV
dpc-4095	152	3	.	.	PUNCT
dpc-4095	153	1	2021;34(1):e14547	2021;34(1):e14547	X
dpc-4095	153	2	.	.	PUNCT
dpc-4095	154	1	doi	doi	NOUN
dpc-4095	154	2	:	:	PUNCT
dpc-4095	154	3	10.1111	10.1111	NUM
dpc-4095	154	4	/	/	SYM
dpc-4095	154	5	dth.14547	dth.14547	PROPN
dpc-4095	154	6	.	.	PUNCT
dpc-4095	155	1	epub	epub	PROPN
dpc-4095	155	2	2020	2020	NUM
dpc-4095	155	3	nov	nov	PROPN
dpc-4095	155	4	23	23	NUM
dpc-4095	155	5	.	.	PUNCT
dpc-4095	156	1	pmid	pmid	NOUN
dpc-4095	156	2	:	:	PUNCT
dpc-4095	156	3	33190397	33190397	NUM
dpc-4095	156	4	;	;	PUNCT
dpc-4095	156	5	pmcid	pmcid	ADJ
dpc-4095	156	6	:	:	PUNCT
dpc-4095	156	7	pmc7744849	pmc7744849	NOUN
dpc-4095	156	8	.	.	PUNCT
dpc-4095	157	1	17	17	NUM
dpc-4095	157	2	.	.	PUNCT
dpc-4095	158	1	kinoshita	kinoshita	PROPN
dpc-4095	158	2	-	-	PUNCT
dpc-4095	158	3	ise	ise	NOUN
dpc-4095	158	4	m	m	PROPN
dpc-4095	158	5	,	,	PUNCT
dpc-4095	158	6	sachdeva	sachdeva	PROPN
dpc-4095	158	7	m.	m.	NOUN
dpc-4095	158	8	update	update	NOUN
dpc-4095	158	9	on	on	ADP
dpc-4095	158	10	trichoscopy	trichoscopy	NOUN
dpc-4095	158	11	:	:	PUNCT
dpc-4095	158	12	integration	integration	NOUN
dpc-4095	158	13	of	of	ADP
dpc-4095	158	14	the	the	DET
dpc-4095	158	15	terminology	terminology	NOUN
dpc-4095	158	16	by	by	ADP
dpc-4095	158	17	systematic	systematic	ADJ
dpc-4095	158	18	approach	approach	NOUN
dpc-4095	158	19	and	and	CCONJ
dpc-4095	158	20	a	a	DET
dpc-4095	158	21	proposal	proposal	NOUN
dpc-4095	158	22	of	of	ADP
dpc-4095	158	23	a	a	DET
dpc-4095	158	24	diagnostic	diagnostic	ADJ
dpc-4095	158	25	flowchart	flowchart	NOUN
dpc-4095	158	26	.	.	PUNCT
dpc-4095	159	1	j	j	PROPN
dpc-4095	159	2	dermatol	dermatol	NOUN
dpc-4095	159	3	.	.	PUNCT
dpc-4095	160	1	2022;49(1):4	2022;49(1):4	NUM
dpc-4095	160	2	-	-	SYM
dpc-4095	160	3	18	18	NUM
dpc-4095	160	4	.	.	PUNCT
dpc-4095	161	1	doi	doi	NOUN
dpc-4095	161	2	:	:	PUNCT
dpc-4095	161	3	10.1111/1346	10.1111/1346	NUM
dpc-4095	161	4	-	-	SYM
dpc-4095	161	5	8138.16233	8138.16233	NUM
dpc-4095	161	6	.	.	PUNCT
dpc-4095	162	1	epub	epub	NOUN
dpc-4095	162	2	2021	2021	NUM
dpc-4095	162	3	nov	nov	NOUN
dpc-4095	162	4	22	22	NUM
dpc-4095	162	5	.	.	PUNCT
dpc-4095	163	1	pmid	pmid	NOUN
dpc-4095	163	2	:	:	PUNCT
dpc-4095	163	3	34806223	34806223	NUM
dpc-4095	163	4	.	.	PUNCT
dpc-4095	164	1	18	18	NUM
dpc-4095	164	2	.	.	X
dpc-4095	164	3	hussain	hussain	PROPN
dpc-4095	164	4	n	n	CCONJ
dpc-4095	164	5	,	,	PUNCT
dpc-4095	164	6	agarwala	agarwala	NOUN
dpc-4095	164	7	p	p	NOUN
dpc-4095	164	8	,	,	PUNCT
dpc-4095	164	9	iqbal	iqbal	PROPN
dpc-4095	164	10	k	k	PROPN
dpc-4095	164	11	,	,	PUNCT
dpc-4095	164	12	et	et	PROPN
dpc-4095	164	13	al	al	PROPN
dpc-4095	164	14	.	.	PUNCT
dpc-4095	165	1	a	a	DET
dpc-4095	165	2	systematic	systematic	ADJ
dpc-4095	165	3	review	review	NOUN
dpc-4095	165	4	of	of	ADP
dpc-4095	165	5	acute	acute	ADJ
dpc-4095	165	6	telogen	telogen	NOUN
dpc-4095	165	7	effluvium	effluvium	NOUN
dpc-4095	165	8	,	,	PUNCT
dpc-4095	165	9	a	a	DET
dpc-4095	165	10	harrowing	harrowing	ADJ
dpc-4095	165	11	post	post	ADJ
dpc-4095	165	12	-	-	ADJ
dpc-4095	165	13	covid-19	covid-19	ADJ
dpc-4095	165	14	manifestation	manifestation	NOUN
dpc-4095	165	15	.	.	PUNCT
dpc-4095	166	1	j	j	PROPN
dpc-4095	166	2	med	med	PROPN
dpc-4095	166	3	virol	virol	NOUN
dpc-4095	166	4	.	.	PUNCT
dpc-4095	167	1	2022;94(4):1391	2022;94(4):1391	NUM
dpc-4095	167	2	-	-	SYM
dpc-4095	167	3	1401	1401	NUM
dpc-4095	167	4	.	.	PUNCT
dpc-4095	168	1	doi	doi	NOUN
dpc-4095	168	2	:	:	PUNCT
dpc-4095	168	3	10.1002/	10.1002/	NUM
dpc-4095	168	4	jmv.27534	jmv.27534	NUM
dpc-4095	168	5	.	.	PUNCT
dpc-4095	169	1	epub	epub	NOUN
dpc-4095	169	2	2021	2021	NUM
dpc-4095	169	3	dec	dec	PROPN
dpc-4095	169	4	28	28	NUM
dpc-4095	169	5	.	.	PUNCT
dpc-4095	170	1	pmid	pmid	NOUN
dpc-4095	170	2	:	:	PUNCT
dpc-4095	170	3	34931698	34931698	NUM
dpc-4095	170	4	.	.	PUNCT
dpc-4095	171	1	19	19	NUM
dpc-4095	171	2	.	.	PUNCT
dpc-4095	172	1	lv	lv	PROPN
dpc-4095	172	2	s	s	PROPN
dpc-4095	172	3	,	,	PUNCT
dpc-4095	172	4	wang	wang	PROPN
dpc-4095	172	5	l	l	PROPN
dpc-4095	172	6	,	,	PUNCT
dpc-4095	172	7	zou	zou	PROPN
dpc-4095	172	8	x	x	PROPN
dpc-4095	172	9	,	,	PUNCT
dpc-4095	172	10	et	et	PROPN
dpc-4095	172	11	al	al	PROPN
dpc-4095	172	12	.	.	PUNCT
dpc-4095	173	1	a	a	DET
dpc-4095	173	2	case	case	NOUN
dpc-4095	173	3	of	of	ADP
dpc-4095	173	4	acute	acute	ADJ
dpc-4095	173	5	telogen	telogen	NOUN
dpc-4095	173	6	effluvium	effluvium	NOUN
dpc-4095	173	7	after	after	ADP
dpc-4095	173	8	sars	sar	NOUN
dpc-4095	173	9	-	-	PUNCT
dpc-4095	173	10	cov-2	cov-2	PART
dpc-4095	173	11	infection	infection	NOUN
dpc-4095	173	12	.	.	PUNCT
dpc-4095	174	1	clin	clin	PROPN
dpc-4095	174	2	cosmet	cosmet	PROPN
dpc-4095	174	3	investig	investig	NOUN
dpc-4095	174	4	dermatol	dermatol	NOUN
dpc-4095	174	5	.	.	PUNCT
dpc-4095	175	1	2021;14:385	2021;14:385	PROPN
dpc-4095	175	2	-	-	SYM
dpc-4095	175	3	387	387	NUM
dpc-4095	175	4	.	.	PUNCT
dpc-4095	175	5	doi	doi	NOUN
dpc-4095	175	6	:	:	PUNCT
dpc-4095	175	7	10.2147	10.2147	NUM
dpc-4095	175	8	/	/	SYM
dpc-4095	175	9	ccid.s307982	ccid.s307982	NOUN
dpc-4095	175	10	.	.	PUNCT
dpc-4095	176	1	pmid	pmid	NOUN
dpc-4095	176	2	:	:	PUNCT
dpc-4095	176	3	33889006	33889006	NUM
dpc-4095	176	4	;	;	PUNCT
dpc-4095	176	5	pmcid	pmcid	ADJ
dpc-4095	176	6	:	:	PUNCT
dpc-4095	176	7	pmc8057787	pmc8057787	NOUN
dpc-4095	176	8	.	.	PUNCT
dpc-4095	177	1	20	20	NUM
dpc-4095	177	2	.	.	X
dpc-4095	177	3	saber	saber	PROPN
dpc-4095	177	4	m	m	PROPN
dpc-4095	177	5	,	,	PUNCT
dpc-4095	177	6	mardani	mardani	PROPN
dpc-4095	177	7	e	e	NOUN
dpc-4095	177	8	,	,	PUNCT
dpc-4095	177	9	shahmoradi	shahmoradi	PROPN
dpc-4095	177	10	z.	z.	PROPN
dpc-4095	177	11	scalp	scalp	PROPN
dpc-4095	177	12	capillarectasia	capillarectasia	PROPN
dpc-4095	177	13	as	as	ADP
dpc-4095	177	14	a	a	DET
dpc-4095	177	15	trichoscopic	trichoscopic	NOUN
dpc-4095	177	16	sign	sign	NOUN
dpc-4095	177	17	of	of	ADP
dpc-4095	177	18	covid-19	covid-19	PROPN
dpc-4095	177	19	-	-	PUNCT
dpc-4095	177	20	associated	associate	VERB
dpc-4095	177	21	telogen	telogen	NOUN
dpc-4095	177	22	effluvium	effluvium	NOUN
dpc-4095	177	23	.	.	PUNCT
dpc-4095	178	1	j	j	PROPN
dpc-4095	178	2	cosmet	cosmet	PROPN
dpc-4095	178	3	dermatol	dermatol	NOUN
dpc-4095	178	4	.	.	PUNCT
dpc-4095	179	1	2023;00:1–2	2023;00:1–2	NUM
dpc-4095	179	2	.	.	PUNCT
dpc-4095	180	1	doi	doi	NOUN
dpc-4095	180	2	:	:	PUNCT
dpc-4095	180	3	10.1111	10.1111	NUM
dpc-4095	180	4	/	/	SYM
dpc-4095	180	5	jocd.15717	jocd.15717	PROPN
dpc-4095	180	6	.	.	PUNCT
dpc-4095	181	1	epub	epub	PROPN
dpc-4095	181	2	2023	2023	NUM
dpc-4095	181	3	mar	mar	PROPN
dpc-4095	181	4	9	9	NUM
dpc-4095	181	5	.	.	PUNCT
dpc-4095	182	1	pmid	pmid	NOUN
dpc-4095	182	2	:	:	PUNCT
dpc-4095	182	3	36896459	36896459	NUM
dpc-4095	182	4	.	.	PUNCT
dpc-4095	183	1	21	21	NUM
dpc-4095	183	2	.	.	PUNCT
dpc-4095	183	3	inamadar	inamadar	PROPN
dpc-4095	183	4	ac	ac	PROPN
dpc-4095	183	5	.	.	PUNCT
dpc-4095	184	1	covid	covid	PROPN
dpc-4095	184	2	induced	induce	VERB
dpc-4095	184	3	telogen	telogen	NOUN
dpc-4095	184	4	effluvium	effluvium	NOUN
dpc-4095	184	5	(	(	PUNCT
dpc-4095	184	6	cite	cite	VERB
dpc-4095	184	7	):	):	PUNCT
dpc-4095	184	8	an	an	DET
dpc-4095	184	9	insight	insight	NOUN
dpc-4095	184	10	.	.	PUNCT
dpc-4095	185	1	indian	indian	ADJ
dpc-4095	185	2	dermatol	dermatol	NOUN
dpc-4095	185	3	online	online	PROPN
dpc-4095	185	4	j.	j.	PROPN
dpc-4095	185	5	2022	2022	NUM
dpc-4095	185	6	jun	jun	PROPN
dpc-4095	185	7	24;13(4):445	24;13(4):445	PROPN
dpc-4095	185	8	-	-	SYM
dpc-4095	185	9	448	448	NUM
dpc-4095	185	10	.	.	PUNCT
dpc-4095	186	1	doi	doi	NOUN
dpc-4095	186	2	:	:	PUNCT
dpc-4095	186	3	10.4103	10.4103	NUM
dpc-4095	186	4	/	/	SYM
dpc-4095	186	5	idoj.idoj_139_22	idoj.idoj_139_22	PROPN
dpc-4095	186	6	.	.	PUNCT
dpc-4095	187	1	pmid	pmid	NOUN
dpc-4095	187	2	:	:	PUNCT
dpc-4095	187	3	36262583	36262583	NUM
dpc-4095	187	4	;	;	PUNCT
dpc-4095	187	5	pmcid	pmcid	ADJ
dpc-4095	187	6	:	:	PUNCT
dpc-4095	187	7	pmc9574152	pmc9574152	NOUN
dpc-4095	187	8	.	.	PUNCT
dpc-4095	188	1	22	22	NUM
dpc-4095	188	2	.	.	PUNCT
dpc-4095	189	1	grymowicz	grymowicz	PROPN
dpc-4095	189	2	m	m	PROPN
dpc-4095	189	3	,	,	PUNCT
dpc-4095	189	4	rudnicka	rudnicka	NOUN
dpc-4095	189	5	e	e	PROPN
dpc-4095	189	6	,	,	PUNCT
dpc-4095	189	7	podfigurna	podfigurna	VERB
dpc-4095	189	8	a	a	DET
dpc-4095	189	9	,	,	PUNCT
dpc-4095	189	10	et	et	PROPN
dpc-4095	189	11	al	al	PROPN
dpc-4095	189	12	.	.	PUNCT
dpc-4095	189	13	hormonal	hormonal	ADJ
dpc-4095	189	14	effects	effect	NOUN
dpc-4095	189	15	on	on	ADP
dpc-4095	189	16	hair	hair	NOUN
dpc-4095	189	17	follicles	follicle	NOUN
dpc-4095	189	18	.	.	PUNCT
dpc-4095	190	1	int	int	PROPN
dpc-4095	190	2	j	j	PROPN
dpc-4095	190	3	mol	mol	ADP
dpc-4095	190	4	sci	sci	PROPN
dpc-4095	190	5	.	.	PUNCT
dpc-4095	191	1	2020;21(15):5342	2020;21(15):5342	X
dpc-4095	191	2	.	.	PUNCT
dpc-4095	191	3	doi	doi	NOUN
dpc-4095	191	4	:	:	PUNCT
dpc-4095	191	5	10.3390	10.3390	NUM
dpc-4095	191	6	/ijms21155342	/ijms21155342	PUNCT
dpc-4095	191	7	.	.	PUNCT
dpc-4095	192	1	pmid	pmid	NOUN
dpc-4095	192	2	:	:	PUNCT
dpc-4095	192	3	32731328	32731328	NUM
dpc-4095	192	4	;	;	PUNCT
dpc-4095	192	5	pmcid	pmcid	ADJ
dpc-4095	192	6	:	:	PUNCT
dpc-4095	192	7	pmc7432488	pmc7432488	NOUN
dpc-4095	192	8	.	.	PUNCT
dpc-4095	193	1	23	23	NUM
dpc-4095	193	2	.	.	PUNCT
dpc-4095	194	1	aksoy	aksoy	PROPN
dpc-4095	194	2	h	h	PROPN
dpc-4095	194	3	,	,	PUNCT
dpc-4095	194	4	yıldırım	yıldırım	PROPN
dpc-4095	194	5	um	um	INTJ
dpc-4095	194	6	,	,	PUNCT
dpc-4095	194	7	ergen	ergen	PROPN
dpc-4095	194	8	p	p	X
dpc-4095	194	9	,	,	PUNCT
dpc-4095	194	10	et	et	PROPN
dpc-4095	194	11	al	al	PROPN
dpc-4095	194	12	.	.	PUNCT
dpc-4095	195	1	covid-19	covid-19	PROPN
dpc-4095	195	2	induced	induce	VERB
dpc-4095	195	3	telogen	telogen	NOUN
dpc-4095	195	4	effluvium	effluvium	NOUN
dpc-4095	195	5	.	.	PUNCT
dpc-4095	196	1	dermatol	dermatol	NOUN
dpc-4095	196	2	ther	ther	ADV
dpc-4095	196	3	.	.	PUNCT
dpc-4095	197	1	2021;34(6):e15175	2021;34(6):e15175	PRON
dpc-4095	197	2	.	.	PUNCT
dpc-4095	198	1	doi	doi	NOUN
dpc-4095	198	2	:	:	PUNCT
dpc-4095	198	3	10.1111	10.1111	NUM
dpc-4095	198	4	/	/	SYM
dpc-4095	198	5	dth	dth	ADJ
dpc-4095	198	6	.15175	.15175	PROPN
dpc-4095	198	7	.	.	PUNCT
dpc-4095	199	1	epub	epub	NOUN
dpc-4095	199	2	2021	2021	NUM
dpc-4095	199	3	nov	nov	NOUN
dpc-4095	199	4	6	6	NUM
dpc-4095	199	5	.	.	PUNCT
dpc-4095	200	1	pmid	pmid	NOUN
dpc-4095	200	2	:	:	PUNCT
dpc-4095	200	3	34708909	34708909	NUM
dpc-4095	200	4	;	;	PUNCT
dpc-4095	200	5	pmcid	pmcid	NOUN
dpc-4095	200	6	:	:	PUNCT
dpc-4095	200	7	pmc8646871	pmc8646871	PROPN
dpc-4095	200	8	.	.	PUNCT
dpc-4095	201	1	the	the	DET
dpc-4095	201	2	main	main	ADJ
dpc-4095	201	3	limitation	limitation	NOUN
dpc-4095	201	4	of	of	ADP
dpc-4095	201	5	the	the	DET
dpc-4095	201	6	study	study	NOUN
dpc-4095	201	7	is	be	AUX
dpc-4095	201	8	its	its	PRON
dpc-4095	201	9	retrospective	retrospective	ADJ
dpc-4095	201	10	design	design	NOUN
dpc-4095	201	11	.	.	PUNCT
dpc-4095	202	1	the	the	DET
dpc-4095	202	2	effects	effect	NOUN
dpc-4095	202	3	of	of	ADP
dpc-4095	202	4	systemic	systemic	ADJ
dpc-4095	202	5	drugs	drug	NOUN
dpc-4095	202	6	and	and	CCONJ
dpc-4095	202	7	sars	sar	NOUN
dpc-4095	202	8	-	-	PUNCT
dpc-4095	202	9	cov-2	cov-2	NOUN
dpc-4095	202	10	vaccines	vaccine	NOUN
dpc-4095	202	11	on	on	ADP
dpc-4095	202	12	cate	cate	NOUN
dpc-4095	202	13	and	and	CCONJ
dpc-4095	202	14	disease	disease	NOUN
dpc-4095	202	15	severity	severity	NOUN
dpc-4095	202	16	have	have	AUX
dpc-4095	202	17	not	not	PART
dpc-4095	202	18	been	be	AUX
dpc-4095	202	19	evaluated	evaluate	VERB
dpc-4095	202	20	.	.	PUNCT
dpc-4095	203	1	on	on	ADP
dpc-4095	203	2	the	the	DET
dpc-4095	203	3	other	other	ADJ
dpc-4095	203	4	hand	hand	NOUN
dpc-4095	203	5	,	,	PUNCT
dpc-4095	203	6	some	some	DET
dpc-4095	203	7	patients	patient	NOUN
dpc-4095	203	8	could	could	AUX
dpc-4095	203	9	associate	associate	VERB
dpc-4095	203	10	different	different	ADJ
dpc-4095	203	11	triggers	trigger	NOUN
dpc-4095	203	12	of	of	ADP
dpc-4095	203	13	te	te	PROPN
dpc-4095	203	14	at	at	ADP
dpc-4095	203	15	the	the	DET
dpc-4095	203	16	same	same	ADJ
dpc-4095	203	17	time	time	NOUN
dpc-4095	203	18	.	.	PUNCT
dpc-4095	204	1	different	different	ADJ
dpc-4095	204	2	trigger	trigger	NOUN
dpc-4095	204	3	factors	factor	NOUN
dpc-4095	204	4	could	could	AUX
dpc-4095	204	5	facilitate	facilitate	VERB
dpc-4095	204	6	hair	hair	NOUN
dpc-4095	204	7	loss	loss	NOUN
dpc-4095	204	8	and	and	CCONJ
dpc-4095	204	9	affect	affect	VERB
dpc-4095	204	10	clinical	clinical	ADJ
dpc-4095	204	11	and	and	CCONJ
dpc-4095	204	12	dermoscopic	dermoscopic	ADJ
dpc-4095	204	13	findings	finding	NOUN
dpc-4095	204	14	.	.	PUNCT
dpc-4095	205	1	in	in	ADP
dpc-4095	205	2	conclusion	conclusion	NOUN
dpc-4095	205	3	,	,	PUNCT
dpc-4095	205	4	cate	cate	PROPN
dpc-4095	205	5	is	be	AUX
dpc-4095	205	6	a	a	DET
dpc-4095	205	7	common	common	ADJ
dpc-4095	205	8	disease	disease	NOUN
dpc-4095	205	9	in	in	ADP
dpc-4095	205	10	patients	patient	NOUN
dpc-4095	205	11	with	with	ADP
dpc-4095	205	12	sars	sar	NOUN
dpc-4095	205	13	-	-	PUNCT
dpc-4095	205	14	cov-2	cov-2	NOUN
dpc-4095	205	15	,	,	PUNCT
dpc-4095	205	16	and	and	CCONJ
dpc-4095	205	17	the	the	DET
dpc-4095	205	18	clinical	clinical	ADJ
dpc-4095	205	19	presentation	presentation	NOUN
dpc-4095	205	20	of	of	ADP
dpc-4095	205	21	cate	cate	NOUN
dpc-4095	205	22	is	be	AUX
dpc-4095	205	23	more	more	ADV
dpc-4095	205	24	acute	acute	ADJ
dpc-4095	205	25	than	than	ADP
dpc-4095	205	26	the	the	DET
dpc-4095	205	27	other	other	ADJ
dpc-4095	205	28	reasons	reason	NOUN
dpc-4095	205	29	for	for	ADP
dpc-4095	205	30	te	te	PROPN
dpc-4095	205	31	.	.	PUNCT
dpc-4095	205	32	dermoscopic	dermoscopic	PROPN
dpc-4095	205	33	findings	finding	NOUN
dpc-4095	205	34	such	such	ADJ
dpc-4095	205	35	as	as	ADP
dpc-4095	205	36	empty	empty	ADJ
dpc-4095	205	37	follicular	follicular	ADJ
dpc-4095	205	38	openings	opening	NOUN
dpc-4095	205	39	and	and	CCONJ
dpc-4095	205	40	yellow	yellow	ADJ
dpc-4095	205	41	dots	dot	NOUN
dpc-4095	205	42	may	may	AUX
dpc-4095	205	43	help	help	VERB
dpc-4095	205	44	clinicians	clinician	NOUN
dpc-4095	205	45	in	in	ADP
dpc-4095	205	46	diagnosis	diagnosis	NOUN
dpc-4095	205	47	.	.	PUNCT
dpc-4095	206	1	references	reference	NOUN
dpc-4095	206	2	1	1	NUM
dpc-4095	206	3	.	.	PUNCT
dpc-4095	207	1	headington	headington	PROPN
dpc-4095	207	2	jt	jt	PROPN
dpc-4095	207	3	.	.	PUNCT
dpc-4095	207	4	telogen	telogen	PROPN
dpc-4095	207	5	effluvium	effluvium	NOUN
dpc-4095	207	6	.	.	PUNCT
dpc-4095	208	1	new	new	ADJ
dpc-4095	208	2	concepts	concept	NOUN
dpc-4095	208	3	and	and	CCONJ
dpc-4095	208	4	review	review	NOUN
dpc-4095	208	5	.	.	PUNCT
dpc-4095	209	1	arch	arch	ADJ
dpc-4095	209	2	dermatol	dermatol	NOUN
dpc-4095	209	3	.	.	PUNCT
dpc-4095	210	1	1993;129(3):356	1993;129(3):356	NUM
dpc-4095	210	2	-	-	SYM
dpc-4095	210	3	363	363	NUM
dpc-4095	210	4	.	.	PUNCT
dpc-4095	211	1	doi	doi	NOUN
dpc-4095	211	2	:	:	PUNCT
dpc-4095	211	3	10.1001	10.1001	NUM
dpc-4095	211	4	/	/	SYM
dpc-4095	211	5	archderm.129.3	archderm.129.3	PROPN
dpc-4095	211	6	.356	.356	NUM
dpc-4095	211	7	.	.	PUNCT
dpc-4095	212	1	pmid	pmid	NOUN
dpc-4095	212	2	:	:	PUNCT
dpc-4095	212	3	8447677	8447677	NUM
dpc-4095	212	4	.	.	PUNCT
dpc-4095	213	1	2	2	X
dpc-4095	213	2	.	.	X
dpc-4095	213	3	turkmen	turkmen	PROPN
dpc-4095	213	4	d	d	PROPN
dpc-4095	213	5	,	,	PUNCT
dpc-4095	213	6	altunisik	altunisik	ADJ
dpc-4095	213	7	n	n	CCONJ
dpc-4095	213	8	,	,	PUNCT
dpc-4095	213	9	sener	sener	NOUN
dpc-4095	213	10	s	s	PROPN
dpc-4095	213	11	,	,	PUNCT
dpc-4095	213	12	et	et	PROPN
dpc-4095	213	13	al	al	PROPN
dpc-4095	213	14	.	.	PUNCT
dpc-4095	213	15	evaluation	evaluation	NOUN
dpc-4095	213	16	of	of	ADP
dpc-4095	213	17	the	the	DET
dpc-4095	213	18	effects	effect	NOUN
dpc-4095	213	19	of	of	ADP
dpc-4095	213	20	covid-19	covid-19	PROPN
dpc-4095	213	21	pandemic	pandemic	ADJ
dpc-4095	213	22	on	on	ADP
dpc-4095	213	23	hair	hair	NOUN
dpc-4095	213	24	diseases	disease	NOUN
dpc-4095	213	25	through	through	ADP
dpc-4095	213	26	a	a	DET
dpc-4095	213	27	web	web	NOUN
dpc-4095	213	28	-	-	PUNCT
dpc-4095	213	29	based	base	VERB
dpc-4095	213	30	questionnaire	questionnaire	NOUN
dpc-4095	213	31	.	.	PUNCT
dpc-4095	214	1	dermatol	dermatol	NOUN
dpc-4095	214	2	ther	ther	ADV
dpc-4095	214	3	.	.	PUNCT
dpc-4095	215	1	2020;33	2020;33	NUM
dpc-4095	215	2	:	:	PUNCT
dpc-4095	215	3	e13923	e13923	PROPN
dpc-4095	215	4	.	.	PUNCT
dpc-4095	216	1	doi	doi	PROPN
dpc-4095	216	2	:	:	PUNCT
dpc-4095	216	3	10.1111/	10.1111/	NUM
dpc-4095	216	4	dth.13923	dth.13923	X
dpc-4095	216	5	.	.	PUNCT
dpc-4095	217	1	pmid	pmid	NOUN
dpc-4095	217	2	:	:	PUNCT
dpc-4095	217	3	32594627	32594627	NUM
dpc-4095	217	4	.	.	PUNCT
dpc-4095	218	1	pmcid	pmcid	NOUN
dpc-4095	218	2	:	:	PUNCT
dpc-4095	218	3	pmc7361059	pmc7361059	NOUN
dpc-4095	218	4	.	.	PUNCT
dpc-4095	219	1	3	3	X
dpc-4095	219	2	.	.	X
dpc-4095	219	3	aryanian	aryanian	PROPN
dpc-4095	219	4	z	z	PROPN
dpc-4095	219	5	,	,	PUNCT
dpc-4095	219	6	balighi	balighi	PROPN
dpc-4095	219	7	k	k	PROPN
dpc-4095	219	8	,	,	PUNCT
dpc-4095	219	9	hatami	hatami	NOUN
dpc-4095	219	10	p	p	PROPN
dpc-4095	219	11	,	,	PUNCT
dpc-4095	219	12	et	et	PROPN
dpc-4095	219	13	al	al	PROPN
dpc-4095	219	14	.	.	PUNCT
dpc-4095	220	1	the	the	DET
dpc-4095	220	2	role	role	NOUN
dpc-4095	220	3	of	of	ADP
dpc-4095	220	4	sars	sar	NOUN
dpc-4095	220	5	-	-	PUNCT
dpc-4095	220	6	cov-2	cov-2	PART
dpc-4095	220	7	infection	infection	NOUN
dpc-4095	220	8	and	and	CCONJ
dpc-4095	220	9	its	its	PRON
dpc-4095	220	10	vaccines	vaccine	NOUN
dpc-4095	220	11	in	in	ADP
dpc-4095	220	12	various	various	ADJ
dpc-4095	220	13	types	type	NOUN
dpc-4095	220	14	of	of	ADP
dpc-4095	220	15	hair	hair	NOUN
dpc-4095	220	16	loss	loss	NOUN
dpc-4095	220	17	.	.	PUNCT
dpc-4095	221	1	dermatol	dermatol	NOUN
dpc-4095	221	2	ther	ther	ADV
dpc-4095	221	3	.	.	PUNCT
dpc-4095	222	1	2022;35(6):e15433	2022;35(6):e15433	X
dpc-4095	222	2	.	.	PUNCT
dpc-4095	222	3	doi	doi	NOUN
dpc-4095	222	4	:	:	PUNCT
dpc-4095	222	5	10.1111	10.1111	NUM
dpc-4095	222	6	/	/	SYM
dpc-4095	222	7	dth.15433	dth.15433	PROPN
dpc-4095	222	8	.	.	PUNCT
dpc-4095	223	1	epub	epub	NOUN
dpc-4095	223	2	2022	2022	NUM
dpc-4095	223	3	apr	apr	NOUN
dpc-4095	223	4	1	1	NUM
dpc-4095	223	5	.	.	PUNCT
dpc-4095	224	1	pmid	pmid	NOUN
dpc-4095	224	2	:	:	PUNCT
dpc-4095	224	3	35266262	35266262	NUM
dpc-4095	224	4	;	;	PUNCT
dpc-4095	224	5	pmcid	pmcid	PROPN
dpc-4095	224	6	:	:	PUNCT
dpc-4095	224	7	pmc9111640	pmc9111640	ADJ
dpc-4095	224	8	.	.	PUNCT
dpc-4095	225	1	4	4	X
dpc-4095	225	2	.	.	X
dpc-4095	225	3	hernández	hernández	PROPN
dpc-4095	225	4	arroyo	arroyo	PROPN
dpc-4095	225	5	j	j	PROPN
dpc-4095	225	6	,	,	PUNCT
dpc-4095	225	7	izquierdo	izquierdo	PROPN
dpc-4095	225	8	-	-	PUNCT
dpc-4095	225	9	condoy	condoy	NOUN
dpc-4095	225	10	js	js	PROPN
dpc-4095	225	11	,	,	PUNCT
dpc-4095	225	12	ortiz	ortiz	PROPN
dpc-4095	225	13	-	-	PUNCT
dpc-4095	225	14	prado	prado	PROPN
dpc-4095	226	1	e.	e.	PROPN
dpc-4095	227	1	a	a	DET
dpc-4095	227	2	case	case	NOUN
dpc-4095	227	3	series	series	NOUN
dpc-4095	227	4	and	and	CCONJ
dpc-4095	227	5	literature	literature	PROPN
dpc-4095	227	6	review	review	NOUN
dpc-4095	227	7	of	of	ADP
dpc-4095	227	8	telogen	telogen	NOUN
dpc-4095	227	9	effluvium	effluvium	NOUN
dpc-4095	227	10	and	and	CCONJ
dpc-4095	227	11	alopecia	alopecia	NOUN
dpc-4095	227	12	universalis	universali	VERB
dpc-4095	227	13	after	after	ADP
dpc-4095	227	14	the	the	DET
dpc-4095	227	15	administration	administration	NOUN
dpc-4095	227	16	of	of	ADP
dpc-4095	227	17	a	a	DET
dpc-4095	227	18	heterologous	heterologous	ADJ
dpc-4095	227	19	covid-19	covid-19	PROPN
dpc-4095	227	20	vaccine	vaccine	NOUN
dpc-4095	227	21	scheme	scheme	NOUN
dpc-4095	227	22	.	.	PUNCT
dpc-4095	228	1	vaccines	vaccine	NOUN
dpc-4095	228	2	(	(	PUNCT
dpc-4095	228	3	basel	basel	PROPN
dpc-4095	228	4	)	)	PUNCT
dpc-4095	228	5	.	.	PUNCT
dpc-4095	229	1	2023;11(2):444	2023;11(2):444	NUM
dpc-4095	229	2	.	.	PUNCT
dpc-4095	230	1	doi	doi	NOUN
dpc-4095	230	2	:	:	PUNCT
dpc-4095	230	3	10.3390	10.3390	NUM
dpc-4095	230	4	/	/	SYM
dpc-4095	230	5	vaccines11020444	vaccines11020444	PROPN
dpc-4095	230	6	.	.	PUNCT
dpc-4095	231	1	pmid	pmid	NOUN
dpc-4095	231	2	:	:	PUNCT
dpc-4095	231	3	36851320	36851320	NUM
dpc-4095	231	4	;	;	PUNCT
dpc-4095	231	5	pmcid	pmcid	NOUN
dpc-4095	231	6	:	:	PUNCT
dpc-4095	231	7	pmc9968192	pmc9968192	VERB
dpc-4095	231	8	.	.	PUNCT
dpc-4095	232	1	5	5	X
dpc-4095	232	2	.	.	X
dpc-4095	232	3	guarnieri	guarnieri	PROPN
dpc-4095	232	4	g	g	PROPN
dpc-4095	232	5	,	,	PUNCT
dpc-4095	232	6	bertagna	bertagna	PROPN
dpc-4095	232	7	de	de	PROPN
dpc-4095	232	8	marchi	marchi	PROPN
dpc-4095	232	9	l	l	PROPN
dpc-4095	232	10	,	,	PUNCT
dpc-4095	232	11	marcon	marcon	PROPN
dpc-4095	232	12	a	a	X
dpc-4095	232	13	,	,	PUNCT
dpc-4095	232	14	et	et	PROPN
dpc-4095	232	15	al	al	PROPN
dpc-4095	232	16	.	.	PROPN
dpc-4095	232	17	relationship	relationship	NOUN
dpc-4095	232	18	between	between	ADP
dpc-4095	232	19	hair	hair	NOUN
dpc-4095	232	20	shedding	shed	VERB
dpc-4095	232	21	and	and	CCONJ
dpc-4095	232	22	systemic	systemic	ADJ
dpc-4095	232	23	inflammation	inflammation	NOUN
dpc-4095	232	24	in	in	ADP
dpc-4095	232	25	covid-19	covid-19	PROPN
dpc-4095	232	26	pneumonia	pneumonia	NOUN
dpc-4095	232	27	.	.	PUNCT
dpc-4095	233	1	ann	ann	PROPN
dpc-4095	233	2	med	med	PROPN
dpc-4095	233	3	.	.	PUNCT
dpc-4095	234	1	2022;54(1):869	2022;54(1):869	NUM
dpc-4095	234	2	-	-	PUNCT
dpc-4095	234	3	874	874	NUM
dpc-4095	234	4	.	.	PUNCT
dpc-4095	235	1	doi	doi	NOUN
dpc-4095	235	2	:	:	PUNCT
dpc-4095	235	3	10.1080/07853890.2022.2054026	10.1080/07853890.2022.2054026	NUM
dpc-4095	235	4	.	.	PUNCT
dpc-4095	236	1	pmid	pmid	NOUN
dpc-4095	236	2	:	:	PUNCT
dpc-4095	236	3	35341398	35341398	NUM
dpc-4095	236	4	;	;	PUNCT
dpc-4095	236	5	pmcid	pmcid	NOUN
dpc-4095	236	6	:	:	PUNCT
dpc-4095	236	7	pmc8959503	pmc8959503	ADJ
dpc-4095	236	8	.	.	PUNCT
dpc-4095	237	1	6	6	X
dpc-4095	237	2	.	.	X
dpc-4095	237	3	olds	old	NOUN
dpc-4095	237	4	h	h	PROPN
dpc-4095	237	5	,	,	PUNCT
dpc-4095	237	6	liu	liu	PROPN
dpc-4095	237	7	j	j	PROPN
dpc-4095	237	8	,	,	PUNCT
dpc-4095	237	9	luk	luk	PROPN
dpc-4095	237	10	k.	k.	PROPN
dpc-4095	237	11	et	et	PROPN
dpc-4095	237	12	al	al	PROPN
dpc-4095	237	13	.	.	PROPN
dpc-4095	237	14	telogen	telogen	PROPN
dpc-4095	237	15	effluvium	effluvium	NOUN
dpc-4095	237	16	associated	associate	VERB
dpc-4095	237	17	with	with	ADP
dpc-4095	237	18	covid-19	covid-19	PROPN
dpc-4095	237	19	infection	infection	NOUN
dpc-4095	237	20	.	.	PUNCT
dpc-4095	238	1	dermatol	dermatol	NOUN
dpc-4095	238	2	ther	ther	ADV
dpc-4095	238	3	.	.	PUNCT
dpc-4095	239	1	2021;34(2):e14761	2021;34(2):e14761	X
dpc-4095	239	2	.	.	PUNCT
dpc-4095	239	3	doi:10.1111	doi:10.1111	ADJ
dpc-4095	239	4	/	/	SYM
dpc-4095	239	5	dth.14761	dth.14761	NOUN
dpc-4095	239	6	.	.	PUNCT
dpc-4095	240	1	epub	epub	NOUN
dpc-4095	240	2	2021	2021	NUM
dpc-4095	240	3	jan	jan	PROPN
dpc-4095	240	4	14	14	NUM
dpc-4095	240	5	.	.	PUNCT
dpc-4095	241	1	pmid	pmid	NOUN
dpc-4095	241	2	:	:	PUNCT
dpc-4095	241	3	33405302	33405302	NUM
dpc-4095	241	4	;	;	PUNCT
dpc-4095	241	5	pmcid	pmcid	PROPN
dpc-4095	241	6	:	:	PUNCT
dpc-4095	241	7	pmc7883200	pmc7883200	PROPN
dpc-4095	241	8	.	.	PUNCT
dpc-4095	242	1	7	7	X
dpc-4095	242	2	.	.	X
dpc-4095	242	3	starace	starace	PROPN
dpc-4095	242	4	m	m	PROPN
dpc-4095	242	5	,	,	PUNCT
dpc-4095	242	6	iorizzo	iorizzo	VERB
dpc-4095	242	7	m	m	PROPN
dpc-4095	242	8	,	,	PUNCT
dpc-4095	242	9	sechi	sechi	PROPN
dpc-4095	242	10	a	a	PROPN
dpc-4095	242	11	,	,	PUNCT
dpc-4095	242	12	et	et	PROPN
dpc-4095	242	13	al	al	PROPN
dpc-4095	242	14	.	.	PUNCT
dpc-4095	243	1	trichodynia	trichodynia	PROPN
dpc-4095	243	2	and	and	CCONJ
dpc-4095	243	3	telogen	telogen	NOUN
dpc-4095	243	4	effluvium	effluvium	NOUN
dpc-4095	243	5	in	in	ADP
dpc-4095	243	6	covid-19	covid-19	PROPN
dpc-4095	243	7	patients	patient	NOUN
dpc-4095	243	8	:	:	PUNCT
dpc-4095	243	9	results	result	NOUN
dpc-4095	243	10	of	of	ADP
dpc-4095	243	11	an	an	DET
dpc-4095	243	12	international	international	ADJ
dpc-4095	243	13	expert	expert	NOUN
dpc-4095	243	14	opinion	opinion	NOUN
dpc-4095	243	15	survey	survey	NOUN
dpc-4095	243	16	on	on	ADP
dpc-4095	243	17	diagnosis	diagnosis	NOUN
dpc-4095	243	18	and	and	CCONJ
dpc-4095	243	19	management	management	NOUN
dpc-4095	243	20	.	.	PUNCT
dpc-4095	244	1	jaad	jaad	PROPN
dpc-4095	244	2	int	int	PROPN
dpc-4095	244	3	.	.	PUNCT
dpc-4095	245	1	2021;5:11	2021;5:11	PROPN
dpc-4095	245	2	-	-	PUNCT
dpc-4095	245	3	18	18	NUM
dpc-4095	245	4	.	.	PUNCT
dpc-4095	246	1	doi	doi	NOUN
dpc-4095	246	2	:	:	PUNCT
dpc-4095	246	3	10.1016	10.1016	NUM
dpc-4095	246	4	/	/	SYM
dpc-4095	246	5	j.jdin.2021.07.006	j.jdin.2021.07.006	PROPN
dpc-4095	246	6	.	.	PUNCT
dpc-4095	247	1	epub	epub	PROPN
dpc-4095	247	2	2021	2021	NUM
dpc-4095	247	3	aug	aug	PROPN
dpc-4095	247	4	3	3	NUM
dpc-4095	247	5	.	.	PUNCT
dpc-4095	248	1	pmid	pmid	NOUN
dpc-4095	248	2	:	:	PUNCT
dpc-4095	248	3	34368790	34368790	NUM
dpc-4095	248	4	;	;	PUNCT
dpc-4095	248	5	pmcid	pmcid	ADJ
dpc-4095	248	6	:	:	PUNCT
dpc-4095	248	7	pmc8328568	pmc8328568	NOUN
dpc-4095	248	8	.	.	PUNCT
dpc-4095	249	1	8	8	X
dpc-4095	249	2	.	.	X
dpc-4095	249	3	babaei	babaei	PROPN
dpc-4095	249	4	k	k	PROPN
dpc-4095	249	5	,	,	PUNCT
dpc-4095	249	6	kavoussi	kavoussi	PROPN
dpc-4095	249	7	h	h	PROPN
dpc-4095	249	8	,	,	PUNCT
dpc-4095	249	9	rezaei	rezaei	PROPN
dpc-4095	249	10	m	m	PROPN
dpc-4095	249	11	,	,	PUNCT
dpc-4095	249	12	et	et	PROPN
dpc-4095	249	13	.	.	PUNCT
dpc-4095	250	1	al	al	PROPN
dpc-4095	250	2	characteristics	characteristic	NOUN
dpc-4095	250	3	of	of	ADP
dpc-4095	250	4	telogen	telogen	NOUN
dpc-4095	250	5	efflivium	efflivium	NOUN
dpc-4095	250	6	in	in	ADP
dpc-4095	250	7	covid-19	covid-19	PROPN
dpc-4095	250	8	in	in	ADP
dpc-4095	250	9	western	western	ADJ
dpc-4095	250	10	iran	iran	PROPN
dpc-4095	250	11	(	(	PUNCT
dpc-4095	250	12	2020	2020	NUM
dpc-4095	250	13	)	)	PUNCT
dpc-4095	250	14	.	.	PUNCT
dpc-4095	251	1	an	an	DET
dpc-4095	251	2	bras	bras	NOUN
dpc-4095	251	3	dermatol	dermatol	NOUN
dpc-4095	251	4	.	.	PUNCT
dpc-4095	252	1	2021	2021	NUM
dpc-4095	252	2	nov	nov	NOUN
dpc-4095	252	3	-	-	PUNCT
dpc-4095	252	4	dec;96(6):688	dec;96(6):688	ADP
dpc-4095	252	5	-	-	PUNCT
dpc-4095	252	6	692	692	NUM
dpc-4095	252	7	.	.	PUNCT
dpc-4095	253	1	doi	doi	NOUN
dpc-4095	253	2	:	:	PUNCT
dpc-4095	253	3	10.1016	10.1016	NUM
dpc-4095	253	4	/	/	SYM
dpc-4095	253	5	j.abd	j.abd	PROPN
dpc-4095	253	6	.2021.05.006	.2021.05.006	PROPN
dpc-4095	253	7	.	.	PUNCT
dpc-4095	254	1	epub	epub	NOUN
dpc-4095	254	2	2021	2021	NUM
dpc-4095	254	3	sep	sep	PROPN
dpc-4095	254	4	15	15	NUM
dpc-4095	254	5	.	.	PUNCT
dpc-4095	255	1	pmid	pmid	NOUN
dpc-4095	255	2	:	:	PUNCT
dpc-4095	255	3	34593265	34593265	NUM
dpc-4095	255	4	;	;	PUNCT
dpc-4095	255	5	pmcid	pmcid	ADJ
dpc-4095	255	6	:	:	PUNCT
dpc-4095	255	7	pmc8440166	pmc8440166	NOUN
dpc-4095	255	8	.	.	PUNCT
dpc-4095	256	1	9	9	X
dpc-4095	256	2	.	.	X
dpc-4095	256	3	moreno	moreno	PROPN
dpc-4095	256	4	-	-	PUNCT
dpc-4095	256	5	arrones	arrones	PROPN
dpc-4095	256	6	om	om	NOUN
dpc-4095	256	7	,	,	PUNCT
dpc-4095	256	8	lobato	lobato	PROPN
dpc-4095	256	9	-	-	PUNCT
dpc-4095	256	10	berezo	berezo	PROPN
dpc-4095	256	11	a	a	PRON
dpc-4095	256	12	,	,	PUNCT
dpc-4095	256	13	gomez	gomez	NOUN
dpc-4095	256	14	-	-	PUNCT
dpc-4095	256	15	zubiaur	zubiaur	PROPN
dpc-4095	256	16	a	a	NOUN
dpc-4095	256	17	,	,	PUNCT
dpc-4095	256	18	et	et	PROPN
dpc-4095	256	19	  	  	SPACE
dpc-4095	256	20	al	al	PROPN
dpc-4095	256	21	.	.	PUNCT
dpc-4095	257	1	sars	sars	PROPN
dpc-4095	257	2	-	-	PUNCT
dpc-4095	257	3	cov-2	cov-2	ADV
dpc-4095	257	4	-	-	PUNCT
dpc-4095	257	5	induced	induced	ADJ
dpc-4095	257	6	telogen	telogen	NOUN
dpc-4095	257	7	effluvium	effluvium	NOUN
dpc-4095	257	8	:	:	PUNCT
dpc-4095	257	9	a	a	DET
dpc-4095	257	10	multicentric	multicentric	ADJ
dpc-4095	257	11	study	study	NOUN
dpc-4095	257	12	.	.	PUNCT
dpc-4095	258	1	j	j	PROPN
dpc-4095	258	2	eur	eur	PROPN
dpc-4095	258	3	acad	acad	PROPN
dpc-4095	258	4	dermatol	dermatol	NOUN
dpc-4095	258	5	venereol	venereol	NOUN
dpc-4095	258	6	.	.	PUNCT
dpc-4095	259	1	2021;35(3):e181	2021;35(3):e181	X
dpc-4095	259	2	-	-	PUNCT
dpc-4095	259	3	e183	e183	PROPN
dpc-4095	259	4	.	.	PUNCT
dpc-4095	259	5	doi	doi	NOUN
dpc-4095	259	6	:	:	PUNCT
dpc-4095	259	7	10.1111	10.1111	NUM
dpc-4095	259	8	/	/	SYM
dpc-4095	259	9	jdv.17045	jdv.17045	PROPN
dpc-4095	259	10	.	.	PUNCT
dpc-4095	260	1	epub	epub	NOUN
dpc-4095	260	2	2020	2020	NUM
dpc-4095	260	3	dec	dec	PROPN
dpc-4095	260	4	9	9	NUM
dpc-4095	260	5	.	.	PUNCT
dpc-4095	261	1	pmid	pmid	NOUN
dpc-4095	261	2	:	:	PUNCT
dpc-4095	261	3	33220124	33220124	NUM
dpc-4095	261	4	;	;	PUNCT
dpc-4095	261	5	pmcid	pmcid	PROPN
dpc-4095	261	6	:	:	PUNCT
dpc-4095	261	7	pmc7753386	pmc7753386	PROPN
dpc-4095	261	8	.	.	PUNCT